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August, 2014 
Abstract 
Background 
Low grade systemic inflammation plays a key role in atherosclerosis, and C-reactive 
protein (hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor- alpha (TNF -a), 
markers of systemic inflammation, are associated with cardiovascular events and 
adiposity. Cardiorespiratory fitness has shown health benefits by reducing circulating 
levels of inflammatory markers. However, it remains uncertain whether the negative 
association between cardiorespiratory fitness and inflammatory biomarkers is due to 
cardiorespiratory fitness itself or results from lower levels of adiposity. Moreover, the 
evidence examining the interaction between cardiorespiratory fitness and adiposity in 
inflammation in young adults is lacking. 
Purpose 
The aims of this study were to (1) determine the strength of the associations of 
cardiorespiratory fitness and adiposity (body mass index [BMI], waist circumference 
[WC]) with circulating levels of plasma hs-CRP, IL-6, and TNF-a; and (2) test the 
moderating effect of adiposity on the strength of the association between 
cardiorespiratory fitness and circulating levels of plasma hs-CRP, IL-6, and TNF -a. 
Methods 
A cross-sectional study was conducted with 88 young adults aged 20-34 years without 
diagnosed diseases. A submaximal treadmill walking test was used to assess 
v 
cardiorespiratory fitness. BMI and WC were measured to assess adiposity. The hs-CRP, 
IL-6 and TNF-a were assayed and were log10-transformed. For aim one, a separate 
multiple regression analysis was conducted with each ofhs-CRP, IL-6, and TNF-a as 
dependent variables and adjusted for confounders. Analysis of covariance (ANCOVA) 
was used and adjusted for confounders for aim two. Confounding variables tested were 
sex, ethnicity, oral contraceptive use, and education level. 
Results 
Aiml: Cardiorespiratory fitness was not significantly associated with log1ohs-CRP after 
adjustment for BMI or WC and confounders. Cardiorespiratory fitness was not 
significantly associated with log10IL-6 after adjustment for BMI and confounders. 
However, cardiorespiratory fitness was significantly and negatively associated with 
log10IL-6 after adjustment for WC and confounders (Model adjusted R2 =.273,p < .0001; 
p = -.341, t = -1.995,p =.049). Aim 2: Cardiorespiratory fitness X BMI or we interaction 
was not significantly associated with log10hs-CRP after adjustment for confounders. 
Similarly, cardiorespiratory fitness x BMI interaction was not significantly associated 
with log10IL-6 after adjustment for confounders. However, cardiorespiratory fitness x 
WC interaction was significantly associated with log10IL-6 after adjustment for 
confounders (Model adjusted R2 = .258,p < .0001; partial eta2 =.056, F = 4.730,p = 
.033). There were no associations of cardiorespiratory fitness, adiposity, and log10 TNF-a. 
Conclusions 
In young adults, higher cardiorespiratory fitness is significantly associated with lower 
levels of IL-6, particularly in young adults with central adiposity. Further studies are 
warranted to determine if experimentally induced increases in cardiorespiratory fitness 
Vl 
reduce inflammatory markers in young adults. Longitudinal studies are needed to 
understand the underlying inflammatory mechanisms related to interaction between 
cardiorespiratory fitness and adiposity, and its influence on cardiovascular disease risk in 
young adults. 
Vll 
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Summary of Study 
The dissertation consists of the proposal, two manuscripts reporting study results, 
and appendixes. The proposal consists of specific aims, research strategy, facilities/ 
resources/ consultants, and human subject concerns. Two manuscripts are included: 
manuscript 1. Anthropometric Adiposity Measures and Inflammatory Biomarkers in 
Adolescents and Young Adults: A Systematic Review and manuscript 2. Association of 
Cardiorespiratory Fitness and Adiposity with Inflammatory Biomarkers in Young Adults: 
dissertation. 
Manuscript 1 is the systematic review on the associations between anthropometric 
adiposity measures (BMI, WC, WHR, WHtR, and BF%) and inflammatory biomarkers 
( CRP, IL-6, and TNF -a) in adolescents and young adults. This review found that 
anthropometric adiposity measures are positively associated with CRP in adolescents and 
young adults. However, anthropometric adiposity measures and IL-6 and TNF-a in 
adolescents and young adults is inconclusive. Additional studies are needed to identify 
the strength and patterns of association of anthropometric adiposity measures with CRP, 
IL-6 and TNF-a. 
Manuscript 2 is a dissertation study. This cross-sectional study is to ( 1) determine 
the strength of the associations of cardiorespiratory fitness and adiposity (body mass 
index [BMI], waist circumference [WC]) with circulating levels of plasma hs-CRP, IL-6, 
and TNF -a; and (2) test the moderating effect of adiposity on the strength of the 
association between cardiorespiratory fitness and circulating levels of plasma hs-CRP, 
IL-6, and TNF-a. This study found that in young adults, higher cardiorespiratory fitness 
is significantly associated with lower levels of IL-6, particularly in young adults with 
central adiposity. Further studies are warranted to determine if experimentally induced 
increases in cardiorespiratory fitness reduce inflammatory markers in young adults. 
Appendices include study protocols, IRB approval letters and human subject 
concerns. Curriculum vitae constitute the final section of the dissertation. 
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Abstract 
Purpose: The proposed study is to investigate the association of cardiorespiratory fitness 
(CRF) and adiposity with inflammatory biomarkers in healthy young adults. Specific 
aims are ( 1) to determine· the strength of the association between CRF levels with 
circulating levels of plasma high sensitivity C-reactive protein (hs-CRP), interleukin-6 
(IL-6), and tumor necrosis factor- alpha (TNF-a); (2) to determine the strength of the 
association between adiposity levels and circulating levels of plasma hs-CRP, IL-6, and 
TNF-a; and (3) to test the moderating effect of adiposity on the strength of the 
association between CRF levels and circulating levels of plasma hs-CRP, IL-6, and TNF-
a. 
Significance: Atherosclerotic cardiovascular disease is a significant public health 
concern. Low grade chronic vascular inflammation plays a key role in atherosclerosis. 
CRF has shown health benefits by reducing circulating levels of inflammatory markers. 
However, it is uncertain whether the beneficial effect of CRF derives from the CRF itself 
or from inadequate adjustment for adiposity. Moreover, the evidence examining adiposity 
as a modifier of this association in young adults is lacking. 
Methods: A cross-sectional analytic design will be conducted to achieve the three 
specific aims. Participants will be recruited through flyers and emails. Inclusion criteria 
include young adults aged 20-34 years old, healthy (without diagnosis of disease), being 
capable of completing the CRF testing, and not using any hormonal therapy. After 
screening for eligibility, 88 participants will be enrolled and they will be scheduled for a 
data collection session. Data will be collected on each participant through CRF testing, 
anthropometric measurement and blood sampling of inflammatory biomarkers in one 
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session at the University of Texas Health Science Center at Houston School of Nursing. 
CRF will be estimate by a submaximal treadmill test and adiposity will be assessed by 
body mass index and waist circumference. Inflammatory markers will be measured by 
enzyme-linked immunosorbent assay (ELISA). Separate analyses will be conducted with 
each of the inflammatory markers (hs-CRP, IL-6, and TNF-a) as the dependent variable 
in multiple linear regression for aims one and two. Multiple linear regression models, 
with interaction terms (CRF x BMI) (CRF x waist circumference) will be addressed to 
assess aim three. 
Nursing Implications: This information provides more accurate evaluation and 
interpretation of inflammatory biomarkers in clinical practice as related to CRF and 
adiposity. Additionally, these finding will be useful in understanding the physiological 
mechanisms ofCRF, adiposity, and inflammatory biomarkers, which contributes to 
decreased atherosclerosis risk. Lastly, these findings will be useful in in planning 
preventive strategies to reduce low-grade chronic inflammation in obese as well as 
healthy weight young adults, which in turn delay the progression of atherosclerosis and 
reduce the risk of CVD events. 
Specific Aims 
Chronic, low-grade vascular inflammation plays a key role in the initiation and 
progression of atherosclerosis (Packard & Libby, 2008). C-reactive protein (hs-CRP), 
interleukin-6 {IL-6), and tumor necrosis factor-a. (TNF -a.) have been documented as the 
major inflammatory markers associated with atherosclerotic progression and events 
(Packard & Libby, 2008). It has demonstrated that atherosclerotic lesions begin early in 
life albeit clinical manifestations are not observed until symptoms occur in later life 
(Loria et al., 2007). 
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Cardiorespiratory fitness (CRF) has shown health benefits in reducing circulating 
levels of inflammatory markers, but it is still uncertain whether there is a definitive link 
between CRF and inflammatory biomarkers in healthy young adults (Hamer, 2007). 
There is also evidence that adiposity might be a factor attenuating the link of CRF with 
low grade inflammation (Hamer, 2007). However, no previous studies have examined the 
interplay of CRF and adiposity on inflammatory biomakers in healthy young adults. 
In this proposed study, the principal investigator (PI) will examine the associations of 
CRF and adiposity with inflammatory biomarkers and the interaction of CRF and 
adiposity on inflammatory biomarkers in healthy young adults aged 20 to 34 years. 
Adiposity is defined as body mass index (BMI) and waist circumference in this study. 
The PI will pursue the main purpose of this study through three specific aims as follows: 
Aiml. To determine the strength of the association between CRF levels with 
circulating levels of plasma hs-CRP, IL-6, and TNF-a.. Hypothesis: Higher levels 
of CRF will be related to lower levels of circulating plasma hs-CRP, IL-6, and 
TNF-a.. 
Aim2. To determine the strength of the association between adiposity levels and 
circulating levels of plasma hs-CRP, IL-6, and TNF-a. Hypothesis: 2a. Higher 
levels ofBMI will be related to higher levels of circulating plasma hs-CRP, IL-6, 
and TNF-a. 2b. Higher levels of waist circumference will be related to higher 
levels of circulating plasma hs-CRP, IL-6, and TNF -a. 
Aim3. To test the moderating effect of adiposity on the strength of the association 
between CRF levels and circulating levels of plasma hs-CRP, IL-6, and TNF-a. 
Hypothesis: 3a. Individuals with higher levels of BMI and higher levels of CRF 
will have lower levels of circulating plasma hs-CRP, IL-6, and TNF -a compared 
with individuals with higher levels ofBMI and lower levels ofCRF. 3b. 
Individuals with higher waist circumference and higher levels of CRF will have 
lower levels of circulating plasma hs-CRP, IL-6, and TNF -a compared with 
individuals with higher waist circumference and lower levels of CRF. 
For public health strategies and improvements of cardiovascular health, the 
proposed work is innovative in that it will test the central hypothesis that young adults 
with higher levels of CRF will have lower levels of inflammatory markers than those 
with lower levels of CRF, even among individuals who have greater adiposity as 
measured by BMI and waist circumference. Additionally, understanding the interplay of 
CRF, adiposity and inflammatory markers is of great importance because it will 
contribute to more accurate evaluation and interpretation of inflammatory markers in 
clinical practice. Finally, these findings will be useful in planning interventions to reduce 
low-grade chronic inflammation in obese as well as healthy weight young adults, which 
in turn may delay the progression of atherosclerosis and reduce the risk of CVD. 
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Research Strategy 
Significance 
Atherosclerotic cardiovascular disease (CVD) is a significant public health burden 
in the United States (Go et al., 2013). Atherosclerosis, a systemic disease process in 
which amassment of plaque builds up in the arterial wall, is the major underlying cause of 
the clinical CVD and CVD events (Go et al., 2013; Libby et al, 2009). It has been 
demonstrated that low-grade systemic vascular inflammation plays a pivotal role in the 
initiation and progression of atherosclerosis (Libby et al., 2009) by impairing endothelial 
function (Hansson, 2005; Ferri et al., 2007). Among the many inflammatory biomarkers, 
hs-CRP, IL-6, and TNF-a are well-recognized markers of inflammation in relation to 
atherogenesis (Calabro, Golia, & Yeh, 2009; Haddy et al., 2003). Hs-CRP, a primitive 
acute phase inflammatory protein, is secreted by the liver in reaction to IL-6 and has been 
demonstrated to be represented in atherosclerotic plaque (Clearfield, 2005; Wilson, Ryan, 
& Boyle, 2006). The "high sensitivity (hs )" term means "the measurement of CRP in 
serum or plasma sample using immunoassay methods with sufficient sensitivity" in 
asymptomatic individuals (Bajpai, Goyal, & Sperling, 2010, p.191 ). IL-6 is a pro-
inflammatory cytokine and produced by fibroblasts, endothelial cells, monocytes, and 
adipose tissue (Schuett, Luchtefeld, Grothusen, Grote, & Schieffer, 2009). IL-6 plays an 
important role in controlling hepatic production of inflammatory proteins, including hs-
CRP and fibrinogen (Antuna-Puente, Feve, Fellahi, & Bastard, 2008). TNF-a, a pro-
inflammatory cytokine, is secreted by macrophages, lymphocyte, and adipose tissue 
(Petersen & Pedersen, 2005). TNF-a activates the production ofiL-6 in adipose tissue 
and blood mononuclear cells (Petersen & Pedersen, 2005). 
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Although clinical symptoms of atherosclerotic CVD, such as chest pain or 
discomfort, shortness of breath or fatigue, numbness, and blurred vision are not 
commonly detected until adulthood it is a progressive atherosclerotic process that occurs 
early in life and has clinical indications, including acute coronary syndrome and acute 
stroke usually later in life (Loria et al., 2007; Frank et al., 2010). Hence, young adults 
could be a main target for preventive endeavors, such as individual's health behaviors 
because these efforts might minimize or delay atherosclerotic process, which could 
eventually decrease the incidence of clinical CVD throughout middle and older adulthood 
(Loria et al., 2007). 
CRF refers to the health-related component of physical fitness (Caspersen, Powell, 
& Christenson, 1985). CRF defined as "the ability to perform large muscle, dynamic, 
moderate-to-high intensity exercise for prolong periods of time" (American College of 
Sports Medicine [ACSM], 2010b, p.71). CRF is "an individual's capacity of the 
cardiovascular, respiratory, and muscle systems to supply oxygen during sustained 
physical activity" (ACSM, 2010a, p.3).1t has reported that higher levels ofCRF are 
closely related to higher levels of habitual physical activity (Blair et al., 1995). The "gold 
standard" or criterion measure of CRF is maximal oxygen uptake (V02max) (ACSM, 
201 0). The VO 2max reflects the capacity of the heart, lungs, and blood to deliver oxygen 
to the working muscles during dynamic exercise involving large muscle mass (Heyward, 
2010). The V02max commonly estimates either a maximal or submaximal exercise test. 
CRF in this study will be estimated by using a submaximal treadmill walking protocol 
because maximal exercise testing is not always feasible or practical in the health and 
research settings (Heyward, 201 0). Additionally, maximal exercise testing with analysis 
10 
of expired gases requires expensive laboratory equipment, considerable amount time, 
trained personnel and possible physician oversight. Further, there is considerable 
participant burden, associated safety considerations, and obtaining a valid estimate 
requires participant motivation (Heyward, 201 0). The selected submaximal treadmill 
walking test protocol will utilize individual's heart rate (HR) response to submaximal 
treadmill work rates to estimate V02max (Ebbeling et al., 1991). It has reported that CRF 
is inversely associated with CRP in young adults (Kuo, Yen, Chen, Yu, & Bean, 2007; 
Williams et al., 2005). However, it is remain uncertain whether an inverse association 
between CRF and inflammatory biomarkers is due to the health benefits of CRF or results 
from changes in adiposity (Harmer, 2007). 
Adiposity is defmed as "the quality or state of being fat" (Merriam-Webster 
Dictionary). The adiposity is a synonym for obesity or fatness (Merriam-Webster 
Dictionary). Adiposity has been assessed by anthropometric measures in public health 
and clinical practices. Adiposity in this study will be assessed by BMI and waist 
circumference (WC). BMI (kg/m2) has been recommended for the identification of 
measuring body fat (WHO, 2000) and the most widely accepted measures of overall 
adiposity (Stevens, McClain, & Truesdale, 2008); however, BMI does not differentiate 
fat mass from bone and muscle mass and does not provide any information on the 
distribution of body fat, particularly central body fat (Stevens, McClain, & Truesdale, 
2008). Thus, WC will be assessed for measuring central adiposity (Stevens, McClain, & 
Truesdale, 2008). A growing body of evidence has supported that there is positive 
association of adiposity with inflammatory biomarkers (Park, Park, & Yu, 2005; Wang, 
Reed, Goli, & Goswarni, 2011). However, there is not enough evidence to identify the 
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strength and patterns of association of anthropometric adiposity measures with CRP, IL-6 
and TNF-a. 
Although there is evidence that CRF is inversely associated with inflammatory 
biomarkers (Hamer, 2007), it is still under debate whether the beneficial effect of CRF 
derives from the CRF itself or from inadequate adjustment for adiposity (Hamer, 2007), 
which adiposity also may influence in inflammatory processes (Rocha & Libby, 2009). 
More importantly, only two studies have examined the association of CRF and CRP in 
young adults over the past decade (Kuo et al., 2007; Williams, Milne, Hancox, & Poulton, 
2005). One study measured CRP using a low sensitivity CRP assay, which may 
underestimate the strength of the association between CRF and inflammation (Williams 
et al., 2005). The other study was population-based study, which included study 
participants with CVD risk factors, such as hypertension, diabetes and current smokers or 
participants with anti-inflammatory or CVD medications (Kuo et al., 2007), thus, the 
findings cannot be generalized to healthy young adults. Neither study examined adiposity 
as moderator of the association between inflammation and CRF, and what extent that 
adiposity influences the association between CRF and inflammation. Furthermore, these 
two previous studies only focused on CRP as a biomarker of inflammation. It is essential 
to investigate other inflammatory markers, such as IL-6 and TNF -a in order to better 
understand inflammatory processes in relation to adiposity and CRF. Therefore, this 
proposed study is significant as it will provide data on the role of adiposity as a 
moderator of the strength of the association between CRF and three inflammatory 
biomarkers. This will fill an important gap in knowledge. Figure 1 shows a schematic 
diagram of the conceptual framework and specific aims of this proposed study. 
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The proposed study is significant as it will 
(1) Provide a basis for more accurate interpretation and evaluation of inflammatory 
biomarkers in clinical settings as related to CRF and adiposity assessment. 
(2) Contribute a better understanding inflammatory process in relation to CRF and 
adiposity in a young adult population. 
(3) Provide knowledge for the design of preventive strategies to reduce low 
grade chronic inflammation in obese as well as healthy weight young adults, which 
inturn may delay the progression of atherosclerosis risk and reduce the risk of CVD. 
Cardiorespiratory 
Fitness (Walking 
treadmiU test) 
Adiposity 
(BMI, \VC) 
Cardiorespiratory 
Fitness x Adiposity 
Aim2 
Inflammatory 
biomarkers (BS-CRP, 
ll...-6, Th"F -a) 
Figure 1. Conceptual framework for cardiorespiratory fitness, adiposity and 
Inflammatory biomarkers In young adults 
Innovation 
The proposed study is innovative in that it will 
(1) No previous studies have examined the interplay ofCRF and adiposity on 
inflammatory makers in young adults. 
(2) Be one of the few studies that assessed CRF in young adults without known 
diagnosis of disease using a single-stage submaximal treadmill walking test in 
community setting. 
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(3) Provide CRF levels, adiposity levels and plasma inflammatory biomarkers levels 
not only hs-CRP but it also IL-6 and TNF -a in young adults. To our knowledge, 
this is the first study to include IL-6 and TNF-a in relation to CRF in healthy 
young adults. There is limited data on these variables in young adults. This 
information will expand scientific knowledge on the inflammatory mechanisms 
related to CRF and adiposity, which may contribute to atherosclerosis risk in this 
population. 
Approach 
Preliminary study. 
Effects of exercise intervention on inflammatory markers in healthy young and 
middle aged adults: A systematic review. The PI conducted a systematic review of 
effects of exercise interventions on inflammatory markers in healthy young and middle 
aged adults (Park &Meininger). The aim of this systematic review was to assess the 
effects of exercise interventions on circulating levels of inflammatory markers CRP, IL-6, 
and TNF -a in healthy young and middle aged adults. Method of this study was that 
Medline and PubMed databases were searched for studies published between 1966 and 
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July 2011 using keywords related to "exercise", "C-reactive protein", "interleukin-6", 
and "tumor necrosis factor-alpha". Inclusion criteria were (a) randomized controlled trials 
(RCTs ), (b) exercise interventions with a minimum duration of 4 weeks, and (c) 
participants' ages 18 to 65 years old. Main findings were as follows: Of 1 ,490 identified 
publications, 93 were retrieved for detailed evaluation and 8 met inclusion criteria. Of 6 
RCTs on CRP, 1 study reported decreased CRP (P<0.05) in aerobic exercise. Of3 RCTs 
on IL-6, 1 study showed decreased IL-6 (P~0.02) in aerobic exercise. Of 4 RCTs on 1NF-
a, 1 study reported elevated TNF-a (P<0.05) in aerobic exercise among females, and 1 
study demonstrated decreased 1NF-a (P<O.Ol) in high-intensity aerobic exercise. The 
evidence supporting the effects of exercise interventions on CRP, IL-6 and TNF -a is 
sparse and inconsistent, and degree of adiposity was not considered. Further research is 
needed on the potential role of body fat as it relates to the effects of exercise and CR 
fitness on inflammatory biomarkers. 
Anthropometric adiposity measures and inflammatory biomarkers in 
adolescents and young adults: A systematic review. The purpose of the systematic 
review was to determine the associations between anthropometric adiposity measures 
(BMI, WC, WHR, WHtR, and BF%) and inflammatory biomarkers (CRP, IL-6, and 
TNF-a) in healthy adolescents and young adults without a known diagnosis of diseases. 
Method of this study was that MEDLINE (from 1946 to June 08, 2012), CINAHL (from 
1995 to June 08, 2012), and SCOPUS (from 1960 to June 08, 2012) using keywords 
related to anthropometric adiposity measures;"body mass index,"" waist circumference," 
and inflammatory biomarkers; "C-reactive protein", "interleukin-6", and "tumor necrosis 
factor-alpha". Inclusion criteria were (1) adolescents and young adults aged 13 to 40 
15 
years; (2) investigated the association between at least one anthropometric adiposity 
measures and CRP, IL-6, and/or TNF-a; (3) anthropometric adiposity measured by BMI, 
WC, WHR, WHtR, and/or body percentage assessing a skinfold thickness; (4) eRP, IL-6, 
and TNF -a levels measured by blood; ( 5) if cross-sectional data from the same study 
cohort was published in more than one studies, then only results from the report that most 
directly evaluated the association of anthropometric adiposity and inflammation was 
included; ( 6) all types of research designs; (7) reported in an original study; (8) no 
country restriction; and (9) published study in English language. Exclusion criteria were: 
(1) adolescent and young adults with diagnosed diseases and infectious diseases; (2) 
pregnant women; (3) reported adiposity measured only by DEXA or MRI; (4) reported a 
review or an editorial article; and ( 5) reported in an abstract. Main findings were as 
follows: Of3,714 identified publications, 166 full text studies were retrieved for detailed 
evaluation and 27 met inclusion criteria. The main findings of the systematic review 
showed that there was significant and positive association of anthropometric adiposity 
measured by both total adiposity and central adiposity (BMI, we, WHtR, WHR, and 
BF%) with CRP in adolescents and young adults in 23 studies (96%) (p < 0.05) and there 
was no significant association in adolescents in one study (4%). The findings of the 
review in the associations between anthropometric adiposity measures (BMI, we, WHR, 
and BF%) with IL-6 and TNF-a in adolescents and young adults remained inconsistent. 
Further research is needed to focus on the interplay of diet, physical activity, or weight 
loss with eRP, IL-6 and TNF-a for developing appropriate and effective lifestyle 
modification in reducing circulating levels of CRP, IL-6 and TNF -a and in preventing 
further development of atherosclerotic CVD and acute CVD events in later life. 
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Methods 
Research design. The proposed cross-sectional analytic study is designed to 
achieve three specific aims. After screening for eligibility, health young adults 20-34 
years old will be enrolled. Data will be collected on each participant through CRF testing, 
anthropometric measurement and blood sampling of inflammatory biomarkers in one 
session at the University of Texas Health Science Center at Houston (UTHSC-H) School 
ofNursing (SON). 
Participants and setting. The target population for this study is healthy young 
adults aged 20 to 34 years residing in Houston, a large metropolitan city and with an 
ethnically diverse population in southeast Texas. Adults can be divided into young 
adulthood (the 20s and 30s), middle adulthood (the 40s and 50s), and later adulthood (age 
60 or 65 and up) based on developmental periods in the human lifespan (Craig & Dunn, 
201 0). The focus of this study is on young adults aged 20 to 34 without a known 
diagnosis of diseases because women's menopause occurs after age of 40 to 45 and 
perimenopause typically begins several years before menopause. A sample of the 
population will be accessed using non-probability quota sampling approach in the area of 
UTHSC-H. 
Sample size. Sample size was estimated based on a multiple linear regression 
model, regression coefficient (R2) with interactions using nQuery Advisor version 7.0 
(nQuery, Saugus, MA). The estimated sample size was 88 subjects to detect a medium 
effect size (0.059 ~ R2 < 0.138) according to Jacob Cohen (1998), a power of80%, and 
an alpha level of 0.050 for a two-tailed test. With a sample size of 88, the interaction of 
adiposity and CRF would be stated by at p < 0.05 if the change in R2 with the addition of 
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the interaction term were as lower at 0.069. To address possible attrition up to 20%, 110 
participants will be recruited. Since there were no previous studies to estimate for the 
interaction term, the PI chose the medium (R2) of 0.069 for interactions for a multiple 
linear regression model in this study. 
Inclusion and exclusion criteria. Inclusion criteria are (1) young adults age 20-34 
years; (2) healthy (defined as "not currently having acute or chronic diseases" as 
specified in exclusion criteria); (3) capable of completing the CRF test and there is no 
minimal or maximal value for vo2 max as long as participants are physically able to do 
CRF testing safely (ACSM, 2010a; ACSM, 2010b); and (4) able to speak and read 
English. Exclusion criteria are as follows in both males and females: (1) currently non-
smoker or smoking cessation greater than 1 year because smoking status may increase hs-
CRP, IL-6 and possibly certain cytokine receptors antagonists (O'Connor et al., 2009); (2) 
alcohol dependence or regular consumption of more than 7 servings per week because 
alcohol intake alters inflammatory biomarkers (O'Connor et al., 2009 ); (3) acute 
infections, including a current or recent influenza illness, recent flu shot recipients, acute 
respiratory infection within 2 weeks; ( 4) dental infection and problem within 2 weeks; ( 5) 
CVD, such as hypertension, heperlipidemia and diabetes mellitus type I or II; (6) 
rheumatoid arthritis and immune disorders because of the possible alteration of 
inflammatory markers; (7) history of inflammatory bowel disease, such as Crohn' s 
disease and ulcerative colitis; (8) recent surgery within 1 month; (9) currently taking 
medications, such as hormone replacement therapy, antihypertensive medications, allergy 
shots or systemic corticosteroids, aspirin, statin, and selective serotonin uptake inhibitors 
(SSRis), and anti-inflammatory medications, all of which may impact levels of 
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circulatory inflammatory biomarkers (O'Connor et al., 2009); (10) history of orthopedic 
injury in the past and limitations due to the musculoskeletal demands of CRF test (11) 
other medical conditions and medications that would increase inflammatory markers and 
would prohibit CRF test; and (12) the maximum hs-CRP cut off point will be set at 10.0 
mg/L which may have potentially reflected inflammation due to sepsis and an acute 
infection or other inflammatory conditions (Pearson et al., 2003). For females, inclusion 
criteria are as follows: (1) self-reported menstrual cycle length of24-35 days during the 2 
months before entering the study; and (2) self-reported without a menstrual period at the 
time of data collection because menses may impact increased levels of CRP (Gaskins et 
al., 2012). Exclusion criteria are as follows: (1) natural or surgical menopausal status; (2) 
use of hormone replacement therapy (HRT); (3) not currently or recently (past 6 months) 
pregnant status; ( 4) not currently or recently (past 2 months) lactating females because 
breast feeding may influence CRP (Williams, Williams & Poulton, 2006); (5) history of 
gynecologic problems, such as fibroids, endometriosis, or polycystic ovary syndrome 
because these gynecologic problems have been reported to increase CRP (Escobar-
Morreale, Luque-Ramirez, & Gonzalez, 2011); (6) hormonal contraception use within the 
past three months , such as hormone patch and vaginal ring methods; and (7) IUDs with 
hormones and Depo-Provera within the past 12 months, which of all may increase 
inflammatory biomarkers (Gaskins et al., 2011; O'Connor et al., 2009). Those taking oral 
contraceptives will not be excluded from the study, but data on this variable will be 
collected so that it can be included as a covariate in the analysis. 
Setting for data collection. The data will be collected by the PI at the Center for 
Nursing Research, and a biological sciences laboratory in the UTHSC-H SON. Data 
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collection will be performed in a CRF study room in the UTHSC-H SON. The room will 
be maintained between 68 and 76 degrees Fahrenheit, with a humidity level between 20 
to 60 percent using a room temperature thermometer (Q-Track IAQ monitor, TSI 
Incorporated, Shoreview, MN) throughout the data collection period based on the 
Occupational Safety and Health Administration recommendations (2003). 
Recruitment of subject and data collection procedure. Participants will be 
recruited by posting fliers in the UTHSC-H and surrounding communities ofUTHSC-H 
as well as by sending e-mails to students and employees of the UTHSC-H. The 
recruitment will begin from the end ofNovember 2012 through December 2013. Time 
frame of project activity is provided (Appendix F). A flyer and email will describe the 
need for healthy young adult volunteers, age 20-34 years, of all fitness and weight levels. 
The flyers will include a very brief description of the study, and will provide the PI's 
phone number and e-mail address for further information (Appendix A). If participants 
are interested in the study, they will contact the Pl. The PI will provide detailed 
information on the study, including the purpose of the study, study procedures, data 
collection plan, and potential risks and benefits. During a telephone interview, the PI will 
screen participant's eligibility. When participants meet the inclusion criteria and they 
show an interest in participating in the study, they will be scheduled to attend a data 
collection session in the UTHSC-H SON. For preparation of data collection, participants 
will be instructed (1) not to eat after 8 pm the night or 12 hours before the testing; (2) not 
to do strenuous exercise, consume alcohol, or use anti-inflammatory drugs 24 hours prior 
to blood sampling; (3) to arrive at the UTHSC-H SON bioscience laboratory between 
8am and 10 am; ( 4) to wear comfortable exercise-type clothing; ( 5) to avoid tobacco and 
caffeine 3 hours prior to test; ( 6) to consume plenty of fluids; and (7) to obtain an 
adequate amount of sleep the night before the test (ACSM a, 2010; ACSM b, 2010). 
Because inflammatory markers are elevated during menstruation, women participants 
will be scheduled for a day when they are not menstruating (Gaskins et al., 2011). 
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Before collecting the data, informed consent will be obtained by the PI. The PI will 
thoroughly explain and will clarify any information on this study. After obtaining 
informed consent, each participant will complete an interview guided pre-assessment 
health questionnaire (ACSM a, 2010). The questionnaire was designed to identify 
whether the participants are safe to test for CRF (ACSM a, 201 0). If the participant will 
not be safe to perform CRF testing, he or she will be excluded such as high blood 
pressure, short of breath, chest pain, heart palpitation, heart murmur, fainting, back pain 
and intermittent leg pain. Once the participant is eligible to perform CRF testing, the 
eligible participant's blood test will be collected between Sam and lOam. After collecting 
blood samples, anthropometric characteristics (height, weight and waist circumference) 
will be measured. A light snack and water will be provided. After a brief resting period, 
the PI will conduct CRF testing. The CRF test will take 20-30 minutes of walking on the 
treadmill including warm-up and cool down stages. Participants who complete all 
procedures will be compensated with a $10 gift card. All procedures will be conducted by 
the PI. The results of CRF levels, body anthropometric measurements and levels of 
inflammatory markers will be released for participants who show an interest in knowing 
their results. Procedures for obtaining informed consent and all protocols will be 
approved by the Committee for the Protection of Human Subjects at the UTHSC-H. 
21 
Instruments. 
Demographic characteristics. The PI will complete pre-assessment questionnaire 
regarding demographic and health-related information, lifestyle, and activity levels from 
participant's self-report. The pre-assessment questionnaire was developed by ACSM 
(2010a).The demographic information includes information on age, gender, ethnicity, 
marital status, and education. Age, gender, ethnicity and education will be described 
participants' characteristics and be used as covariates in the multiple regression analysis. 
Assessment of CRF. CRF will be assessed by a single-stage submaximal 
treadmill walking test (SSTWT). The SSTWTwas developed by Ebbeling et al. (1991) 
for estimating V02max of low-risk, healthy adults 20 to 50 years. The SSTWT was 
validated by correlating the indirectly estimated V02max based on individual's walking 
speed, heart rate (HR), age and sex and the directly measured respiratory gas exchange 
(V02max) in the cross-validation group (N = 22) (Ebbeling et al., 1991). A correlation (r) 
of .96 was reported, with multiple correlation (R2) of .86 (SEE= 4.85 ml· kg-1·mim-1) 
(Ebbeling et al., 1991 ). 
Single-stage submaximal treadmill walking test protocol. The SSTWT consisted 
of a 4-minute warm-up stage, 4-minute workload stage, and a 2- 5minute cooldown stage. 
The treadmill will be calibrated before CRF test to ensure the accuracy of the test. Prior 
to beginning the SSTWT, participants will be familiarized with the treadmill (Precor 956i, 
Precor, Inc., Woodinville, WA), including a visual demonstration in order to maximize 
participant safety. 
In the first warm-up stage, participants will walk on the treadmill for a 4-minute 
at 0% incline and a walking speed (2.0 to 4.5 mph) that brings the HR to between 50% 
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and 70% beats per minute (bpm) age-predicted maximal HR by the Pl. In workload stage, 
the treadmill incline will increase to 5% at the same speed for a 4-to 5-minute. Following 
a workload stage, the participants will complete a cooldown stage at a slow walk and 0% 
incline for a 2-5minute. Resting BP and HR using the oscillometric technique (HEM-
907SL, Omron Healthcare, Inc., Bannockburn, IL) will be assessed prior to a warm-up 
stage, twice and after a cool-down stage one time. If the participant's resting blood 
pressure ~ 130/90 mmHg or resting HR ~ 100 per minute, the participant will not be 
allowed to have a SSTWT. Polar HR (Vintage NV model, Polar CIC, Inc., Port 
Washington, NY) will be recorded during the SSTWT protocol and the Borg Ratings of 
Perceived Exertion scale (RPE) will be documented at the end of the warm-up stage and 
the workload stage. The Borg Scale takes into account a participant's fitness level. It 
matches how hard he or she feels he or she is working with numbers from 6 (very, very 
light) to 20 (very, very hard) (Borg, 1970). Steady-state HR defines as a HR within± 5 
bpm during the last 2minute of the workload stage. 
The main outcome of the CRF test will be estimated maximal oxygen uptake 
(V02max). The SSTWT prediction equation will be used to estimate V02max based on 
age, sex, walking speed (mph), and steady-state HR. 
Estimated V02 max (ml·kg-1·min-1) = 15.1 +21.8 (speed in mph)- 0.327 (steady 
state HR in bpm)- 0.263 (speed x age in years)+ 0.00504 (SS HR in bpm age in 
years)+ 5.98 (sex; female= 0, male= 1) 
Assessment of adiposity. Adiposity will be assessed using BMI and waist 
circumference. BMI will be calculated by dividing the participant's weight in kilograms 
by the height in meters squared (kg/m2). Height will be measured without shoes to the 
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nearest 0.1 em using a wall-mounted stadiometer (Accustat, Genentech Inc.). Weight will 
be measured to the nearest 1/4th lb with a calibrated balance beam scale. Height and 
weight will be measured with minimal clothing and without shoes and hats (NHANES, 
2010). Waist circumference (WC) is a measure of the degree of central of body fat. WC 
will be measured to the nearest 0.1 em using a flexible, nonstrectchable tape. The tape 
measure will be placed just above the uppermost lateral border of the right ilium crest and 
will be extended around the waist in a horizontal plane (NHANES, 201 0). 
Measurement of hs-CRP, IL-6, and TNF-a. Prior to blood sample collection, the 
PI will ascertain that the participant is comfortable with instructions and procedures for 
collecting blood sample. A 10 ml fasting blood will be collected from an antecubital vein 
into two vacutainers containing ethylene diamine tetra acetic acid (EDTA) vacutainers by 
the PI. After collecting two EDT A vacutainers, the blood samples will be transported to 
the Bioscience Laboratory in the UTHSC-H SON on dry ice pellets with ice designed for 
frozen temperature to maintain that temperature. The blood samples will be immediately 
centrifuged at 1,630 relative centrifugal force (ret) at -4°C for 30 minutes 
(Centrifuge5810R, Eppendorf AG Hamburg, Germany). After centrifugation, plasma 
samples will be divided into eight aliquots. Each cryo-tube will be labeled in numerical 
order of the participant study identification, date, year, and stored at -80°C for up to a 
maximum of one year. 
Plasma hs-CRP will be determined by a sandwich ELISA (Alpco C-reactive 
protein (hs-CRP), EIA, Salem, N.H., USA). Plasma hs-CRP will present in milligram per 
liter (mg/L). Intra- and inter-assay coefficients of variation are less than 2%. Plasma IL-6 
concentration will be measured using the BIOSOURCE Enzyme Amplified Sensitivity 
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Immunoassay (EASIA) kit (BioSource, Nivelles, Belgium). Plasma TNF-a will be 
quantified using a solid phase sandwich ELISA (ALPCO Diagnostics). Plasma IL-6 and 
TNF-a will be represent in pictogram per milliliter (pg/ml). Plates of biomarkers will be 
read on a microplate reader using absorbance (Bioteck instruments Inc., Winooski, VT). 
WorkOut™ software (version 2.5, Perkin Elmer Life and Analytical Sciences) will be 
used for analyzing assay results. Intra- and inter-assay coefficients of variation will be 
below 1 0%. All inflammatory biomarkers will be assayed at the Bioscience Laboratory at 
the UTHSC-H SON for this study. 
Data Analysis 
Statistical analyses will be performed by using statistical software SPSS version 
22.0 (SPSS Inc., Chicago, IL). Descriptive statistics will be used to summarize 
characteristics of study participants, including mean, standard deviation, frequency and 
percentage. For continuous variables, histograms, box plots, and normality probability 
plot will be used to identify normality of distribution, outliers, and missing data. 
Appropriate transformations will be performed where necessary. All analyses will be 
two-tailed and P-value < 0.05 will be considered statistically significant. 
Separate analysis will be conducted with each of the inflammatory markers (hs-CRP, IL-
6, and TNF-a) as the dependent variable in multiple linear regression analysis for aim 1: 
the strength of the association between CRF and inflammatory biomarkers, and the aim 2: 
the strength of the association between adiposity and inflammatory biomarkers. Analyses 
for aim 1 and 2 will be adjusted for possible confounders including age, sex, ethnicity 
and education. 
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Aiml. To determine the strength of the association between CRF levels with 
circulating levels of plasma hs-CRP, IL-6, and TNF -a. Hypothesis: Higher levels of CRF 
will be related to lower levels of circulating plasma hs-CRP, IL-6, and TNF -a. 
Aim2. To determine the strength of the association between adiposity levels and 
circulating levels of plasma hs-CRP, IL-6, and TNF -a. Hypothesis: 2a. Higher levels of 
BMI will be related to higher levels of circulating plasma hs-CRP, IL-6, and TNF -a. 2b. 
Higher levels of waist circumference will be related to higher levels of circulating plasma 
hs-CRP, IL-6, and TNF-a. 
Multiple linear regression models, with interaction terms (CRF x BMI) (CRF x 
waist circumference) will be examined to assess aim 3: the moderating effect of adiposity 
(moderator) on the strength of the association ofCRF (independent variable) with 
inflammatory biomarkers (dependent variable). Analyses for aim 3 will be adjusted for 
possible confounders including age, gender, ethnicity and education. 
Aim3. To test the moderating effect of adiposity on the strength of the association 
between CRF levels and circulating levels of plasma hs-CRP, IL-6, and TNF -a. 
Hypothesis: 3a. Individuals with higher levels of BMI and higher levels of CRF will have 
lower levels of circulating plasma hs-CRP, IL-6, and TNF-a compared with individuals 
with higher levels ofBMI and lower levels ofCR fitness. 3b. Individuals with higher 
waist circumference and higher levels of CRF will have lower levels of circulating 
plasma hs-CRP, IL-6, and TNF-a compared with individuals with higher waist 
circumference and lower levels of CRF. 
Limitations 
Firstly, a weakness of this study is the difficulty of establishing causal 
relationships from data collected in a cross-sectional time frame. Secondly, a non-
probability sampling method in a university setting will limit generalization of the 
findings of this study. In spite of these limitations, the findings will provide important 
knowledge about inflammatory markers in young adults and will be used for designing 
longitudinal studies and interventions to improve cardiovascular health in this target 
population. 
Facilities/Resources/Consultants 
26 
Center for Nursing Research for CR fitness and bioscience laboratory for 
handling and analyzing inflammatory biomarkers at the UTHSC-H SON are available for 
the conduct of this project. Additionally, statisticians to assist with data management and 
analysis are available. Lastly, fitness experts at UTHSC-H Recreation Center and School 
of Public Health are available for consultation. 
Human Subjects Concerns 
Protection of human subjects. Protection of human subjects' rights will be 
assured with obtaining appropriate approval from the University of Texas Health Science 
Center at Houston Committee for Protection of Human Subjects (UTHSC-H CPS). The 
PI will be trained on Collaborative Institutional Training Initiative (CITI) and iRIS. The 
PI will thoroughly explain the purpose and overall procedure of the study, and potential 
benefits and risks of participating in the study prior to obtaining informed consent. 
Participants will be informed that if they are unwilling to participate in this study, they 
can withdraw at any time. Participants will be allowed and encouraged to ask any 
questions regarding the study before completing the informed consent process with a 
signature. No data will be collected before informed consent. Information regarding 
protection of privacy and confidentiality, and how the data will be handled with 
confidentiality will be provided to the participants. 
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Potential benefits and risk of the proposed study to the subjects. Participants 
may benefit from learning about physical inactivity, body fatness and weight as related to 
risk for cardiovascular disease. Participants will be informed of potential discomforts and 
risks as related to CR fitness and blood sampling. With regards to blood test, participants 
may feel some pain and have a bruise at the needle site. There might be a risk for 
developing an infection at the needle site but this is rare. In relation to CR fitness, 
participants may feel some discomforts during and after fitness test. These include 
dizziness and fainting but these effects are rare. The trained professional is available to 
assist with unusual situations that may arise. If participants are interested in their results, 
they will be received a copy of their results. 
Data and safety monitoring plan. The PI will be responsible for monitoring and 
managing data safety and analysis procedures. Each participant will be given a study 
identification number. Forms and documents will be kept separate from the data file and 
kept in a locked cabinet. Data files and blood samples will be coded by the study 
identification numbers. Confidentiality of the data will be assured through coding 
systems without specific participant's identifiers. Protected data will be entered into a 
double password protected computer database with restricted access to the system. 
Inclusion of minorities, women, and children. The target population of this 
proposed study is healthy young adults aged 20-34 years. This study population will 
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include diverse ethnic groups, such as African American, Asian, and Hispanic. This study 
will exclude children, adolescents, elderly, and pregnant women. 
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Abstract 
Background 
Overweight and obesity are major risk factors for cardiovascular disease (CVD) 
morbidity and mortality. Low- grade chronic inflammation may be a mediating factor in 
the association of overweight and obesity with development of atherosclerosis and higher 
risk for CVD and CVD events. C-reactive protein (CRP), interleukin-6 (IL-6), and tumor 
necrosis factor-alpha (TNF-a.) are well-recognized markers of inflammatory response to 
atherosclerosis. 
Purpose 
The purpose of the systematic review was to determine the associations between 
anthropometric adiposity measures (BMI, WC, WHR, WHtR, and BF%) and 
inflammatory biomarkers (CRP, IL-6, and TNF-a.) in adolescents and young adults. 
Methods 
The electronic databases Ovid MEDLINE, CINAHL, and SCOPUS were searched for 
studies published between 1946 and July 2013. Inclusion criteria were (a) adolescents 
and young adults aged 13 to 40 years without a known diagnosis of diseases (b) 
examined the association between at least one anthropometric adiposity measures and 
CRP, IL-6, and /or TNF-a., and (c) published study in English language. 
Results 
Of 4,876 identified publications, 176 were retrieved for detailed evaluation and 28 met 
inclusion criteria. There is a significant and positive association between anthropometric 
adiposity measured by total and central adiposity (BMI, WC, WHtR, WHR, and BF%) 
and CRP in adolescents and young adults in 22 out of 23 studies (96% ). Findings of 
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anthropometric adiposity measures (BMI, WC, WHR, and BF%) and IL-6 and TNF -a in 
adolescents and young adults remain inconclusive. No single anthropometric adiposity 
measures in adolescents and young adults would appear to be superior in relation to CRP, 
IL-6 and TNF-a. 
Conclusions 
The evidence supports that anthropometric adiposity measures are positively associated 
with CRP in adolescents and young adults. However, anthropometric adiposity measures 
and IL-6 and TNF -a in adolescents and young adults is inconclusive. Additional studies 
are needed to identify the strength and patterns of association of anthropometric adiposity 
measures with CRP, IL-6 and TNF -a. Further studies are needed to identify sex and 
ethnicity differences in the association of anthropometric adiposity measures and 
inflammatory biomarkers. 
Keywords: body mass index; waist circumference; waist to hip ratio; waist to height 
ratio; body fat percentage; c-reactive protein; interlukin-6; tumor necrosis factor-a; 
adolescents; young adults 
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Anthropometric Adiposity Measures and Inflammatory Biomarkers in Adolescents and 
Young Adults: A Systematic Review 
Atherosclerosis is a systemic disease process in which accumulation of plaque 
builds up in the arterial wall and a main pathophysiological determinant of clinical 
cardiovascular events, morbidity and mortality (Go et al., 2013 ). It has been shown that 
chronic, low-grade inflammation plays an important role in the initiation and progression 
of atherosclerosis by impairing endothelial function (Libby, Ridker, & Hansso~ 2009; 
Widlansky, Gokce, Keaney, & Vita, 2003). The endothelial dysfunction promotes 
development, progression, and clinical expression of atherosclerosis, such as an acute 
atherosclerotic event (Bucdkley, Rongwei, Freeman, Rogers, & Helfand, 2009; Packard 
& Libby, 2008; Wildansky et al., 2003). C-reactive protein (CRP), interleukin-6 (IL-6), 
and tumor necrosis factor-a (TNF-a) are well-recognized biomarkers of inflammation in 
relation to atherogenesis (Libby et al., 2009). CRP, a primitive acute phase inflammatory 
protein, plays an essential role in innate immune response and inflammatory processes 
(Wilson, Ryan, & Boyle, 2006). CRP is primarily produced in the liver and is synthesized 
by hepatocytes in response to inflammatory cytokines, mainly IL-6 (Wilson et al., 2006). 
IL-6 is a pro-inflammatory cytokine that play a major role in the acute phase response in 
relation to infection and is produced by various cells, such as fibroblasts, endothelial 
cells, monocytes, and adipocytes (Schuett, Luchtefeld, Grothusen, Grote, & Schieffer, 
2009). The important role of IL-6 is controlling hepatic production of inflammatory 
proteins, including CRP (Schuett et al., 2009). TNF -a is a pro-inflammatory cytokine that 
is secreted by various cells, such as macrophages, lymphocyte, and adipocytes (Petersen 
& Pedersen, 2005). 
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The prevalence of overweight and obesity is a significant public health problem 
worldwide, and it has grown substantially over the past few decades (Lobstein, Baur, & 
Uauy, 2004; World Health Organization [WHO], 2012). It is estimated that worldwide 
obesity has more than doubled since 1980 (WHO, 2012). Overweight and obesity are 
considered major risk factors for cardiovascular disease (CVD) mortality and morbidity 
(Roger et al., 2012; WHO, 2012). The underlying mechanisms for the relationship of 
overweight and obesity with CVD have not been fully elucidated. A growing body of 
evidence indicates that chronic inflammation may be a mediating factor in the association 
of obesity with development of atherosclerosis (Mathieu, Lemieux & Depres, 2010; 
Rocha & Libby, 2009; Wang & Nakayama, 2010). More specifically, excess adipose 
tissue induces pro-inflammatory cytokines, including IL-6 and TNF-a (Calabro et al., 
2009) which precipitate the release ofCRP from the liver (Wang & Nakayama, 2010; 
Yudkin, Stheouwer, Emeis & Coppack, 1999). In this way, obesity itself promotes 
inflammatory process which induces endothelial dysfunction and plaque formation, thus 
contributing atherosclerosis and higher risk for future CVD and CVD events (McGill, 
McMahan, Herderick et al., 2002; Meyers & Gokce, 2007; Ikeoka, Mader, & Pieber, 
2010). 
Albeit clinical symptoms related to atherosclerosis, such as chest pain or 
discomfort, shortness of breath or fatigue, numbness, and blurred vision commonly are 
not detected in adolescents and young adults, atherosclerotic changes in the vessel wall 
already begin early in life, and these changes progress and predispose to the development 
of atherosclerotic CVD and acute CVD events in middle-aged and older adult populations 
(Jarvisalo et al., 2002). In addition, the growing overweight and obesity in adolescents 
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and young adults accelerate atherosclerotic inflammatory processes (McGill, McMahan, 
Herderick et al., 2002; Rocha & Libby, 2009). Therefore, knowledge of inflammatory 
biomarkers in relation to adiposity in adolescents and young adults may lead to new 
avenues to deter atherosclerotic processes that increase the risk of atherosclerotic CVD 
and acute CVD events in middle and older adults. 
Although dual-energy x-ray absorptiometry (DEXA), computed tomography 
( CT), magnetic resonance imaging (MRI), and underwater weighing are more precise and 
reliable measures of adiposity, these require greater cost and are not feasible in routine 
public health and clinical practices (Stevens et al., 2008). For these reasons, adiposity has 
been assessed by anthropometric measures (Body mass index [BMI], body fat percentage 
[BF%], waist circumference [WC], waist to hip ratio [WHR], and waist to height ratio 
[WHtR]) in public health and clinical practices. BMI is the most widely used 
anthropometric measure and is calculated as body weight in kilograms divided by height 
in meters squared (kg/m2) (Cornier et al., 2011). BF%, which can be estimated from 
measurement of skinfold thickness or bioelectrical impedance, is also used for assessing 
fat mass, or adiposity, as a proportion of total body mass (Stevens, McClain, & 
Truesdale, 2008). BMI and BF% are measures of total adiposity whereas WC, WHR, and 
WHtR are measures of central adiposity (Cornier et al., 2011). WC has been measured in 
different ways. The National Institutes of Health National Heart, Lung, and Blood 
Institute (HNHLB) (2000), currently recommends using an inelastic tape in a horizontal 
plane at the end of normal expiration in United States for the measurement of WC. The 
WHO (2011) recommends the use of the midpoint between the lower margin of the last 
palpable rib and the top of the iliac crest. WHR is the circumference of the waist divided 
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by the circumference of the hip and has been used for assessing body fat distribution 
(Cornier et al., 2011). Hip circumference is measured at the level of the widest portion of 
the buttocks (Cornier et al., 2011; WHO, 2011). WHtR is the circumference of the waist 
divided by the height (Cornier et al., 2011). 
To date, there is only one systematic review and meta-analysis addressing the 
obesity and CRP in various populations (Choi, Joseph, & Pilote, 2012); however, this 
review only focused on the CRP as a biomarker of inflammation. It is important to 
evaluate other inflammatory markers, such as IL-6 and TNF-a in order to better 
understand inflammatory processes in relation to anthropometric total and central 
adiposity measures. Therefore, the purpose of the systematic review was to determine the 
associations between anthropometric adiposity measures (BMI, WC, WHR, WHtR, and 
BF%) and inflammatory biomarkers (CRP, IL-6, and TNF-a) in adolescents and young 
adults without a known diagnosis of diseases. The goal of this systematic is to provide 
better understanding of the evidence linking anthropometric adiposity measures with 
inflammatory processes in young individuals free of co-morbidities. This review may 
provide an insight for early intervention strategies, such as a lifestyle modification and 
weight loss for improving long-term outcomes of reducing inflammation as related to 
adiposity. Additionally, this systemic review identifies gaps in current knowledge and 
provides future directions for research and practice. 
Methods 
Literature Search 
A systematic literature search was conducted to identify potentially relevant 
studies examining the association between anthropometric adiposity measures and 
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circulating levels ofCRP, IL-6, and TNF-a in adolescents and young adults. The 
electronic databases Ovid MEDLINE (from 1946 to July 03, 2013), CINAHL (from 1995 
to July 05, 2013), and SCOPUS (from 1960 to July 05, 2013) were searched. Reference 
lists of articles that met the inclusion criteria were searched manually for any additional 
studies. Search terms included Medical Subject Headings (MeSH) and keywords related 
to anthropometric adiposity measures ("body mass index,"" waist circumference," 
"abdominal obesity," "abdominal adiposity," "abdominal diameter," "waist to hip ratio," 
"waist to height ratio," "skinfold thickness," "body fat percentage," "body fat 
distribution," "body composition"); inflammatory markers ("inflammation," "C-reactive 
protein", "interleukin-6","tumor necrosis factor-alpha"); and "adolescent," "teen," 
"university student," "college student," and "young adult." Each category of variables 
was combined with each population using the "OR" Boolean operator. The variables and 
population were then combined using the ''AND" Boolean operator. Literature searches 
were limited to the English language and human subjects. The process of the search 
strategy is shown in Figure 1. 
Inclusion and Exclusion Criteria 
Inclusion criteria were: ( 1) adolescents and young adults aged 13 to 40 years; (2) 
investigated the association between at least one anthropometric adiposity measures and 
CRP, IL-6, and/or TNF-a; (3) anthropometric adiposity measured by BMI, WC, WHR, 
WHtR, and/or body fat percentage assessing a skinfold thickness or bioelectrical 
impedance ; ( 4) CRP, IL-6, and TNF -a levels measured from blood samples; ( 5) all types 
of research designs; ( 6) an original study; (7) no country restriction; and (8) published 
study in English language. Exclusion criteria were: (1) adolescent and young adults with 
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diagnosed diseases and infectious diseases; (2) pregnant women; (3) adiposity measured 
only by DEXA or MRI; ( 4) a review or an editorial article; and (5) an abstract. 
Data Extraction and Synthesis 
This review extracted year of publication, country, participants, setting, design, 
study period, anthropometric measures, measures ofCRP, IL-6 and TNF-a., results, 
analysis and significance of the association, and adjustment of co variates (Table 1 and 
Table 2). Mean, range, and proportion of age, sex, ethnicity, BMI, and sample size were 
reported. The statistical analyses and significance of associations or correlations between 
anthropometric adiposity measures and CRP, IL-6 and TNF -a for each study were 
presented as odds ratios, correlation coefficients, and/or regression coefficients with p-
value and 95% confidence interval if original studies were reported in this way. If the 
results of the studies were not reported in this way, the study findings were summarized 
for this review. Due to variation in growth rates, hormonal changes and pubertal stage of 
adolescents and young adults, the two groups were considered separately in this review. 
Study Quality Assessment 
Study method and quality were assessed using an evaluation checklist, which was 
developed by the first author based on the guidelines for assessing observational studies 
(Pocock et al., 2004; von Elm et al., 2007; Zaccai, 2004). This evaluation checklist 
included 11 questions to evaluate the main issues and potential biases related to design, 
sampling, setting, measurements, analyses, and peer-review of each study (Table 3 and 
Table 4). Each item was scored as "Yes=1," "No=O," and "Not reported=O", allowing the 
range of the score to be 0 to 11. 
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Results 
Study Selection 
As can be seen in Figure 2, a total of 4,876 studies were found from the Ovid 
MEDLINE, CINAHL, SCOPUS databases, and manual search of references. Of these, 
264 studies were identified by title and abstract. After the removal of duplicates, 176 
relevant studies remained for further detailed evaluation of the full text. Of the 176 
studies, 139 studies were excluded: 61 were not relevant to the research questions; 42 
studies were excluded for not meeting the criteria of age 13-40 years; 27 did not report 
associations or correlations between anthropometric adiposity measures and 
inflammatory markers; in four studies adiposity was measured by only DEXA or MRI; 
and in two studies participants had diagnosed diseases. In addition, two studies were 
excluded since dependent variables were not related to inflammatory biomarkers (CRP, 
IL-6, and TNF-a). Three cross-sectional studies were excluded due to same data from the 
same study cohort were collected. Four studies were a review or editorial and two studies 
reported an abstract only. Lastly, one systematic review and meta-analysis was excluded 
(Choi, Joseph & Pilote, 2013). Thus, 28 studies were included in this systematic review. 
The specific search strategies are illustrated in Figure 2. 
Study Characteristics 
Of 28 studies, six were conducted in United States, 17 were conducted in 
Australia, Egypt, Germany, Spain, Brazil, Italy, United Kingdom, Columbia, Finland, 
and New Zealand, and five studies were conducted in Korea, China, Philippines and 
India. Age of participants ranged from 13 to 39 years. The studies enrolled a total of 
15,862 participants; 4,859 adolescents and 11,003 young adults. Sample size ranged from 
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30 to 3,289 per study. Of the 28 studies, five studies consisted of males only (Jung et al., 
2008; Vikram et al., 2006; Bo, Raspo, Morra, Isaia et al., 2004; Bo, Raspo, Morra, 
Cassader et al., 2004; Perez et al., 2003), four studies consisted of females only (El-
Wakkad et al., 2013; Serrano et al., 2010; Brydon et al., 2008; Morrison et al., 2011), and 
19 studies consisted of both males and females . Of the 28 studies, nine studies reported 
participant's ethnicity (Huang et al., 2011; Jung et al., 2008; Khan et al., 2010; Moon et 
al., 2004; Petty et al., 201 0; Brydon et al., 2008; Mills et al., 2008; Morrison et al., 2011; 
Wang, Christoffel et al., 2011 ). 
For study design, only one out of28 studies had a prospective design (Khan et al., 
201 0), whereas the other remaining 27 studies used cross sectional designs. Although the 
data of the two studies were from the same study cohort (McDade et al., 2009; McDade 
et al., 2011), this review included these two studies because the outcomes of the 
inflammatory biomarkers are different; One study focused on CRP only (McDade et al., 
2009) and the other study examined IL-6 only (McDade et al., 2011). 
Of the 28 studies, nine studies analyzed data combining both males and females 
(Herder et al., 2007; Khan et al., 2010; Martinez-Gomez et al., 2010; Moon et al., 2004; 
Hermsdorff et al., 2011; McDade et al., 2009; McDade et al., 2011; Mills et al., 2008; 
Orri et al., 201 0). Eight studies conducted a separate analysis for males and females 
(Denney-Wilson et al., 2008; Huang et al., 2011; Petty et al., 201 0; Wang et al., 2011; 
Wamber et al., 2006; Nazmi et al., 2008; Raitakari et al., 2005; Williams et al., 2002). 
Two studies reported data for a combined analysis for males and females as well a 
separate analysis for males and females (Hermsdorff et al., 2012; Wang, Reed et al., 
2011 ). In addition, none of the studies reflected ethnic influences or ethnic differences in 
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the association between anthropometric adiposity and inflammatory biomarkers in this 
review. Two studies reported ethnicity, but they did not determine the association 
between anthropometric adiposity and inflammatory biomarkers (Khan et al., 201 0; 
McDade et al., 2011 ). The association between adiposity and inflammatory biomarkers 
was analyzed using odds ratio, Pearson coefficient, Spearman coefficient, or regression 
coefficient. The detailed characteristics of each study were summarized in Table 1 and 
Table 2. 
Anthropometric Adiposity Measures 
Anthropometric adiposity was assessed by BMI, WC, WHR, WHtR, and BF. The 
BF (mm) or (%) was examined by sum of skinfold thickness using a skinfold caliper or 
by bioelectrical impedance. Of the total 28 studies, 24 studies included two or more 
anthropometric measures; two studies used BMI only (Khan et al., 2010; McDade et al., 
2011); one study used WC only (Jung et al., 2008); and one study used BF% only 
(Hermsdorff et al., 20 12). Twenty six studies considered adiposity as a continuous 
variable and two studies analyzed adiposity as a categorical variable (Denney-Wilson et 
al., 2008; Nazmi et al., 2008). Of these two studies, one study categorized BMI into non-
obese, overweight and obesity based on the International Obesity Task Force and the 
United Kingdom Child Growth Foundation Charts (Denney-Wilson et al., 2008) and the 
other study categorized BMI into WHO recommendation: < 18.5kg/m2 
(underweight),18.5-24.9 kg/m2 (normal), 25.0-29.9 kg/m2 (overweight), and 30kg/m2 
(obese) (Nazmi et al., 2008) (Table 1 and Table 2). 
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Measurement of CRP, IL-6 and TNF -a 
CRP was measured using diverse immunoassay tests. Five studies used enzyme-
linked immunosorbent assay (ELIZA), 5 studies used immune-turbidimetry, 2 studies 
used high-sensitivity immunoassay, 2 studies used automated DPC immulite 
chemiluminescent immunoassay, and other studies used ultrasensitive assay, high 
sensitive-monoclonal antibody assay, latex enhanced immune-turbidometry, sandwich 
immunoassay, high sensitivity-Denka-Seiken assay, high sensitivity-latex enhanced 
immune-nephelometric assay and Cardio high sensitivity-CRP assay. For IL-6, 6 studies 
used ELIZA, and other studies used high sensitivity-human cytokine, and high 
sensitivity-multiplex immunoassay. For TNF-a, 4 studies used ELIZA. Of the 28 studies, 
21 studies have an overnight fast. 
Study Quality Assessment 
None of the studies met all of the evaluation quality criteria. Of the 28 studies, 
eight studies met high quality ( 1 0 out of 11 ); eight studies met nine out of 11; six studies 
met eight out of 11; five studies met seven out 11; and one studies met low quality (six 
out of 11 ). Of the 28 studies, 25 studies reported study designs either in method section, 
discussion or limitation section. Of the 28 studies, 10 studies did not specify inclusion 
and exclusion criteria, and only one study reported a sample size estimate (Nazmi et al., 
2008). Of the 28 studies, six studies (Jung et al., 2009; Bo et al., 2004; Mills et al., 2008; 
Morrison et al., 2011; Orri et al., 201 0; Raitakari et al., 2005) did not report how 
anthropometric adiposity was measured in detail and three studies (Hennsdorff et al., 
20 12; Hennsdorff et al., 2011; McDade et al., 2009) provided protocols and guidelines on 
the measurements of anthropometric adiposity in their reference section (Table 3, Table 
ANTHROPOMETRIC ADIPOSITY AND INFLAMMATION 49 
4). Of the 28 studies, 12 adjusted for covariates in data analysis. Covariates included age, 
gender, ethnicity, lipids, family income, physical activity, pubertal status, and 
homeostasis model assessment of insulin resistance (HOMA-IR) in adolescent studies, 
whereas, age, gender, smoking status, physical activity, skin color, family income, years 
of education were included in young adult studies. 
Associations of Anthropometric Adiposity Measures with Inflammation in 
Adolescents 
Thirteen studies identified associations between anthropometric adiposity 
measures (BMI, WC, WHR, WHtR, and BF) and inflammatory biomarkers (CRP, IL-6, 
and TNF-a) in adolescents. The descriptive values on anthropometric adiposity measures 
(BMI, WC, WHR, WHtR, and BF) and inflammatory biomarkers (CRP, IL-6, and TNF-
a) were reported in Table 1. 
Anthropometric adiposity and CRP. Of these 13 studies, 10 studies examined 
the association of anthropometric adiposity measures and CRP levels (Denney-Wilson et 
al., 2008; Huang et al., 2011; Jung et al., 2009; Khan, Rieder, Cohen, Coupey, & 
Wildman, 201 0; Martinez-Gomez et al., 201 0; Petty et al., 201 0; Serrano et al., 201 0; 
Vikram et al., 2006; Wang, Christoffel et al., 2011; Warn berg et al., 2006). Of the 10 
studies, nine studies found significantly positive associations between one or more 
anthropometric adiposity measures (BMI, WC, WHR, WHtR, and BF) and CRP 
(Denney-Wilson et al., 2008; Huang et al., 2011; Jung et al., 2009; Khan, Rieder, Cohen, 
Coupey, & Wildman, 201 0; Martinez-Gomez et al., 201 0; Petty et al., 201 0; Vikram et 
al., 2006; Wang, Christoffel et al., 2011; Warnberg et al., 2006). However, one study did 
not find any significant association ofBMI and WC with CRP (Petty et al., 2010). Of the 
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nine studies, five studies included males and females separately (Denney-Wilson et al., 
2008; Huang et al., 2011; Petty et al., 201 0; Wang, Christoffel et al., 2011; Wamberg et 
al., 2006). Of the five studies, four studies revealed that there were significantly positive 
associations between two and more anthropometric adiposity measures (BMI, WC, 
WHtR, and BF) and CRP in both males and females (Denney-Wilson et al., 2008; Huang 
et al., 2011; Wang, Christoffel et al., 2011; Wamberg et al., 2006). However, one study 
revealed that there were significantly positive associations ofBMI and WC with CRP 
only for females but not males (Petty et al., 201 0). 
Anthropometric adiposity and IL-6. Of these 13 studies, three studies 
determined associations of anthropometric adiposity measures (BMI, WC, and BF) and 
IL-6levels (Herder et al., 2007; Martinez-Gomez et al., 2010; Petty et al., 2010). Only 
one study revealed that there were significantly positive associations between 
anthropometric adiposity measures (BMI and WC) and IL-6levels (Herder et al., 2007). 
In contrast, the remaining two studies revealed that no significant association between 
anthropometric adiposity measures and IL-6 (Martinez-Gomez et al., 201 0; Petty et al., 
201 0). Of the three studies, only one study included a separate analysis for males and 
females (Petty et al., 201 0). This study found that there were no significant associations 
ofBMI and WC with IL-6 in males or females (Petty et al., 2010). 
Anthropometric adiposity and TNF -a. Of these 13 studies, three examined 
associations of anthropometric adiposity measures (BMI, WC, WHR, and BF) and TNF-
a. Two studies found that there were significant positive associations of BMI, WC, and 
WHR with TNF-a (El-Wakkad et al., 2013; Moon et al., 2004). However, one study did 
ANTHROPOMETRIC ADIPOSITY AND INFLAMMATION 51 
not find significant associations ofBMI and WC with TNF-a (Herder et al., 2007). None 
of these studies included sex differences. 
Association of Anthropometric Adiposity Measures and Inflammation in Young 
Adults 
Fifteen studies found associations between anthropometric measures (BMI, WC, 
WHR, WHtR, and BF) and inflammatory biomarkers (CRP, IL-6, and TNF-a) in young 
adults. The descriptive values on anthropometric adiposity measures (BMI, WC, WHR, 
WHtR, and BF) and inflammatory biomarkers ( CRP, IL-6, and TNF -a) were reported in 
Table 2. 
Anthropometric adiposity and CRP. Of the 15 studies, 13 studies determined 
the association of anthropometric adiposity measures and eRP (Bo, Raspo, Morra, 
eassader, et al., 2004; Bo, Raspo, Morra, Isaia, et al., 2004; Hermsdorff et al., 2012; 
Hermsdorff, Zulet, Puchau, & Martinez, 20 II; McDade et al., 2009; Mills et al., 2008; 
Morrison et al., 2011; Nazmi et al., 2008; Orri, Carter, & Howington, 2010; Perez et al., 
2003; Raitakari et al., 2005; Wang, Reed, Goli, & Goswami, 2011; Williams et al., 2002). 
All of the 13 studies found that there were significant positive associations between one 
or more anthropometric adiposity measures (BMI, we, WHR, and BF) and CRP. Of the 
13 studies, five studies included a sex differences (Hermsdorff et al., 2012; Nazmi et al., 
2008; Raitakari et al., 2005; Wang, Reed et al., 2011; Williams et al., 2002). Of the five 
studies, four found that there were significantly positive associations between two or 
more anthropometric adiposity measures (BMI, we, WHR, and BF) and eRP in both 
males and females (Hermsdorff et al., 2012; Nazmi et al., 2008; Raitakari et al., 2005; 
Williams et al., 2002). However, remaining one study showed that there were significant 
ANTHROPOMETRIC ADIPOSITY AND INFLAMMATION 52 
positive associations ofBMI and BF% with CRP in females but not males (Wang, Reed 
et al., 2011 ). 
Anthropometric adiposity and IL-6. Of these 15 studies, five studies focused on 
associations between anthropometric adiposity measures (BMI, WC, WHR, and BF%) 
and IL-6. Of the five studies, four reported a significant positive associations between 
one or more anthropometric adiposity measures (BMI, WHR, and BF%) and IL-6 
(Brydon et al., 2008; Hermsdoff et al., 2011; McDade et al., 2011; Mills et al., 2008). 
However, one study did not find significant associations of BMI and BF% with IL-6 
(Wang, Reed et al., 2011 ). Of the five studies, sex differences were examined only in one 
study, in which no significant associations of BMI and BF% with IL-6 in either males or 
females were found (Wang, Reed et al., 2011). 
Anthropometric adiposity and TNF -a. Of these 15 studies, only one study 
examined associations between anthropometric adiposity measures (BMI and BF%) and 
TNF-a (Wang, Reed et al., 2011). The study did not find significant associations ofBMI 
and BF% with TNF -a (Wang, Reed et al., 2011 ). In sex differences, the study did not 
find significant associations ofBMI and BF% with TNF-a in either males or females 
(Wang, Reed et al., 2011). 
Discussion 
Synthesis of Main Findings and Knowledge 
The major finding of this systematic review is that there is a significant and 
positive association between anthropometric adiposity measured by total and central 
adiposity (BMI, WC, WHtR, WHR, and BF%) and CRP in adolescents and young adults 
in 22 out of 23 studies (96% ). These positive associations are consistent with the findings 
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of a previous review on the positive association between abdominal adiposity and CRP in 
adults (Brooks et al., 201 0) and a previous systematic review and meta-analysis on 
obesity and CRP in various populations (Choi, Joseph, & Pilote, 2012). In addition, 
elevated circulating levels of CRP were found in obese participants when compared with 
non-obese counterparts, which supported evidence for an association of obesity and CRP 
(Denney-Wilson et al., 200; Nazmi et al., 2008) (p < 0.05). The finding of a significant 
association between obesity and CRP is in agreement with previous results showing that 
weight loss was associated with a decline in circulating levels ofCRP in obese 
individuals aged 20 to 46 years (Esposito et al., 2003) and systematic review (Selvin, 
Paynter, & Erlinger, 2007) which provide additional supportive evidence for a link of 
obesity and CRP. Only one study did not indicate.any significant associations between 
the anthropometric measures (BMI, WC, WHR, and BF%) and CRP in female 
adolescents in Brazil (Serrano et al., 201 0). This study did not report detailed information 
about the measurement of CRP assay and coefficients of variation (CV), and did not 
discuss any limitations regarding the fmdings. 
The present systematic review examined additional inflammatory biomarkers, 
including IL-6 and TNF -a and anthropometric adiposity. The findings of the review in 
the associations between anthropometric adiposity measures (BMI, WC, WHR, and 
BF%) with IL-6 from eight studies and TNF -a from four studies in adolescents and 
young adults have shown inconsistent results. Of the eight studies of IL-6, five studies 
revealed significant positive associations (p < 0.05) in adolescents (Herder et al., 2007) 
and young adults (Brydon et al., 2008; Hermsdoff et al., 2011; McDade et al., 2011; Mills 
et al., 2008), whereas three studies showed no significant associations in adolescents 
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(Martinez-Gomez et al., 2010; Petty et al., 2010) and young adults (Wang, Reed et al., 
2011). Of the four studies in TNF-a, two studies revealed significantly positive 
associations (p < 0.05) in adolescents (El-Wakkad et al., 2013; Moon et al., 2004) and 
two studies found no significant associations in adolescents and young adults (Herder et 
al., 2007; Wang et al., 2011). One of the possible reasons for the discrepancy may be due 
to the different sampling strategies. For instance, some studies consisted primarily of 
non-obese participants (Herder et al., 2007; Martinez-Gomez et al., 2010; Petty et al., 
201 0; Wang, Reed et al., 2011, whereas other studies had a preponderance of obese 
participants (El-Wakkad et al., 2013; Moon et al., 2004). The latter might be better able 
to identify an obesity-induced inflammatory association than the former. Another 
possible reason for the discrepant findings may be attributable to low blood 
concentrations of IL-6 and TNF -a if some studies have participants who are mostly from 
a non-obese population. Of studies showing the positive association of anthropometric 
measures with CRP, IL-6 and TNF-a in adolescents and young adults, there was no 
single anthropometric adiposity measure that suggested a stronger correlation than others 
with CRP, IL-6 and TNF -a in adolescents and young adults. 
Sex 
Sex has been reported to influence the association between anthropometric 
adiposity measures and inflammatory biomarkers. For sex differences, only two studies 
reported there were significant positive associations of anthropometric adiposity 
measures (BMI, WC, and BF%) with CRP in female but not males (Petty et al., 2010; 
Wang et al., 2011). The findings are congruent with previous systematic review and 
meta-analysis showing that r for BMI and ln(CRP) was greater in women than men by 
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0.24 (CI, 0.09-0.37) in adults (Choi, Joseph, & Pilote, 2012). In a previous population-
based study of middle-aged men and women, adiposity was strongly associated with 
higher CRP levels in women as compared to men (Thorand et al., 2006). It could be 
explained in several ways. First of all, women have more total adiposity and 
subcutaneous fat than men (Lohman, 1981 ). In addition, women have higher levels of 
CRP as compared to men (Khera et al., 2005). Moreover, women who take oral 
contraceptives have higher levels of CRP compared with those taking a placebo 
(Eilertsen et al., 2005). Furthermore, women during menses have higher levels of CRP 
(median, 0.74mg/L), than CRP during the follicular phase of the menstrual cycle and 
CRP during ovulation is lowest (Gaskins et al., 2011 ). In these cases, study designs could 
control use of oral contraceptives as a covariate. Also, data on CRP could be collected at 
times other than the menstrual phase. Thus, the associations between anthropometric 
adiposity measures and inflammatory biomarkers might be modified by sex. However, 
further studies are needed to identify sex differences while controlling use of oral 
contraceptives and menses. None of studies determined sex differences in anthropometric 
adiposity measures and IL-6 and TNF-a. 
Etbnicity 
For ethnicity differences, none of the studies reflected ethnic and race differences 
in associations between anthropometric adiposity measures and inflammatory markers in 
this review. Only two studies out of28 studies reported ethnicity, but these studies did 
not determine differences by ethnicity (Khan et al., 201 0; Mills et al., 2008). Previous 
systematic review and meta-analysis found that the association (r) between obesity (BMI) 
and In (CRP) was greater in North Americans/Europeans than Asians by 0.15 (CI, 0-
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0.28), which indicated that ethnicity may be a potential moderator between 
anthropometric adiposity measures and inflammatory markers. Therefore, information on 
ethnicity should be obtained and tested as a moderating variable in the analysis of future 
studies. 
Study Methodological Quality 
The majority of studies used a cross-sectional design, from which causality 
between adiposity and inflammation could not be determined. Additionally, this cross-
sectional design does not allow a prospective evaluation of these associations. Ten 
studies of a total of 28 studies did not address specific inclusion and exclusion criteria of 
participants. Of the 10 studies, seven studies were conducted in nationally representative 
samples and the participants were relatively healthy adolescents and young adults 
(Denney-Wilson et al., 2008; Huang et al., 2011; Martinex-Gomez et al., 2010; McDade 
et al., 2009; Morrison et al., 2011; Nazmi et al., 2008; Wang et al., 2011); however, 
studies without considering inclusion and exclusion criteria had reduced internal validity. 
Interestingly, most studies did not report any power calculation to justify their sample 
size, although most of these studies included a large sample size and were population-
based studies. Studies conducted with a small sample size without achieving sufficient 
power also may reduce generalizability and external validity. 
In addition ten of these 28 studies did not report CV of the assay, so the degree of 
measurement error is unknown. Moreover, one study addressed that CRP was measured 
by non-high sensitive assay, which potentially could lead to underestimation of the 
association of anthropometric adiposity and CRP (Williams, et al., 2002). More sensitive 
biomarkers should be required to accurately detect circulating levels of the inflammation 
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especially in healthy populations in order to avoid reducing internal validity. 
Furthermore, the majority of studies assessed a single CRP, IL-6 and TNF-a 
measurement, which may not accurately reflect long term-low grade inflammatory status. 
Sixteen of the 28 studies did not report potential confounders, such as age, sex, ethnicity, 
acute smoking/current smokers, and alcohol dependence for their statistical analyses 
(O'Connor et al., 2009). This lack of identification and control of potential confounding 
variables also reduced internal validity. 
Gaps and Future Directions 
In order to further advance knowledge in the area of anthropometric adiposity 
measures and inflammation in adolescents and young adults, gaps are identified and 
recommendations are proposed based on this review. First of all, there is not enough 
evidence to arrive at the conclusion of anthropometric adiposity measures with IL-6 and 
TNF -a. More evidence is required for anthropometric adiposity measures with IL-6 and 
TNF-a, particularly using continuous variables for more accurate estimation of the 
strength of associations. Also, stratified sampling or quota sampling strategies regarding 
non-obese, overweight, and obese participants should be considered for better detection 
of associations between adiposity and inflammatory processes. Secondly, of the 28 
studies, ten studies included a sex breakdown and a statistical analysis was performed for 
males and females separately. Of the 28 studies, four studies did not control sex either 
separately or as a covariate (Moon et al., 2004; McDade et al., 2009; Mills et al., 2008; 
Orri et al., 2010), and none of the studies determined ethnicity differences or influences. 
Future studies should routinely obtain and assess sex and ethnicity because of the 
potential impact of sex and ethnicity in the association between adiposity and 
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inflammation (Choi et al., 2012; O'Connor et al., 2009). Thirdly, other important 
variables, such as a smoking status, alcohol dependence, acute exercise, and selective 
serotonin reuptake inhibitor (SSRI) use, which increase in inflammatory markers and 
may contribute to the heterogeneous results, should be assessed, controlled and possibly 
excluded (O'Connor et al., 2009), and explain how and why they chose covariates for 
adjustment or exclusion criteria in order to rule out their effects on the association 
between anthropometric adiposity measures and inflammation. In addition, two studies 
suggested that diet and physical activity/fitness play an important role in reducing 
inflammatory markers (Petty et al., 201 0; Vikram et al., 2006), thus future studies need to 
focus on the interplay of diet and physical activity/fitness, and how those variables 
influence the association between anthropometric adiposity measures and inflammation. 
Fourthly, most studies did not provide the justification of their sample size. Future studies 
should consider sufficient power calculation to justify their enough sample size or a 
larger sample of both genders in order to confirm these findings. Fifthly, since there is a 
limitation of cross-sectional design, the significant association between anthropometric 
adiposity measures and inflammation need to be evaluated in prospective studies in 
adolescents and young adults. Sixthly, most studies pointed out the use of a single 
measurement of inflammatory biomarkers, which may reduce a precision to reflect a 
long-term inflammatory status. Future studies should consider repeated measurements in 
order to ascertain a more stable estimate of inflammatory status. Lastly, in order to 
understand underlying inflammatory mechanisms in relation to anthropometric adiposity, 
other inflammatory markers, such as IL-l~' should be investigated. 
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Review Limitations 
This systematic review has some limitations. First of all, since this review was 
limited by studies published in English language, a reporting bias may exist. Some of the 
included studies did not consider their inclusion and exclusion criteria, which may reduce 
internal validity. In addition, this review only focused on indirect measures of excess 
adiposity; BMI, WC, WHR, WHtR, and BF%, which has less accuracy than direct 
measures, such as DEXA, CT, or MRI. Furthermore, heterogeneity of study populations 
and diverse statistical analyses for associations limited the consolidation for synthesis of 
main findings. The evaluation checklist for study quality assessment was developed 
based on the guidelines for assessing observational studies (Atlantis & Baker, 2008; 
Pocock et al., 2004; von Elm et al., 2007; Zaccai, 2003). The quality score did not 
establish cutoff score to determine strong, moderate, or weak of included studies. Finally, 
the populations of this review only focused on adolescents and young adults therefore the 
findings could be different from middle and older adulthood due to physical and 
biological changes. In spite of these limitations, findings of this review have significant 
implications for assessing inflammatory biomarkers in relation to adiposity in public 
health and clinical practices. More importantly, although associations between obesity 
and CRP has been explored in a systematic review and meta-analysis in various 
populations (Choi et al., 2012), our review included empirical literature investigating the 
associations of anthropometric approach assessing adiposity measures (BMI, WC, WHR, 
WHtR, and BF%) and inflammatory biomarkers, including CRP IL-6 and TNF-a in 
adolescent and young adult populations. 
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Conclusions 
This systematic review overall identified that there are consistently positive 
associations of anthropometric adiposity measures (BMI, WC, WHR, and BF%) and CRP 
in adolescents and young adults without a known diagnosis of diseases. Findings of 
anthropometric adiposity measures (BMI, WC, WHR, and BF%) and IL-6 and TNF -a in 
adolescents and young adults remain inconclusive. No single anthropometric adiposity 
measures in adolescents and young adults would appear to be superior in relation to CRP, 
IL-6 and TNF-a. Further studies are needed to identify the strength and patterns of 
association of anthropometric adiposity measures with CRP, IL-6 and TNF -a. Moreover, 
further studies are needed to identify ethnicity differences in the association of 
anthropometric adiposity measures and inflammatory biomarkers. Lastly, research is 
needed to focus on the interplay of diet, physical activity/fitness, or weight loss with 
CRP, IL-6 and TNF-a for developing appropriate and effective lifestyle modification in 
reducing circulating levels of CRP, IL-6 and TNF -a and in preventing further 
development of atherosclerotic CVD and acute CVD events in later life. 
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1. exp Inflammation/ 
2. exp cytokines/ or exp interleukin-6/ or exp tumor necrosis factor-alpha/ 
3. exp C-Reactive Protein/ 
4. ( crp or c-reactive or interleukin 6 or il-6 or tnf-alpha or tnf).ti,ab. 
5. 1 or 2 or 3 or 4 
6. exp adolescent/ or exp young adult/ 
7. exp young adult/ 
73 
8. (aged adj2 ("24" or "25" or "26" or "27" or "28" or "29" or "30" or "31" or "32" or "33" 
or "34" o_r "35" or "36" or "37" or "38" or "39" or "40")).ab. 
9. (youth or adolescen* or teen* or young adult* or university student*).ti,ab. 
10. 6 or 7 or 8 or 9 
11. body mass index/ or (body mass or bmi).ti,ab. 
12. skinfold thickness/ or skinfold*.ti,ab. 
13. body fat distribution/ or adiposity/ 
14. body fat percentage.ti,ab. or body composition/ 
15. (anthropometric adiposity or anthropometric measure*). ti,ab. 
16. waist to heihgt ratio/ or waist to height ratio.ti,ab. 
17. waist circumference/ or abdominal obesity/ or abdominal adiposity.ti,ab. or 
abdominal diameter.ti,ab. 
18. waist to hip ratio/ or waist to hip ratio.ti,ab. 
19.5 and 10 
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20. 11 or 12 or 13 or 14 or 15 or 16 or 1 7 or 18 
21. 19 and 20 
22.limit 21 to English language 
2,325 articles 
CINAHL search 
(1995 to July 05, 2013) 
74 
S 1. ((MH "Inflammation") OR (MH "Cytokines") OR (MH "Tumor Necrosis Factor") 
OR (MH 11C-Reactive Protein") ) OR TI ( crp or c-reactive or interleukin 6 or tnf or il-6 ) 
OR AB ( crp or c-reactive or interleukin 6 or tnf or il-6 ) 
S2. ( (MH "Adolescence") OR (MH "Young Adult") ) OR TI (youth or adolescen* or 
teen* or young adult* ) OR AB ( youth or adolescen* or teen* or young adult* ) 
S3. Sl and S2 
S4. ((MH "Waist-Hip Ratio") OR (MH "Waist Circumference")) OR TI (adominal 
adiposity or abdominal diameter) OR AB ( adominal adiposity or abdominal diameter) 
S5. (MH "body mass index") OR TI (body mass or bmi) OR AB (body mass or bmi) 
S6. (MH "Skinfold Thickness 11 ) OR TI skinfold* OR AB skinfold* 
S7. (MH "Adipose Tissue Distribution") OR (MH "Adipose Tissue") 
S8. TI "waist to height ratio" OR AB "waist to height ratio 11 
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Figure 1. Database search strategy 
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Total (X = 4,876) 
Ovid MEDL~"E (N = 2,325) 
CINAHL (N = 441) 
SCOPUS (N = 2,108) 
Manual search of references (N = 2) 
1 
Total (X = 264) 
Chid MEDLINE (N = 11 7) 
CINAHL (N = 29) 
SCOPUS (N = 116) 
Manual references (N = 2) 
1 
Full text studies a.'aluated in 
detail for eligibility 
(X= 176) 
j 
Full text studies included 
in re\'iew (X = 28) 
Studies excluded on the bases oftitle and 
abstract review 
N=4,614 
Duplicates removed 
N=88 
Excluded Full text studies ~ = 148) 
Not relevant (N = 61) 
Did not meet age (13-40years) (N = 42) 
No data of association or correlation (N = 27) 
Adiposity measured by DEXA or MRI (N = 4) 
Participants with diagnosed diseases (N = 2) 
No dependent data of inflammatory marker(s) (N = 2) 
Data from the same study cohort (N = 3) 
Review (N = 4) and systematic review (N = 1) 
No full-length studies; Abstract only (N = 2) 
Figure 2. Flowchart of study selection for systematic review 
Table 1 
Studies reporting the association of anthropometric adiposity and inflammatory biomarkers in adolescents 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sexlage/adiposity/inflammatory study adiposity markers for 
country markers: mean:SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI,WC, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
Denney- To determine N=496 Secondary Cross- BMI (kg/m2) Hs-CRP (mg/L) Hs-CRP was Logistic regression No 
Wilson et the association (M/F =290/206) schools in sectional non- Plasma significantly OR(95%CI) 
al, 2008, between Age 15.4 ± 0.4y Sydney overweight vs. Ultrasensitive associated with BMI (M) 
Australia measures of Feb 2004- overweight (~ assay overweight and Non-overweight 
adiposity (BMI, BMI (M) May2004 25) vs. Intra-assay CV obese (defined by I (reO (N = 210) 
WC) and risk 21.4±4.1 obese(~ 30) =Not reported BMI and WC) in Overweight (N = 61) 
factors for heart WC(M) Substudy (International Inter-assay CV both adolescent's 4.7 (1.2-18.5) 
disease, type2 71.9 ± 9.6cm of the Obesity Task =7.4% boys and girls Obese (N = 19) 
diabetes, fatty Hs-CRP (M) (median New Force (p < 0.001). 16.6 (3.5-79.2) 
liver disease, (IQR)): 0.4 (0.2-1.0) South Definition cut Cut-off level = WC(M) 
and the mg/L Wales points) 3.0 mg/L Non-overweight 
clustering of risk Schools > 3.0 (high) 1 (reO (N = 232) 
factors in BMI (F) Physical WC(cm) ~ 3.0 (low or Overweight (N = 29) 
Australian 21.5±3.4 Activity non- normal) 3.0 (0.6-15.6) 
adolescents. WC(F) and overweight Obese (N = 29) 
65.8 ± 7.9cm Nutrition vs. Overnight fast 12.7 (5.0-31.9) 
Hs-CRP (F) (median Survey overweight 
(IQR) ): 0.3(0.2-1.0) (SPANS (91st BMI (F) 
mg!L 2004) percentile) vs. Non-overweight 
obese (95th I (reO (N = 166) 
percentile) (UK Overweight (N = 31) 
Child 6.8 (2.4-19.0) 
Growth Obese (N=9) 
Foundation 6.8 (1.7-27.3) 
Charts 1997 cut WC(F) 
points) Non-overweight 
: measured at 1 (reO (N = 169) 
the narrowest Overweight (N = 20) 
point between 3.2 ( 1.1-9.4}_ 
Author, Purpose Participants Design, 
year, (N/sexlageladiposity/inflammatory study 
country markers: mean±SD), period 
setting/location 
El- To investigate N = 86 (F) Students Cross-
Wakkad, the effect of Age 13-18y from four sectional 
.et al., central obesity BMI > 95 percentile local public (Study 
2013, in obese schools design: 
Egypt adolescent girls Group I (N = 43) Cairo in not 
on the (WHR<0.80) Egypt reported) 
promotion of the WHR: mean± SE 
secretion of pro- 0. 74±0.00045 Study 
inflammatory TNF -a: mean ± SE period: 
(TNF-a, IL-lp, 2.24±0.59 pglml not 
leptin) and anti· reported 
inflammatory Group II (N = 43) 
adiponectin (IL- (WHR~0.80) 
4, IL-5) WHR: mean± SE 
adiponkines in 0.89±0.017 
adolescent TNF-a: mean ± SE 
Egyptian girls. 30.4±1.735 pglml 
Anthropometric 
adiposity 
measures 
(BMI, WC, 
WHR, WHtR, 
BF%) 
the lower 
costal border 
and the iliac 
crest 
WHR: calculated 
by dividing we 
(em) by hip 
circumference 
(em). 
we (em): 
measured the 
smaller 
circumference 
between the iliac 
crest and first 
rib. 
Hip (em): 
measured at the 
most prominent 
area of the 
buttocks at the 
level ofthe 
symphysis pubis. 
Abdominal 
obesity: WHR ~ 
0.80 
Inflammatory Results 
markers 
(CRP, IL-6, TNF-a) 
measurement site, 
assay, CV 
TNF-a (pglmL) There was a 
Serum significant positive 
ELISA correlation 
CV= Not reported between WHR and 
Sensitivity = 2.3 TNF-a of group II. 
pglmL 
Fasting not 
reported 
Analysis and significance 
Obese (N = 17) 
5.3 (0.8-12.1) 
Pearson correlation 
TNF-a 
WHR (~ 0.80): r = 
0.559, p <0.00 1 in 
group II 
Adjustments 
for 
covariates 
No 
-.....) 
00 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sexlage/adiposity/inflammatory study adiposity markers for 
country markers: mean:i:SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
Herder et To characterize N=519 Students Cross- BMI (kg/m2) IL-6 (pglmL) IL-6 was Linear regression Age, sex, 
al, 2007, the pattern of (MIF = 293/226) from sectional we (em): Serum significantly p:regression coefficients lipids 
Germany subclinical Age 15.5 : 0.8y selected measured at a ELISA associated with IL-6 (In-transformed) 
immune secondary In 2005 level midway Intra-assay CV both higher BMI BMI: p = 0.033 
activation that is BMI (M) schools for between the = 5.2% and higher we (p < 0.001) 
associated with 22.4 :i: 4.3 a medical lower rib Inter-assay CV (p::: 0.001). WC:P=0.011 
indices of WC(M) check-up margin and = 15.5% (p = 0.001) 
obesity and 78.2 ± 11.8cm by Public iliac crest to Sensitivity 
insulin IL-6 (M): median Health the nearest =0.08pglml 
resistance in (IQR) Office in O.Scm. 
youth and 0.9 (0.6; 1.5) pglmL DUsseldorf TNF-a (pglmL) TNF -a was not TNF-a (In-transformed) 
analyze whether TNF-a (M): ): median Serum significantly BMI:p= -0.003 
this association (IQR): ELISA associated with (p = 0.395;NS) 
is explained by 1.8 (1.5; 2.2) pg/mL Intra-assay CV both BMI and WC: p = -0.003 
obesity as =6.7% WC(p=NS). (p = 0.114;NS) 
assessed by BMI BMI (F) Inter-assay CV 
and we in 23.3 ±4.9 =8.8% 
adolescents. WC(F) Sensitivity 
76.8 ± 10. 7cm = 0.25pglml 
IL-6 (M): median 
(251h; 75th percentiles) Overnight fast 
0.9 (0.6; 1.6) pg/mL 
TNF-a(M) 
I. 7 ( 1.4; 2.2) pg/mL 
Author, Purpose Participants Design, Anthropometric 
year, (N/sexlage/adiposity/inflammatory study adiposity 
country markers: mean:!:SD), period measures 
setting/location (BMI, WC, 
WHR,WHtR, 
BF%) 
Huanget To detennine N = 1t149 The West Cross- BMI (kg/m2) 
alt whether (MIF = 604/545) Australian sectional we (em): 
2011t individual CV Age 14y pregnancy measured at 
Australia risk factors have Caucasian cohort Study umbilicus 
a different (Raine) period: level 
pattern of BMI (M) study not WHtR 
relationships to 21.0:!: 4.1 follow-up reported 
used WC(M) their 
anthropometric 76.3 :!: 11.2cm children at 
measures. WHtR(M) age 14 
0.46:!: 0.07 
CRP(M) 
2.2 : 0.6 mmoVL 
BMI (F) 
21.8 ± 4.3 
WC(F) 
75.1: 10.4cm 
WHtR(F) 
0.46±0.06 
CRP (F) 
2.4 ± 0.6 mmoi/L 
Inflammatory Results 
markers 
(CRP, IL-6, TNF-a) 
measurement site, 
assay, CV 
CRP (mmoVL) CRP had equally 
Serum and most highly 
Hs- monoclonal correlated with 
antibody assay wet WHtRand 
Intra-assay CV BMiin 
=Not reported adolescents. No 
Inter-assay CV single 
= 2.1-2.6% anthropometric 
Overnight fast measures best 
predicted CRP. 
Analysis and significance 
Stepwise linear regression 
B: regression 
coefficient indicates the 
wnountofchangein 
units of the outcome 
variable (CRP) that is 
associated with a single 
unit change in wet 
WHt~ and BMI. 
CRP (log) 
BMI (M) 
B= 0.11 (p < 0.001) 
R2 =0.34 
B= 0.12 (p < 0.001) 
R2 =0.35 
B= 0.12 (p < 0.001) 
R 2 = not reported 
Adjustments 
for 
covariates 
Unadjusted 
Adjusted for 
Aget family 
income, 
physical 
activity 
Additional 
adjusted for 
pubertal 
staging 
00 
0 
Author, Purpose Participants Design, Anthropometric Inflammatory Results 
year, (N/sexlage/adiposity/inflammatory study adiposity markers 
country markers: mean::I:SD), period measures (CRP, IL-6, TNF-a) 
setting/location (BMI, WC, measurement site, 
WHR,WHtR, assay, CV 
BF%) 
Analysis and significance 
WHtR(M) 
B= 5.55(p = 0.003) 
R2 =not reported 
B= 4.84 (p = 0.02) 
R 2 = not reported 
B= 5.00 (p = 0.02) 
R 2 = not reported 
WC(F) 
B = 3.23 (p = 0.002) 
R2 = 0.17 
B= 3.10 (p = 0.003) 
R2 = 0.18 
Adjustments 
for 
covariates 
Unadjusted 
Adjusted for 
Age, family 
income, 
physical 
activity 
Additional 
adjusted for 
pubertal 
staging 
Unadjusted 
Adjusted for 
Age, family 
income, 
physical 
activity 
00 
-
Author, Purpose Participants Design, 
year, (N/sexlage/adiposity/inflammatory study 
country markers: mean:I:SD), period 
setting/location 
Jung et To investigate N=79 (M) Volunteers Cross-
al, 2008, whetherWC, Age 13-17y from sectional 
Germany BMI standard Caucasian, Schools of (Design: 
deviation score the region not 
predict classical BMI (Median (IQR)) of Jena, reported) 
and new 22.8 (20.5-30.5) Germany 
markers of CV WC (Median (IQR)) Study 
risk and diabetes 81 (73-91) em period: 
in male 48% (n = 38) had a not 
Caucasian we::: 9oth reported 
adolescents. Percentile 
Hs-CRP (Median 
(IQR)) 
0.60 (0.10-1.60) 
mg/L 
Khan et To examine the N = 83 (baseline) A A six-
al, 2010, association of a (M/F=33/50) consecutive month 
USA five percent Age 15.1 :1:: 2.0y sampling longitudin 
change in BMI AA=47 from al study 
over a six-month Hispanic = 36 Children's 
time period on hospital 
levels of Severely obese (BMI weight loss 
traditional and > 951h percentile for clinic at 
newer CVD risk age and sex) initial visit, 
markers in a adolescents and six-
clinical month 
population of BMI : 42.3 :1:: 7.8 At 6 month 
severely obese, CRP (median (IQR)) follow up 
Anthropometric Inflammatory 
adiposity markers 
measures (CRP, IL-6, TNF-a) 
(BMI, WC, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
we (em): Hs-CRP (mg/L) 
Not reported Serum 
ELISA 
CV=Not reported 
Overnight fast 
BMI (kg/m2): CRP (mg/dL): 
At baseline At baseline 
Measurement site 
=Not reported 
Latex 
enhanced 
immune-
turbidometry 
Intra-assay CV 
<5% 
Inter-assay CV 
=Not reported 
Overnight fast 
Results 
we predicts hs-
CRP (p < 0.001). 
BMI directly 
correlated with 
CRP (p :5 0.001) 
at baseline. 
BMI remained 
significantly 
associated with 
CRP after 
adjusting for 
age, sex, and 
ethnicity 
Analysis and significance 
B = 3.05 (p = 0.01) 
R2 =NA 
Linear regression 
HsCRP 
WC: R2 = 0.214 
(p < 0.001) 
Bivariate correlation 
(at baseline) 
BMI: Spearman's 
rho= 0.50 (p < 0.001) 
Multivariates regression 
(at baseline) 
BMI:p=0.04 
95%CI: 0.02-0.04 
(p < 0.001) 
Adjustments 
for 
covariates 
Additional 
adjusted for 
pubertal 
staging 
No 
Adjusted for 
age, sex, 
ethnicity 
00 
N 
Author, Purpose Participants Design, Anthropometric 
year, (N/sex/age/adiposity/intlammatory study adiposity 
country markers: mean::t:SD), period measures 
setting/location (BMI, WC, 
WHR, WHtR, 
BF%) 
AAand 0.5 (0.1, 1.1) mg/dL N=50 
Hispanic 
adolescents. 
BMI (kg/m2): 
6 month follow up 
Martinez To examine the N= 192 A sub- Cross- BMI (kg/m2) 
-Gomez, independent (MIF = 98/94) sample sectional we (em): 
et al, associations of Age 13-17y from the Not reported 
2010, objective AFINOS November BF (mm) 
Spain measured BMI(M+F) surveillanc 2007- measured by 
physical 21.7 ± 3.5 e study: February sum of six 
activity, we (M+F) volunteer 2008 SFs (triceps, 
cardiorespirator 73.4 ± 9.4 em adolescents biceps, 
y fitness, and BF (M+F) in the subscapular, 
fatness with 33.5 ± 12.1 mm region of suprailiac, 
low-grade CRP(M+F) Madrid thigh, calf) 
inflammatory 0. 7 ::t: 1.3 mg/dL using skinfold 
markers in IL-6 (M+F) caliper 
adolescents. 16.6 ± 28.6 pg/mL 
Inflammatory Results 
markers 
(CRP, IL-6, TNF-a) 
measurement site, 
assay, CV 
(p = 0.001) at 
baseline. 
CRP (mg/dL): At 6 month follow 
6 month follow up up, comparison of 
changes in CRP 
level with change 
in BMI, there was 
a significant (p = 
0.05for trend) 
between the three 
groups of BMI 
change. 
CRP (mg!L) BMI, WC and BF 
Serum were significantly 
Immuno- associated with 
turbidimetry CRP (p < 0.001). 
CV= Not reported 
IL-6 {pg/mL) BMI, WC, and BF 
Serum were not 
Hs-Human significant 
Cytokine association with 
MILLIPLEX IL-6. 
MAP kit 
CV= Not reported 
Overnight fast 
Analysis and significance 
At 6 month follow up 
CRP (mg/dL) changes: 
median (IQR) 
~ 5% BMI increase 
0.1 (0, 0.5) (N = 8) 
BMI within 5% 
0 ( -0.2, 0.2) (N = 32) 
~ 5% BMI decrease 
0 ( -0.4, 0) (N = 10) 
(p = 0.05: for trend) 
Partial correlations 
CRP (log) 
BMI: r = 0.250 
(p < 0.001) 
WC: r=0.301 
(p < 0.001) 
BF: r=0.236 
(p < 0.001) 
IL-6 (square-root-
transformed) 
BMI: r = -0.014 
(p=NS) 
WC: r=0.031 
(p=NS) 
BF: r = 0.050 (p = NS) 
Adjustments 
for 
covariates 
Not reported 
Adjusted for 
age, sex, and 
pubertal 
status 
00 
w 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sexlage/adiposity/inflammatory study adiposity markers for 
country markers: mean±SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, we, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
Multiple regression Adjusted for 
CRP (log) age, sex, 
BF: P= 0.241 pubertal 
(p = 0.002) status, and 
R2 =0.040 HOMA-IR 
IL-6 (square-root-
transformed) 
BF: p = -0.016 
(p = 0.842) 
R2 = 0.005 
Moon et To evaluate the N=71 Sampling/ Cross- BMI {kg/m2) TNF-a {pg/mL) The serum TNF -a Linear correlation No 
al, 2004, relationship (MIF =26/45) setting/loca sectional we (em): Serum concentration BMI: r = 0.346 
South between serum Age 15-16y tion were measured ELISA was positively (p < 0.005) 
Korea TNF-a, its Asian not Study midway Intra-assay CV correlated with WC:r=0.525 
receptors, and reported period: between the <7% both the BMI (p (p < 0.001) 
metabolic Non-obese (BMI < Not lowest rib Inter-assay CV < 0.005) and we 
syndrome 23): N= 32 reported margin and the <9% (p < 0.001). 
components and (MIF = 14/25) iliac crest at Sensitivity 
anthropometric BMI 20.6 :!: 0.86 the end of = 3pg/ml 
indices in obese we 74.83 :1: 3.96 em gentle Overnight fast 
and non-obese expiration 
Asian Obese (BMI>25) 
adolescents. :N=39 
(MIF = 12/20) 
BMI 29.44 ±2.92 
we 93.83 :!:5.55 em 
using Asia- Pacific 
criteria 
of obesity 
TNF-a was not 
reported 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sex/age/adiposity/inflammatory study adiposity markers for 
country markers: mean±SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR,WHtR, assay, CV 
BF%) 
Petty et To examine the N= 166 AA Cross- BMI {kg/m2) Hs-CRP (uglmL) In males, CRP and Partial correlations Adjusted for 
at, 2010, sex-specific (M/F =78/88) volunteers sectional WC(cm): Plasma IL-6 were not CRP (M) (log) age 
USA association of Age 14-19y in local measured with ELISA significantly BMI: r= 0.179 
adiposity AA public high June thin clothing on, Inter-assay CV associated with (p=NS) 
variables with schools in 2006-July at the midpoint <7.0% BMiand we. WC: r=0.173 (p=NS) 
five BMI(M) the 2008 between the Intra-assay CV IL-6(M) (log) 
inflammation 24.35 ±4.7 Augusta lowest rib and <8.3% BMI: r= 0.130 
markers: IL-6, WC(M) Richmond the iliac crest. (p=NS) 
leptin, CRP, 80.32 ::1: 11.43 em Country IL-6 (pglmL) WC: r = 0.093 (p = NS) 
adiponectin, and CRP(M) Plasma 
MCPl inAA 1.01±1.8 uglmL ELISA 
adolescents. IL-6 (M) Intra-assay CV 
1.29 :!: 1.3 pglmL <7.8% 
Inter-assay CV 
BMI (F) <9.6% In females, CRP CRP (F) (log) 
26.16::1:6.6 was significantly BMI: r = 0.442 
WC(F) Non-fasting associated with (p < 0.01) 
78.46:!: 11.34 em BMI (p < 0.01) WC: r=0.447 
CRP (F) and we (p< (p < 0.001) 
1.27±1.8 ug/mL 0.001), whereas IL-6(F) (log) 
IL-6 (F) IL-6 was BMI: r= 0.164 
1.80 :1: 1.7 pglmL not significantly (p=NS) 
associated with WC: r = 0.155 (p = NS) 
BMiandWC. 
Serrano To evaluate N = 113 {F) Public Cross- BMI (kg/m2) CRP (mgldL) CRPwasnot Pearson correlation No 
et at, body Age 14-18y schools in sectional WC(cm): Site, assay, and correlated with CRP (positive values) 
2010, composition, Vic;osa, measured at CV=Not BMI, WC, WHR, BMI: r = -0.056 
Brazil anthropometric BMI 22.90 :1: 4.1 Minas Study the minimum reported and BF (%). (p = 0.823) 
changes, we 71.01 ::1: 7.78 em Gerais period: circumference WC: r= -0.05 
biochemical and WHR 0.80 ::1: 0.04 Not between the Overnight fast (p = 0.845) 
clinical BF 28.72:!: 5.14% reported iliac crest and WHR: r=-0.144 
characteristics CRP 3.572 :1: 3. 732 the rib cage (p = 0.569) 
of female mg/dL WHR(cmlcm) BF%: r= 0.112 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sex/age/adiposity/inflam matory study adiposity markers for 
country markers: mean±SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI,WC, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
adolescents. BF%: (p = 0.659) 
measured 
by 
bioelectrical 
impedance 
Hip (em): 
measured at the 
maximum 
protuberance of 
the buttocks 
Vikram To examine the N=324(M) Participants Cross- BMI (kg/m2) Hs-CRP (J.lg/mL) Hs-CRP levels Pearson correlation No 
et al, association of Age 14-25y selected sectional we (em): Serum correlated Hs-CRP (log) 
2006, serum hs-CRP randomly measured ELISA significantly with BMI:r=O.I4 
India with fasting BMI 20.1 ± 3.5 from In 2001- midway Intra-assay CV BMI, WC,and (p < 0.01) 
insulin and we 70.7 ± 7.8 em schools and 2003 between the = 1.7% WHR (p < 0.05). WC: r = 0.17 ( P < 0.01) 
insulin WHR 0.82 ± 0.04 colleges in iliac crest and Inter-assay CV WHR: r=0.16 
resistance in CRP (Geometric southwest the lower-most =3.3% (p<O.Ol) 
urban adolescent mean (95%CI)) New Delhi, margin of the Overnight fast BF%: r = 0.07 (p = NS) 
and young adult 0.63 (0.56-0.71) multistage ribs 
males in north J.lg/mL cluster WHR 
India. sampling BF%: 
measured by 
bioelectrical 
impedance 
Hip (em): 
measured at the 
maximum 
circumference of 
the buttocks, 
subject standing 
with feet placed 
together 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sex/age/adiposity/inflammatory study adiposity markers for 
country markers: mean:I:SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI,WC, measurement site, 
WHR,WHtR, assay, CV 
BF%) 
Wanget To examine the N = 1,180 Large Cross- BMI {kg/m2) CRP (mg/L) BMI and WC were Linear regression Adjusted for 
al, 2011, impact of (M/F = 632/548) community sectional WC(cm): Plasma linearly P:coefficient active/passive 
China pubertal Age 13-21y -based measured at Sandwich associated with CRP (log) smoking, 
development, Asian Chinese In 2005- the level of the Immunoassay log (CRP) levels BMI (M): p = 0.23 Tanner stage, 
gender, and twin cohort 2006 umbilicus to Intra-assay CV both males and (p < 0.0001) and age 
adiposity BMI (M) inAnging, the nearest <5.1% females Partial r = 0.05 16 
distribution on 18.7:1:2.3 China millimeter Inter-assay (p < 0.05). we (M): p = 0.22 
CRP levels in WC(M) =Not reported (p < 0.0001) 
adolescent 68.4:1:6.1 em Fasting: Not Partial r = 0.0366 
twins. CRP (M) (Median reported 
(IQR)) BMI (F): p = 0.31 
0.85 (0.39-1.80) mg/L (p< 0.0001) 
Partial r = o.0665 
BMI (F) we (F): p = 0.31 
19.8:1:2.4 (p < 0.0001) 
WC(F) Partial r = o.o788 
66.1 :1:6.3 em 
CRP (M) (Median 
(IQR)) 
0.75 (0.34-1.72) mg/L 
Author, 
year, 
country 
Wamber 
et al, 
2006, 
Spain 
Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
(N/sex/age/adiposity/intlammatory study adiposity markers for 
markers: mean±SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR,WHtR, assay, CV 
BF%) 
To establish the N::::472 Multiple- Cross- BMI (kg/m2) Hs-eRP (mg!L) Hs-eRPwas Partial correlation Adjusted for 
possible (MIF :::: 248/224) step sectional we (em): Serum significantly In eRP (M) age and 
relations of Age 13-18.5y random Measured Immuno- correlated with BMI: r = 0.268 Tanner stage 
serum sampling In 2000- midway turbidimetry BMI, we. and (p = 0.01) 
inflammatory BMI (M) <25 and then by 2002 between the Intra-assay ev BF (sum of 6 SF We:r=0.226 
proteins with BMI 20.13 ± 2.06 random lowest rib =Not reported Thicknesses) (p = 0.01) 
body fat we 70.60:!: 5.16 em selection of margin and the Inter-assay CV (p < 0.05). WHR: r = 0.107 
estimates and WHR 0.81 :1: 0.04 classrooms iliac crest after <2% (p=NS) 
body fat BF 57.88 ± 18.74mm from public gentle Overnight fast BF: r=0.280 
distribution in BMI (M);:::25 and private expiration (p = 0.01) 
an apparently BMI 26.50:1:2.99 schools in WHR 
healthy Spanish we 86.99:1:8.34 em each city, BF(mm) In eRP (F) 
adolescent WHR 0.85 ± 0.05 and then :6SF BMI: r = 0.265 
population. BF 118.97 ± stratified (triceps, (p = 0.01) 
36.43mm by age and biceps, We: r=0.220 
sex: the subscapular, (p = 0.01) 
BMI (F) <25 multicenter suprailiac, WHR: r = 0.004 
BMI 20.42 ± 1. 75 AVENA thigh and calf) (p=NS) 
we 68.90:1:5.61 em study Hip (em): BF: r=0.274 
WHR 0. 75 ± 0.05 measured at the (p = 0.01) 
BF 88.47 ± 20.96mm point yielding 
BMI (F);::: 25 the maximum 
BMI 26.95 ± 3.67 circumference 
we 81.27 ± 8.79 em over the buttocks 
WHR 0. 79 ± 0.07 
BF 141.94 ± 
33.57mm 
Abbreviations: N, number; M, male; F, female; BMI, body mass index; we, waist circumference; WHR, waist to hip ratio; WHtR, waist to height ratio; BF, body fat; eRP, c-
reactive protein; hs, high sensitivity: IL-6, interleukin 6; TNF-a, tumor necrosis factor alpha; ELISA, enzyme-linked immunosorbent assay; RIA, radioimmunoassay; y, year; ev = 
coefficient of variation; OR, Odds Ratio; ei, confidence interval; NA, not applicable; NS, not significance; CV, cardiovascular; evn, cardiovascular disease; HOMA-IR, 
homeostasis model assessment of insulin resistance; SF, skinfold; ref, reference; AA, African American; log, log transformed (logarithmically transformed); IQR, interquartile 
range 
00 
00 
Table 2 
Studies reporting the association of anthropometric adiposity and inflammatory biomarkers in young adults 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sex/age/adiposity/inflammatory study adiposity/obesity markers (CRP, IL- for 
country markers: mean:I::SD), period measures 6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
Bo, To investigate N = 85 (M) Healthy, Cross- BMI (kglml) CRP (mg/L) CRP levels were Univariate linear No 
Raspo, the Age 31.5::1:: 7.5y non-obese sectional we (em): Plasma significantly regression 
Morra, relationships without measured HS- associated with CRP (log) 
lsaia et between body BMI 23.8 ± 3.5 overt MS Study midway immunoassay the measures of BMI: r = 0.525 
al, 2004, fat, CRP levels we 86.8 :I: 9.9 em from period: between the with a obesity (BMI, (p < 0.0001) 
Italy and metabolic WHR0.9:1::0.l among the not lower margin monoclonal WCand WHR) WC: r=0.617 
variables in CRP (Median (IQR)) sons ofMS reported of the last rib antibody coated (p < 0.001) in (p < 0.0001) 
healthy, non- 0.65 (0.25-1.02) mg/L patient at and the iliac with healthy, non- WHR: r = 0.486 
obese sons of the Lipid crest polystyrene obese sons of MS (p < 0.0001) 
patients Clinic of WHR particles patients. 
affected the Hip (em): CV=Not 
by MS. Department measured around reported 
of the pelvis at the Overnight fast 
Geriatrics point of 
of a maximum 
University buttock 
teaching protrusion 
hospital in 
Turin 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sex/age/adiposity/inflammatory study adiposity markers for 
country markers: mean±SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
Bo, To evaluate N= 87 (M) Volunteers Cross- BMI (kg/m2) Hs-CRP (mg/L) Hs-CRP level was Univariate linear No 
Raspo, whether body fat Age 30± 3.5y of young sectional WC(cm): Plasma strongly regression 
Morra, is an Healthy, non-obese adults men Not reported HS- associated with CRP (log) 
Cassader independent young adults of the Study WHRandhip: immunoassay BMI, WCand BMI: p = 0.147 
et al, predictor of hs- hospital period: Not reported with a WHR (p < 0.001) 
2004, CRP levels in BMI 24.1 ± 3.5 staff at the Not monoclonal (p < 0.001). WC:p=0.061 
Italy healthy, young we 86.8 ± 9.9 em Lipid reported antibody coated (p < 0.001) 
adult non-obese WHR0.9±0.1 Clinic of with WHR: p = 7.454 
subjects. CRP (Median (IQR)) the polystyrene (p < 0.001) 
0.65 (0.25-1.02)mg/dL Department particles 
of CV= Not reported 
Geriatrics Overnight fasting 
of a 
University 
teaching 
hospital in 
Turin. 
Brydon To investigate N = 67 (F) Volunteers Cross- BMI (kg/m2) IL-6 (pg/mL): IL-6 was Partial correlation Adjusted for 
et al., the relationship Age 21.3y of healthy sectional WC(cm): At baseline significantly (at baseline) age, ethnicity, 
2008, between (18-25y) females in measured Plasma related to BF%, BMI: r = 0.31 (p < 0.05) and smoking 
UK measures of White: 66. 7%, the Study midway between ELISA and BMI at WC: r = 0.17 (p = NS) status 
adiposity and Non-white: University period: the lowest rib Intra-assay CV baseline. BF%:r=0.28 
cytokine, CV 33.3% College Not and iliac crest =5.3% (p < 0.05) 
and London reported BF%: Inter-assay CV 
neuroendocrine BMI 23.2 ± 3.1 measured by =9.2% 
response to we 70.3 ± 7.9 em bioelectrical Non-fasting 
stress in healthy BF 25.7 :1: 5.4% impedance 
young women. IL-6 0. 71 ± 0.4 pglmL and %fat was 
calculated as 
fat wt divided 
by total body 
wt (fat+ lean) 
at baseline 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sex/age/adiposity/inflammatory study adiposity markers for 
country markers: mean:I::SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR,WHtR, assay, CV 
BF%) 
Herms do To assess the N=317 Volunteers Cross- BF%: estimated CRP (mg/L) BF significantly Multiple regression Multiple 
rffetal., potential (MIF = 122/195) from the sectional by the equations Plasma presented R 2 for analyses linear 
2012, contribution of Age: 22±3y Federal using four ELISA CRP (11%) in CRP (log) (M+F) regression 
Brazil gender, body fat (18-35y) University Study skinfold Intra-assay CV both sex. BF BF: models were 
and distribution, and ofVi~osa, period: thickness <10% significantly R?- = O.ll(p < 0.001) performed for 
Spain their interactions BMI (M+F) 22.1 ± 2.8 Brazil Not (biceps, triceps, Inter-assay CV presented CRP in B-coefficient (95% CI) sex 
to some BF (M+F) 26.1 ± 6.4% (MIF= reported subscapular, and < 10% men (13%) and = 0.023 (0.0 16; 0.030) separately. 
inflammatory CRP (M+F) (Median 67/92) and clearly suprailiac) Overnight fast women (7%). (p < 0.001) 
marker (IQR)) the 
concentrations 0.83 (0.47-1.58) University CRP (log) (M) 
(CRP, mg/dL of Navarra, BF: 
complement Spain (MIF R?- = 0.13(p < 0.001) 
factor 3 ( C3 ), = 55/103) B-coefficient (95% CI) 
and = 0.035 (0.019; 0.051) 
ceruloplasmin (p < 0.001) 
(Cp) in young 
adults. CRP (log) (F) 
BF: 
R?- = 0.01(p < 0.001) 
B-coefficient (95% CI) 
= 0.032 (0.014; 0.042) 
(p < 0.001) 
Hermsdo To assess the N= 154 Volunteers Cross- WC(cm): CRP {mg/L) Those subjects Multiple linear regression Adjusted for 
rffet at, potential (MIF = 53/101) from the section a] measured Plasma with higher we for trend (r was not age, sex, 
2011, association of Age 21± 3y University midway ELISA and WHR reported p for trend (WC, smoking, and 
Spain some selected of Navarra, Study between the Intra-assay CV (central WHR, and BF% were physical 
plasma BMI (M+F) Spain period: lowest rib and < 10% adiposity) categorized into tertiles to activity. 
inflammatory 22.1 ± 2.7 Not the iliac crest Inter-assay CV Showed higher assess trends.), from linear 
marker WHR(M+F) reported Hip (em): < 10% CRP and IL-6 regression model adjusted 
concentrations 0.74:1::0.06 clearly Measured at the (p < 0.05). for co variates) 
with adiposity BF (M+F) maximal hip 
(total and 20.0:1::6.5% circumference, IL-6 (pg/mL) Only IL-6 CRP 
central) and CRP (M+F) without gluteal Plasma concentration we (p = o.ot5) 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sex/age/adiposity/inflammatory study adiposity markers for 
country markers: mean±SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR,WHtR, assay, CV 
BF%) 
metabolic (Median (IQR)) contraction. ELISA was positively WHR (p = 0.020) 
features in 0.8(0.6-1.4) mg/1 WHR Intra-assay CV associated with BF% (p = 0.053) 
apparently IL-6 (M+F) BF%: < 10% total BF% 
healthy young (Median (IQR)) measured by a Inter-assay CV (p < 0.05). IL-6 
adults. 1.1 (0.8-1.5) pg/1 bioelectric < 10% we (p = o.ool) 
impedance Central adiposity- WHR (p = 0.002) 
and sum of Overnight fast related indicators BF% (p = 0.001) 
four SF (WC/WHR) 
thickness: correlated better 
biceps, triceps, than those 
subscapular, assessing total 
and suprailiac) adiposity with 
plasma 
pro inflammatory 
markers. 
McDade To investigate N = 1,648 The Cebu Cross- BMI (kg/m2) CRP (mg!L) In female, BMI A series of maximum No 
et al, the predictors of (MIF = 916/732) Longitudin sectional WC(cm): Plasma and WCwere likelihood logistic 
2009, CRP in young Age 20.9 ± 0.3y al Health Not reported Hs-immuno- significant regression 
Philipp in adults living in and In 2005 3SF thickness: turbidimetric predictors of :Detailed data were 
es the Philippines. BMI (M+F) 20.7 ± 3.2 Nutrition triceps, method elevated CRP (p: not reported 
we (M+F) Survey subscapular, Intra-assay CV not reported) 
70.3 ± 7.8 em follow up and suprailirac =Not reported although we 
3SF (M+F) Cebu, Inter-assay CV was a strong 
48.5 ±22.3 mm metropolita <7.6% predictor when 
CRP (M+F) (Median n area Overnight fast all measures 
(IQR)) were considered 
0.2 (0.1, 0.9) mg!L Cut-off level = simultaneously. 
3.0 mg!L A 1 em increase 
> 3.0 (high) In WC was 
:5 3.0 (low or associated with a 
normal) 6.0% increase in 
>10 mg/L: the likelihood of 
excluded due to CRP>3mg/L 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sexlage/adiposity/inflammatory study adiposity markers for 
country markers: mean:I::SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR,WHtR, assay, CV 
BF%) 
infectious (OR: 1.060, p < 
diseases 0.001). 
In males, SF 
thickeness was 
significant in 
predicting 
elevated CRP. 
A 1 mm increase 
in the sum of 
3SF measures 
was associated 
with al.1% 
increase in 
the likelihood of 
elevated CRP 
(OR: 1.011, p = 
0.09). 
McDade To report N = 1,569 The Cebu Cross- BMI (kg/m2) IL-6 (pglmL) BMI was Tobit regression model Adjusted for 
et al, concentrations (MIF = 8661703) Longitudin sectional Plasma positively IL-6 (log) sex 
2011, of IL-6 and to Age 20.9 :1:: 0.3y al Health Hs-multiplex associated with BMI: B = 0.039 
Philipp in evaluate (20-22y) and In 2005 Immunoassay IL-6 (SE = 0.016,p < 0.05) 
es adiposity, Nutrition Intra-assay CV concentration 
infectious, and BMI (M+F) 20.7 ± 3.2 Survey =13.3% (p < 0.05). 
socioeconomic IL-6 (M+F) (Median follow up Inter-assay CV 
predictors of (IQR)) Cebu, for low (14.7%) 
individual 1.00 (0.28, 3.21) metropolita and high (12.4%) 
variation in IL-6 pglmL n area Overnight fast 
in young adults. 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sex/age/adiposity/inflammatory study adiposity markers for 
country markers: mean±SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR,WHtR, assay, CV 
BF%) 
Mills et To determine N= 175 Consecutiv Cross- BMI (kg/m2) CRP (mg!L) CRPwas Univarate correlation No 
al, 2008, the unique (M/F = 83/92) e sample, sectional WHRandhip Plasma positively CRP 
USA contributions of AA=28 all (Design: Not reported Hs Denka- associated with BMI: r = 0.340 
metabolic Asian= 56 volunteers not Seiken assay BMiandWHR (p<O.Ol) 
factors as White= 68 were reported) Intra-and inter- (p < 0.05). WHR: r = 0.141 
predictors of Hispanic = 23 employed assay CV < (P< 0.05) 
CRP and IL-6 in Age 30.4 ± 4.8y in full-time 10% 
healthy (22-39y) day shifts Sensitivity < 
younger-aged at the 0.05 mg!L 
adults. BMI(M+F) 24.4 ±3.35 University 
WHR(M+F) of IL-6 (pg/mL) IL-6 
0.823 ± 0.07 California, Plasma IL-6 was positively BMI: r = 0.070 
CRP(M+F) Los ELISA associated with {p=NS) 
0.855 ± 1.24 mg!L Angeles or Intra-and inter- WHR (p < 0.01). WHR: r = 0.306 
IL-6 (M+F) the assayCV < (p<0.01) 
0.864±0.75 pg/mL surroundin 10% 
gLos Sensitivity< 
Angeles 0.72 pg/m1 
area 
Overnight fast 
Morrison To assess hs- N=392 (F) The Cross- BMI (kg/m2) Hs-CRP (mg!L) Hs-CRPwas Bivariate correlation No 
et al, CRP tracking in Age 26y National sectional we (em): Serum Significantly CRP (log) 
2011, black and white Caucasian and AA Growth and Not reported N hs latex correlated with BMI: r=0.56 
USA females from Health enhanced BMiandWC (p < 0.001) 
mid-adolescence BMI, WC, and hs- Study immune- (p < 0.001). WC: r=0.55 
to young CRP were not reported (NGHS), a nephelometric (p < 0.001) 
adulthood and to prospective assay 
identify factors ly followed CV=Not 
associated with up Reported 
hs-CRP. Overnight fast 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sex/age/adiposity/inflam matory study adiposity markers for 
country markers: mean±SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
Nazmi et To identifY N =3,289 The 1982 Cross- BMI (kg/m2) Hs-CRP (mg!L) Hs-CRP was Crude analyses Adjusted for 
al, 2008, factors (MIF= Pelotas sectional WC(cm): Plasma significantly {p-values for trend by skin color, 
Brazil associated with 1,919/1,370) Birth measured at the automated DPC associated with linear regression) age, family 
CRP levels in a Age22.8y Cohort In 2004- narrowest girth (Siemens) BMI and we in Hs-CRP (log) income, and 
young adult (21.9-23. 7y) study in the 2005 of the truck or Immulite men and women BMI (M): p (95%CI) years of 
Brazilian city of halfway between Chern- (p < 0.001). <18.5: p = 0.57 education 
population. BMI and hs-CRP were Pelotas, the costal iluminescent (0.43-0. 75) 
not reported prospective margin and iliac immunoassay 18.5-24.9: 1 (reO 
ly followed crest Intra-assay CV 25.0-29.9: p = 1.54 
up = 10% ( 1.34-1. 76) 
Inter-assay CV ~ 30.0: p = 3.03 
=7% (2.44-3.76) 
Sensitivity (p < 0.001) 
<O.lmg!L we (M): 1 (reO 
Non-fasting ~ 94:P=2.33 
( 1.94-2.82) 
(p < 0.001) 
BMI (F): p (95%CI) 
<18.5:P=0.73 
(0.56-0.96) 
18.5-24.9: 1 (reO 
25.0-29.9: p = 1.68 
( 1.37-2.05) 
~ 30.0: p = 3.34 
(2.56-4.34) 
(p < 0.001) 
WC (F): 1 (ref) 
~80:P=2.29 
(1.93-2.74) 
(p < 0.001) 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sexlage/adiposity/inflammatory study adiposity markers for 
country markers: mean±SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
Orri et al, To determine N=30 Volunteers Cross BMI (kg/m2) CRP (mg/L) CRPwas Pearson correlation No 
2010, the relationship (M/F = 16114) of college sectional WHRand hip: Plasma positively CRP (log) 
USA between CAD Age 22.1 ± 3.1y men and Not reported in Cardio hs-CRP correlated with BMI: r= 0.47 
risk factors and women Over detail assay BMI (r = 0.47, p (p < 0.05) 
CRPamong BMI (M) (4M and SF 2week BF%: CV=Not < 0.05) and BF% WHR: r=0.26 
apparently 26.5 ±4.4 intercollegi period measured reported (r= 0.58,p< (p=NS) 
healthy college- WHR(M) ate by sum ofSFs Sensitivity 0.05). BF%: r=0.58 
aged men and 0.83 ± 0.05 athletes) =0.2 mg/L (p < 0.05) 
women. BF(M) Overnight fast 
14.5 ± 6.5% 
CRP(M) 
0.55 ± 0.51 mg/L 
BMI (F) 
24.2 ± 1.5 
WHR(F) 
0.73 ± 0.03 
BF(F) 
24.3 ±4.5% 
CRP (F) 
0.77 ± 1.16 mg!L 
Perez et To determine N= 145 (M) Young Cross BMI (kg/m2) CRP (mg/L) CRPwas Pearson correlation No 
al, 2003, and evaluate the Age28.9y healthy sectional WC(cm): Plasma significantly BMI: r=0.08 
Colombi level of we and (17-38y) males measured Chern- correlated with (p < 0.00001) 
a CRP levels in a recruited Study midway iluminescent BMI, WCand WC: r=O.ll 
Colombian BMI 24.08 ± 3.97 from period: between the enzyme-labeled WHR (p < 0.00001) 
population. we 83.32 ± 10.11 em different Not iliac crest and inmmunometric (p < 0.00001). WHR: r=0.11 
WHR 0.86 ± 0.06 levels of reported the lower assay (p < 0.00001) 
CRP (N=145) was not tertiles of portion of the CV=Not 
reported. WCthe rib cage Reported 
health WHRandhip: Overnight fast 
service of Not reported 
the 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sexlage/adiposity/inflammatory study adiposity markers for 
country markers: mean±SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
Colombian 
army 
Raitakari To investigate N =2,120 The Cross- BMI (kg/m2) CRP (mg/L) CRPwas Linear regression No 
et al, the distribution (MIF = 975/1,046) Cardiovasc sectional we (em): Serum significantly p: regression coefficients 
2005, of CRP and the Age 31.7 ± 5.ly ular Risk in Not reported Hs correlated with CRP (log) 
Finland population (24-39y) Young In 2001 WHRandhip: turbidimetric BMI, we, and BMI (M): p = 0.0505 
determinants of Finn Study, Not reported immunoassay WHR in men and (p < 0.0001) 
CRP levels in BMI (M) five centre Intra- assay CV women we (M): p = o.oo2o 
young adults. 25.7 ± 4.1 follow up =Not reported (p < 0.0001). (p < 0.0001) 
WC(M) Inter-assay CV WHR (M): p = 2.8674 
89.6 ± 10.7 em = 3.33% (p < 0.0001) 
WHR(M) Overnight fast 
0.90±0.06 BMI (F): p = 0.0498 
CRP(M) (p< 0.0001) 
1.43 ± 3.26 mg/L we (F): p = o.oo19 
(p < 0.0001) 
BMI (F) WHR (F): p = 2.0162 
24.4 ± 4.7 (p < 0.0001) 
WC(F) 
78.8 ± 11.4 em 
WHR(F) 
0.79± 0.06 
CRP {F) 
2.01 ± 3.90 mg/L 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sex/age/adiposity/inflam matory study adiposity markers for 
country markers: mean±SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
Wanget To assess BMI N = 110 Volunteers Cross- BMI (kg/m2) CRP {~g/mL) CRPwas Spearman correlation (r,) No 
al, 2011, and BF%as (M: 28.2%, from the sectional BF%: Plasma significantly CRP 
USA measures of F: 71.80%) university measured by ELISA correlated with BMI 
overweight and Age 21.3y students In 2009- bioelectric CV=Not BMI (p < 0.01) M+F: rs = 0.288 
obesity and to (18-28y) enrolled at 2010 impedance reported and BF%{p< (p < 0.01) 
determine their Texas Tech 0.001) in M: rs=0.206 
relationship to BMI (M+F) University, IL-6 (pg/ml) university {p=NS) 
inflammatory 24.13 ± 4.29 Lubbock, Plasma students. F: rs= 0.422 
markers in BF (M+F) Texas ELISA (p < 0.001) 
university 25.23 ± 8.64 CV=Not Mvs.F BF% 
students. CRP (M+F) reported CRPwasnot M+F: rs = 0.393 
2.34 ± 2.44 ~g/mL significantly (p < 0.001) 
IL-6 (M+F) 1NF-a {pg/ml) correlated with M:rs=O.I12 
0.97 ± 1.56 pg/mL Plasma BMI and BF% in {p=NS) 
TNF-a(M+F) ELISA male, whereas F: rs= 0.362 
1.02 ± 0.84 pg/mL CV=Not CRPwas (p < 0.01) 
reported significantly 
correlated with 
Overnight fast BMI (p < 0.01) 
and BF%(p< 
0.001) in 
females. 
IL-6 and TNF -a IL-6 
were not BMI 
significant M+F: rs = 0.090 
correlated with {p=NS) 
BMI andBF% M:rs=0.242 
in university (p=NS) 
students as well F: rs= 0.108 
as both genders. {p=NS) 
BF% 
M+F: rs = 0.097 
Author, Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance Adjustments 
year, (N/sex/age/adiposity/inflam matory study adiposity markers for 
country markers: mean±SD), period measures (CRP, IL-6, TNF-a) covariates 
setting/location (BMI, WC, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
{p=NS) 
M: rs= 0.015 
{p=NS) 
F: rs= 0.054 
{p=NS) 
TNF-a (log) 
BMI 
M+F: rs = 0.072 
{p=NS) 
M: rs = -0.056 
{p=NS) 
F: rs= 0.140 
{p=NS) 
BF% 
M+F: r5 = 0.105 
{p=NS) 
M: rs = -0.035 
(p =NS) 
F: rs = 0.135 
{p=NS) 
Author, 
year, 
country 
Williams 
et al, 
2002, 
New 
Zealand 
Purpose Participants Design, Anthropometric Inflammatory Results Analysis and significance 
(N/sex/age/adiposity/inflammatory study adiposity markers 
markers: mean±SD), period measures (CRP, IL-6, TNF-a) 
setting/location (BMI, we, measurement site, 
WHR, WHtR, assay, CV 
BF%) 
To evaluate the N=815 The Cross- BMI (kgP) CRP (mg/L) CRPwas Univariate correlation 
relationship (M/F = 436/379) Dunedin sectional we (em): Serum significantly BMI (M): r = 0.11 
between ferritin, Age26y Multidiscip Measured the Immune- correlated with (p < 0.05) 
metabolic linary At age halfway turbidimetric BMiand WC in WC (M): r = 0.10 
cardiovascular BMI (M) Health and 26y between the assay using non- young men and (p < 0.05) 
risk factors, 24.8±4.7 Developme coastal border hs assay women 
CRP, and WC(M) nt Study, a and the iliac Intra-assay CV (p < 0.05). BMI (F): r = 0.29 
anthropometric 84.2:1:8.3 em longitudina crest =Not reported (p ~0.0001) 
measurements in CRP(M) I follow up Inter-assay CV WC (F): r = 0.27 
young men and 2.4 ± 4.4 mg/L study, = 5.6-12.9% (p ~ 0.0001) 
women. BMI (F) Dunedin, Non-fasting 
25.2 ± 3.9 New 
WC(F) Zealand 
75.4 ± 9.3 em 
CRP (F) 
5.3 :1: 6.8 mg/L 
Abbreviations: N, number; M, male; F, female; BMI, body mass index; WC, waist circumference; WHR, waist to hip ratio; WHtR, waist to height ratio; BF, body fat; CRP, c-
reactive protein; hs, high sensitivity: IL-6, interleukin 6; TNF-a, tumor necrosis factor alpha; log, log transformed (logarithmically transformed); ELISA, enzyme-linked 
immunosorbent assay; RIA, radioimmunoassay; y, year; CV =coefficient of variation; OR, Odds Ratio; Cl, confidence interval; NA, not applicable; NS, not significance; CV, 
cardiovascular; CVD, cardiovascular disease; HOMA-IR, homeostasis model assessment of insulin resistance; SF, skinfold; wt, weight; min, minimum; max, maximum; MS, 
metabolic syndrome; UK, United Kingdom; ref, reference 
Adjustments 
for 
covariates 
No 
...... 
0 
0 
Table 3 
Quality assessment of included studies in Adolescents 
Study, year, Design: Sample Setting: Measurements Analyses Peer Quality 
journal review lndicat 
Were Were Were any Was sample Was Were Were the Were the Were the Was the journal: ors met 
study eligibilit sources and size clearly setting anthropometric inflammato statistical statistical adequate 
design y criteria methods of justified and clearly adiposity ry markers methods to methods of adjustment Was this 
clearly specified selection of determined? described? variables measured infer the data analysis for publication 
described? ? participants reliably using valid independent appropriate confounding peer-
clearly measured and instruments (exposure) for the levels in the reviewed? 
described? described? ? variable and of analyses? 
dependent measurement 
(outcome) of the 
variables variable? 
associated/carr 
elated/covary? 
Denney- Yes No Yes No Yes Yes Yes Yes Yes No Yes 8/11 
Wilson et al, 
2008, 
Archives of 
Pediatrics and 
Adolescent 
Medicine 
El-Wakkad et Not Yes Yes No Yes Yes Yes Yes Yes No Yes 8/11 
al., Cytokine reported 
Herder et al, Yes No Yes No Yes Yes Yes Yes Yes Yes Yes 9/11 
2007, 
Journal of 
Clinical 
Endocrinology 
and 
Metabolism 
-0 
-
Study, year, Design: Sample Setting: Measurements Analyses Peer Quality 
journal review Indicat 
Were Were Were any Was sample Was Were Were the Were the Were the Was the journal: ors met 
study eligibilit sources and size clearly setting anthropometric inflammato statistical statistical adequate 
design y criteria methods of justified and clearly adiposity ry markers methods to methods of adjustment Was this 
clearly specified selection of determined? described? variables measured infer the data analysis for publication 
described? ? participants reliably using valid independent appropriate confounding peer-
clearly measured and instruments (exposure) for the levels in the reviewed? 
described? described? ? variable and of analyses? 
dependent measurement 
(outcome) of the 
variables variable? 
associated/carr 
elated/covary? 
Huang et al, Yes No Yes No Yes Yes Yes Yes Yes Yes Yes 9/11 
2011, 
International 
Journal of 
Pediatric 
Obesity 
Jung et al, Not Yes Yes No Yes Not reported No Yes Yes No Yes 6/11 
2009, reported 
Pediatric 
Diabetes 
Khan et al, Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes 10111 
2010, 
Obesity 
Research and 
Clinical 
Practice 
Martinex- Yes No Yes No Yes Yes Yes Yes Yes Yes Yes 9/11 
Gomez et al, 
2010, 
International 
Journal of 
Obesity 
Study, year, Design: Sample Setting: Measurements Analyses Peer Quality 
journal review Indicat 
Were Were Were any Was sample Was Were Were the Were the Were the Was the journal: ors met 
study eligibilit sources and size clearly setting anthropometric inflammato statistical statistical adequate 
design y criteria methods of justified and clearly adiposity ry markers methods to methods of adjustment Was this 
clearly specified selection of detennined? described? variables measured infer the data analysis for publication 
described? ? participants reliably using valid independent appropriate confounding peer-
clearly measured and instruments (exposure) for the levels in the reviewed? 
described? described? ? variable and of analyses? 
dependent measurement 
(outcome) of the 
variables variable? 
associated/carr 
elated/covary? 
Moon et al, Yes Yes Not No Not Yes Yes Yes Yes No Yes 7/11 
2004, reported reported 
Metabolism: 
Clinical & 
Experimental 
Petty et al, Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes 10111 
2010, 
International 
Journal of 
Pediatric 
Obesity 
Serrano et al, Yes No Yes No Yes Yes No Yes Yes No Yes 7/11 
2010, 
Arquivos 
Brasileiros De 
Cardio/ogia 
Vikram et al, Yes Yes Yes No Yes Yes Yes Yes Yes No Yes 9/11 
2006, 
Indian Journal 
of Medical 
Research 
-0 
w 
Study, year, Design: Sample Setting: Measurements Analyses Peer Quality 
journal review lndicat 
Were Were Were any Was sample Was Were Were the Were the Were the Was the journal: ors met 
study eligibilit sources and size clearly setting anthropometric inflammato statistical statistical adequate 
design y criteria methods of justified and clearly adiposity ry markers methods to methods of adjustment Was this 
clearly specified selection of determined? described? variables measured infer the data analysis for publication 
described? ? participants reliably using valid independent appropriate confounding peer-
clearly measured and instruments (exposure) for the levels in the reviewed? 
described? described? ? variable and of analyses? 
dependent measurement 
(outcome) of the 
variables variable? 
associated/corr 
elated/covary? 
Wang, Yes No Yes No Yes Yes Yes Yes Yes Yes Yes 9111 
Christoffel et 
al, 2011, 
Journal of 
Clinical 
Endocrinology 
and 
Metabolism 
Wtimberget Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes 10111 
al, 2006, 
American 
Journal of 
Clinical 
Nutrition 
-0 
~ 
Table 4 
Quality assessment of included studies in Young Adults 
Study, year, Design: Sample Setting: Measurements Analyses Peer Quality 
journal review Indicat 
Were study Were Were any Was Was Were Were the Were the Were the Was the journal: ors met 
design eligibility sources and sample size setting anthropometric inflammatory statistical statistical adequate 
clearly criteria methods of clearly clearly adiposity markers methods to methods of adjustme Was this 
described? specified? selection of justified described? variables measured infer the data analysis nt for publication 
participants and reliably using valid independent appropriate confound peer-
clearly determined measured and instruments? (exposure) for the levels ing in the reviewed? 
described? ? described? variable and of analyses 
dependent measurement ? 
(outcome) of the 
variables variable? 
associated/cor 
related/covary 
? 
Bo et al., Yes Yes Yes No Yes Yes Yes Yes Yes No Yes 9/11 
2004, 
Metabolism: 
Clinical and 
Experimental 
Bo et al., Yes Yes Yes No Yes Not reported Yes Yes Yes No Yes 8111 
2004, 
Nutrition, 
Metabolism 
and 
Cardiovascul 
ar Diseases 
Brydon et al., Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes 10/11 
2008, 
International 
Journal of 
Obesity 
Study, year, Design: Sample Setting: Measurements Analyses Peer Quality 
journal review Indicat 
Were study Were Were any Was Was Were Were the Were the Were the Was the journal: ors met 
design eligibility sources and sample size setting anthropometric inflammatory statistical statistical adequate 
clearly criteria methods of clearly clearly adiposity markers methods to methods of adjustme Was this 
described? specified? selection of justified described? variables measured infer the data analysis nt for publication 
participants and reliably using valid independent appropriate confound peer-
clearly determined measured and instruments? (exposure) for the levels ing in the reviewed? 
described? ? described? variable and of analyses 
dependent measurement ? 
(outcome) of the 
variables variable? 
associated/cor 
related/covary 
? 
Hennsdorff et Yes Yes Yes No Yes Reported in a Yes Yes Yes Yes Yes 10/11 
al., 2012, previous 
Inflammation reference 
Research 
Hennsdorff et Yes Yes Yes No Yes Reported in a Yes Yes Yes Yes Yes 10/11 
al., 2011, previous 
Inflammation references 
McDade et Yes No Yes No Yes Reported in a Yes Yes Yes No Yes 8/11 
al., 2009, previous 
American references 
Journal of 
Clinical 
Nutrition 
McDadeet Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes 10/11 
al., 2011, 
American 
Journal of 
Physical 
Anthropology 
-0 
0\ 
Study, year, Design: Sample Setting: Measurements Analyses Peer Quality 
journal review lndicat 
Were study Were Were any Was Was Were Were the Were the Were the Was the journal: ors met 
design eligibility sources and sample size setting anthropometric inflammatory statistical statistical adequate 
clearly criteria methods of clearly clearly adiposity markers methods to methods of adjustme Was this 
described? specified? selection of justified described? variables measured infer the data analysis nt for publication 
participants and reliably using valid independent appropriate confound peer-
clearly determined measured and instruments? (exposure) for the levels ing in the reviewed? 
described? ? described? variable and of analyses 
dependent measurement ? 
(outcome) of the 
variables variable? 
associated/cor 
related/covary 
? 
Mills et al., Not Yes Yes No Yes Not reported Yes Yes Yes No Yes 7/11 
2008, reported 
Obesity 
Morrison et Yes No Yes No Yes Not reported Yes Yes Yes No Yes 7/11 
al., 2011, 
/SRN 
Pediatrics 
Nazmi et al., Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes 10/11 
2008, 
Brazilian 
Journal of 
Medical and 
Biological 
Research 
Orri et al., Yes No Yes No Yes Not reported Yes Yes Yes No Yes 7/11 
2010, 
Journal of 
Sports 
Medicine and 
Physical 
Fitness 
-0 
'-l 
Study, year, Design: Sample Setting: Measurements 
journal 
Were study Were Were any Was Was Were 
design eligibility sources and sample size setting anthropometric 
clearly criteria methods of clearly clearly adiposity 
described? specified? selection of justified described? variables 
participants and reliably 
clearly determined measured and 
described? ? described? 
Perez et al., Yes Yes Yes No Yes Yes 
2003, 
European 
Journal of 
Cardiovascul 
ar Prevention 
and 
Rehabilitatio 
n 
Raitakari et Yes Yes Yes No Yes Not reported 
al., 2005, 
Journal of 
Internal 
Medicine 
Wang, Reed Yes Yes Yes No Yes Yes 
et al., 2011 , 
Nutrition 
Research 
Analyses 
Were the Were the Were the 
inflammatory statistical statistical 
markers methods to methods of 
measured infer the data analysis 
using valid independent appropriate 
instruments? (exposure) for the levels 
variable and of 
dependent measurement 
(outcome) of the 
variables variable? 
associated/cor 
related/covary 
? 
Yes Yes Yes 
Yes Yes Yes 
Yes Yes Yes 
Was the 
adequate 
adjustme 
nt for 
confound 
ing in the 
analyses 
? 
No 
No 
No 
Peer 
review 
journal: 
Was this 
publication 
peer-
reviewed? 
Yes 
Yes 
Yes 
Quality 
Indicat 
ors met 
9/11 
8/11 
9/11 
........ 
0 
00 
Study, year, Design: Sample Setting: Measurements Analyses Peer Quality 
journal review Indicat 
Were study Were Were any Was Was Were Were the Were the Were the Was the journal: ors met 
design eligibility sources and sample size setting anthropometric inflammatory statistical statistical adequate 
clearly criteria methods of clearly clearly adiposity markers methods to methods of adjustme Was this 
described? specified? selection of justified described? variables measured infer the data analysis nt for publication 
participants and reliably using valid independent appropriate confound peer-
clearly determined measured and instruments? (exposure) for the levels ing in the reviewed? 
described? ? described? variable and of analyses 
dependent measurement ? 
(outcome) of the 
variables variable? 
associated/cor 
related/covary 
? 
Williams et Yes Yes Yes No Yes Yes No Yes Yes No Yes 8111 
al., 2002, (measuring 
Atherosc/eros non-high 
is sensitivity 
CRP assay) 
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Abstract 
Background 
Low grade systemic inflammation plays a key role in atherosclerosis, and C-reactive 
protein (hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor- alpha (TNF-a), 
markers of systemic inflammation, are associated with cardiovascular events and 
adiposity. Cardiorespiratory fitness has shown health benefits by reducing circulating 
levels of inflammatory markers. However, it remains uncertain whether the negative 
association between cardiorespiratory fitness and inflammatory biomarkers is due to 
cardiorespiratory fitness itself or results from lower levels of adiposity. Moreover, the 
evidence examining the interaction between cardiorespiratory fitness and adiposity in 
inflammation in young adults is lacking. 
Purpose 
The aims of this study were to (1) determine the strength of the associations of 
cardiorespiratory fitness and adiposity (body mass index [BMI], waist circumference 
[WC]) with circulating levels of plasma hs-CRP, IL-6, and TNF-a; and (2) test the 
moderating effect of adiposity on the strength of the association between 
cardiorespiratory fitness and circulating levels of plasma hs-CRP, IL-6, and TNF-a. 
Methods 
A cross-sectional study was conducted with 88 young adults aged 20-34 years without 
diagnosed diseases. A submaximal treadmill walking test was used to assess 
cardiorespiratory fitness. BMI and WC were measured to assess adiposity. The hs-CRP, 
IL-6 and TNF-a were assayed and were log10-transformed. For aim one, a separate 
multiple regression analysis was conducted with each ofhs-CRP, IL-6, and TNF-a as 
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dependent variables and adjusted for confounders. Analysis of covariance (ANCOV A) 
was used and adjusted for confounders for aim two. Confounding variables tested were 
sex, ethnicity, oral contraceptive use, and education level. 
Results 
Aim1: Cardiorespiratory fitness was not significantly associated with log10hs-CRP after 
adjustment for BMI or WC and confounders. Cardiorespiratory fitness was not 
significantly associated with log10IL-6 after adjustment for BMI and confounders. 
However, cardiorespiratory fitness was significantly and negatively associated with 
log10IL-6 after adjustment for WC and confounders (Model adjusted R2 =.273,p < .0001; 
p = -.341' t = -1.995, p =.049). Aim 2: Cardiorespiratory fitness X BMI or we interaction 
was not significantly associated with log10hs-CRP after adjustment for confounders. 
Similarly, cardiorespiratory fitness x BMI interaction was not significantly associated 
with log10IL-6 after adjustment for confounders. However, cardiorespiratory fitness x 
WC interaction was significantly associated with log10IL-6 after adjustment for 
confounders (Model adjusted R2 = .258,p < .0001; partial eta2 =.056, F = 4.730,p = .033). 
There were no associations of cardiorespiratory fitness, adiposity, and log10 TNF -a. 
Conclusions 
In young adults, higher cardiorespiratory fitness is significantly associated with lower 
levels of IL-6, particularly in young adults with central adiposity. Further studies are 
warranted to determine if experimentally induced increases in cardiorespiratory fitness 
reduce inflammatory markers in young adults. Longitudinal studies are needed to 
understand the underlying inflammatory mechanisms related to interaction between 
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cardiorespiratory fitness and adiposity, and its influence on cardiovascular disease risk in 
young adults. 
Keywords: cardiorespiratory fitness; body mass index; waist circumference; c-reactive 
protein; interlukin-6; tumor necrosis factor-a; young adults 
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Association of Cardiorespiratory Fitness and Adiposity with Inflammatory Biomarkers in 
Young Adults 
Atherosclerotic cardiovascular disease (CVD) is a significant public health burden in 
the United States (Go et al., 2013). Atherosclerosis, a systemic disease process in which 
amassment of plaque builds up in the arterial wall, is the major underlying cause of the 
clinical CVD and CVD events (Go et al., 2013; Libby et al, 2009). It has been 
demonstrated that low-grade systemic inflammation plays a pivotal role in the initiation 
and progression of atherosclerosis (Libby et al., 2009) by impairing endothelial function 
(Ferri et al., 2007). Among the many inflammatory biomarkers, high sensitivity C-
reactive protein (hs-CRP), interleukinkin-6 (IL-6), and tumor necrosis factor -alpha 
(TNF-a) are well-recognized markers of inflammation in relation to atherogenesis 
(Calabro, Golia, & Yeh, 2009; Haddy et al., 2003). 
C-reactive protein (CRP) is a major acute phase inflammatory protein, which is 
mainly produced by the liver in response to numerous inflammatory cytokines, 
particularly IL-6 (Bajpai, Goyal, & Sperling, 2010). The "high sensitivity (hs)-CRP" term 
is defined as "the measurement of CRP in serum or plasma sample using immunoassay 
methods with sufficient sensitivity to quantify CRP throughout its normai range" in 
asymptomatic individuals (Bajpai, Goyal, & Sperling, 2010, p.191). Hs-CRP detects the 
same CRP molecule as CRP test, but it detects substantially lower levels of inflammation 
(Bajpai, Goyal, & Sperling, 201 0). Numerous prospective studies have indicated that 
plasma level of hs-CRP is a strong independent predictor for future cardiovascular events 
in individual with no prior history ofCVD (Buckley, Fu, Freeman, Rogers, & Helfand, 
2009; Ridker, 2001; Ridker, 2003). 
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IL-6 is a pro-inflammatory cytokine and produced by fibroblasts, endothelial cells, 
monocytes, and adipose tissue (Schuett, Luchtefeld, Grothusen, Grote, & Schieffer, 
2009). IL-6 plays an important role in controlling hepatic production of inflammatory 
proteins, including hs-CRP and fibrinogen (Antuna-Puente, Feve, Fellahi, & Bastard, 
2008). A previous prospective study has reported that elevated levels ofiL-6 are 
associated with increased risk of future myocardial infarction in 14,916 apparently 
healthy men (Ridker, Rifai, Stampfer, & Hennekens, 2000).TNF-a, a pro-inflammatory 
cytokine, is secreted by macrophages, lymphocytes, and adipose tissue (Petersen & 
Pedersen, 2005). TNF -a activates the production of IL-6 in adipose tissue and blood 
mononuclear cells (Petersen & Pedersen, 2005). It has been reported that TNF-a is 
associated with degree of early atherosclerosis and correlates with metabolic and cellular 
perturbations in atherogenesis (Skoog et al., 2002). 
Although clinical symptoms of atherosclerotic CVD, such as chest pain or 
discomfort, shortness of breath or fatigue, numbness, and blurred vision are not 
commonly detected until adulthood it is a progressive atherosclerotic process that occurs 
early in life and has clinical indications for acute coronary syndrome and acute stroke 
usually later in life (Franks et al., 201 0; Loria et al., 2007). Hence, young adults could be 
an optimal target for preventive endeavors to minimize or delay atherosclerotic process, 
which could eventually decrease the incidence of clinical CVD throughout middle and 
older adulthood (Loria et al., 2007). 
This study is focused on cardiorespiratory fitness and adiposity of young adults in 
relation to hs-CRP, IL-6 and TNF -a. Cardiorespiratory fitness refers to "the ability of the 
circulatory and respiratory systems to supply oxygen and nutrients during sustained 
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physical activity" (Caspersen, Powell, & Christenson, 1985). Cardiorespiratory fitness is 
related to "the ability to perform large muscle dynamic, moderate-to-high intensity 
exercise for prolonged periods of time" (American College of Sports Medicine [ACSM], 
p. 71 ). It has been reported that higher levels of cardiorespiratory fitness are closely 
related to higher levels of habitual physical activity (Blair et al., 1995). Maximal oxygen 
uptake (V02max) is the gold standard or criterion measure of cardiorespiratory fitness 
(ACSM, 2010) and is commonly assessed with either a maximal or submaximal exercise 
test, using a treadmill or cycle ergometer (ACSM, 2010). Cardiorespiratory fitness in this 
present study was estimated using a submaximal treadmill walking protocol, which 
utilizes individual's heart rate (HR) response to submaximal treadmill work rates to 
estimate V02max (Ebbeling et al., 1991). Although direct measurement of 
cardiorespiratory fitness using a maximal exercise test (with or without collection of 
expired gases) is more precise than a submaximal exercise test, the maximal exercise test 
is not always feasible or practical in health and research settings due to the need for 
expensive laboratory equipment, trained personnel, possible physician oversight, 
participant burden, and associated safety considerations (Heyward, 201 0). 
Cardiorespiratory fitness has shown health benefits in lowering circulating levels of 
inflammatory biomarkers in various populations (Church, Barlow, Earnest, Kampert, 
Priest, & Blair, 2002; Kullo, Khaleghi, & Hensrud, 2007, Kuo, Yen, Chen, Y u, & Bean, 
2007; Isasi, Deckelbaum, Tracy, Stare, Berglund, & Shea, 2003; Williams et al., 2005). 
However, it remains uncertain whether the negative association between 
cardiorespiratory fitness and inflammatory biomarkers is due to the health benefits of 
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cardiorespiratory fitness itself or results from its association with lower levels of 
adiposity (Harmer, 2007). 
Adiposity is defined as "the quality or state of being fat" (Merriam-Webster 
Dictionary), and a synonym for obesity or fatness (Merriam-Webster Dictionary). 
Adiposity has been assessed by anthropometric measures in public health and clinical 
practice. Adiposity in this study was assessed by BMI and waist circumference (WC). 
BMI (kg/m2) has been recommended for the identification of measuring total body fat 
and the most widely accepted measures of overall adiposity (Stevens, McClain, & 
Truesdale, 2008); however, BMI does not differentiate fat mass from bone and muscle 
mass and does not provide any information on the distribution of body fat, particularly 
central body fat (Stevens, McClain, & Truesdale, 2008). Thus, this study included WC 
for assessing central adiposity (Stevens, McClain, & Truesdale, 2008). Adiposity has 
been positively associated with CRP in various populations (Brook, Blaha, & 
Blumenthal, 2010; Choi, Joseph, & Pilote, 2013). 
Only two studies have reported the association of cardiorespiratory fitness and 
inflammation measured by CRP in young adults over the past decade (Kuo et al., 2007; 
Williams, Milne, Hancox, & Poulton, 2006). Both studies reported that cardiorespiratory 
fitness was negatively associated with CRP in young adults independent of BMI, age, 
race, and cardiovascular risk factors, such as blood pressure, smoking, etc. In the study 
by Williams et al., investigators measured CRP using a low sensitivity CRP assay, which 
may underestimate the strength of the association between cardiorespiratory fitness and 
CRP (Williams et al., 2005). In the population-based study by Kuo et al., they included 
study participants with CVD risk factors, such as hypertension, diabetes and current 
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smokers or participants with anti-inflammatory or CVD medications (Kuo et al., 2007), 
which may influence levels of inflammatory biomarkers. Neither study examined 
adiposity as moderator of the association between inflammation and cardiorespiratory 
fitness, nor the extent to which adiposity influences the association between 
cardiorespiratory fitness and inflammation. In addition, neither study assessed central 
adiposity in detail. Furthermore, these two previous studies focused only on CRP as a 
biomarker of inflammation. It is essential to investigate other inflammatory markers, such 
as IL-6 and TNF -a in order to better understand inflammatory processes in relation to 
adiposity and cardiorespiratory fitness. 
This study aimed to (1) determine the strength of the association of cardiorespiratory 
fitness and adiposity (BMI and WC) with circulating levels of plasma hs-CRP, IL-6, and 
TNF-a; and (2) test the moderating effect of adiposity (BMI and WC) on the strength of 
the association between cardiorespiratory fitness levels and circulating levels of plasma 
hs-CRP, IL-6, and TNF -a in young adults aged 20 to 34 years. This study may fill an 
important gap in the literature by providing data on the role of adiposity as a moderator of 
the strength of the association between cardiorespiratory fitness and three inflammatory 
biomarkers. 
Methods 
Design 
This present study utilized a cross-sectional analytic design. Data were collected 
on each young adult through cardiorespiratory fitness testing, anthropometric 
measurement and blood sampling of inflammatory biomarkers in one session, lasting 
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approximately one and halfhours, at the University of Texas Health Science Center at 
Houston {UTHSC-H) School ofNursing (SON). 
Participant, sampling plan and recruitment 
The target population for this study was young adults aged 20 to 34 years residing 
in Houston, a large metropolitan city with an ethnically diverse population in southeast 
Texas. A sample of the population was accessed using a non-probability quota sampling 
approach in order to include approximately equal numbers of males and females of 
normal weight (BMI < 25 kg/m2), and overweight or obese (BMI ~ 25 kg/m2). The 
estimated sample size was 88 subjects to detect a medium effect size (0.059 ~ R2 < 0.138) 
according to Cohen ( 1998), a power of 80%, and an alpha level of .05 for a two-tailed test 
using nQuery Advisor version 7.0 (nQuery, Saugus, MA). 
The inclusion criteria were: (1) young adults aged 20-34 years; (2) no diagnosed 
diseases; (3) physically capacity for completing the cardiorespiratory fitness testing 
safely (ACSM, 2010); and (4) ability to speak and read English. Exclusion criteria were: 
(1) current smoker; (2) alcohol dependence or regular consumption of more than 7 
servings per week; (3) acute infections, including a current or recent influenza illness, flu 
shot recipients within last 4weeks, acute respiratory infection within last 3weeks; (4) 
dental infection and problems; ( 5) cardiometabolic dieseases, such as hypertension, 
hyperlipidemia and diabetes mellitus type I or II; ( 6) rheumatoid arthritis or immune 
disorders; (7) history of inflammatory bowel disease, such as Crohn' s disease and 
ulcerative colitis; (8) a surgery within the past one month; (9) currently taking 
medications, such as use of hormone replacement therapy, antihypertensive medications, 
allergy shots or systemic corticosteroids, aspirin, statin, and selective serotonin uptake 
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inhibitors (SSRis), and anti-inflammatory medications; (10) history of orthopedic injury 
in the past and limitations due to the musculoskeletal demands of cardiorespiratory test ; 
and ( 11) other medical conditions and medications that would increase inflammatory 
markers or would prohibit cardiorespiratory fitness testing (O'Connor et al., 2009). For 
females, additional inclusion criteria were: ( 1) self-reported regular menstrual cycle 
length of24-35 days; and (2) self-report of no menstruation at the time of data collection 
because menses may affect the levels ofhs-CRP (Gaskins et al., 2012). Additional 
exclusion criteria were: ( 1) natural or surgical menopause; (2) current or recent 
pregnancy (past 6 months); (3) currently or recently (past 2 months) lactating females 
(Williams, Williams & Poulton, 2006); ( 4) history of gynecologic problems, such as 
fibroids, endometriosis, or polycystic ovary syndrome (Escobar-Morreale, Luque-
Ramirez, & Gonzalez, 2011 ); ( 5) use of contraceptive hormone patch or vaginal ring 
methods of contraception currently or within the past three months; and ( 6) intrauterine 
device (IUD) with hormones or Depo-Provera currently or within the past 12 months 
(Gaskins et al., 2011; O'Connor et al., 2009). This study included females who currently 
or in the past have taken oral contraceptives, and included as a covariate in the analysis. 
Participants were recruited by posting fliers in the UTHSC-H, surrounding communities 
of the UTHSC-H, and multiple campuses in Houston. The recruitment began at the end of 
March 2013 and continued through December 2013. Individuals interested in the study 
contacted the principal investigator (PI) by phone or e-mail and were screened by 
interview. Participants that met the selection criteria were invited to a data collection 
session. 
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Procedures 
The data were collected by the PI at the Center for Nursing Research in the 
UTHSC-H, school of nursing (SON). The fitness room was maintained between 68 and 
76 degrees Fahrenheit, with a humidity level between 20 to 60 percent using a room 
temperature thermometer (Q-Track IAQ monitor, TSI Incorporated, Shoreview, MN) 
throughout the data collection period (ACSM, 201 0). 
To prepare for data collection, participants were instructed (1) to fast from eating 
food for 12-hours prior to test but were allowed to drink water only; (2) not to engage in 
strenuous exercise, consume alcohol, or use anti-inflammatory drugs 24 hours prior to 
blood sampling; (3) to arrive at the UTHSC-H SON bioscience laboratory between 8am 
and 10 am; (4) to wear comfortable exercise-type clothing; (5) to avoid caffeine 12- hours 
prior to test; ( 6) to consume plenty of fluids; and (7) to obtain an adequate amount of 
sleep the night before the test (ACSM, 2010). The informed consent was obtained from 
each participant. All procedures were administered by the PI. Participants received 
$10.00 and a free sandwich for completion of data collection protocol. All study 
procedures were approved by the Committee for the Protection of Human Subjects at the 
UTHSC-H. 
Instruments and Data Collection 
Assessment of cardiorespiratory fitness. Cardiorespiratory fitness was assessed 
by a single-stage submaximal treadmill walking test (SSTWT). The SSTWT was 
developed by Ebbeling et al. ( 1991) for estimating V 02max of low-risk, healthy adults 20 
to 50 years old. The SSTWT was validated by correlating the indirectly estimated 
V02max based on individual's walking speed, heart rate (HR), age and sex and the 
CARDIORESPIRATORY FITNESS, ADIPOSITY, AND INFLAMMATION 122 
directly measured respiratory gas exchange (V02max) in the cross-validation group (n = 
22) (Ebbeling et al., 1991). A correlation (r) of .96 was reported, with multiple 
correlation (R2) of .86 (SEE= 4.85 mllkg·mim) (Ebbeling et al., 1991). 
Single-stage submaximal treadmill walking test protocol. The SSTWT consisted 
of a 4-minute warm-up stage, 4-minute workload stage, and a 2- Sminute cool-down 
stage. The treadmill was calibrated before cardiorespiratory fitness test to ensure the 
accuracy of the test. Prior to beginning the SSTWT, participants were familiarized with 
the treadmill (Precor 956i, Precor, Inc., Woodinville, WA), including a visual 
demonstration in order to maximize participant safety. In the first warm-up stage, 
participants walked on the treadmill for 4-minutes at 0% incline and a walking speed 
(2.0 to 4.5 mph) that brings the HR to between 50% and 70% beats per minute (bpm) 
age-predicted maximal HR by the Pl. In workload stage, the treadmill incline was 
increased to 5% at the same speed for a 4-to 5-minute period. Following a workload 
stage, the participants completed a cool-down stage at a slower walking pace and 0% 
incline for a 2-Sminute period. Resting BP and HR using the oscillometric technique 
(HEM-907SL, Omron Healthcare, Inc., Bannockburn, IL) was assessed prior to a warm-
up stage, twice and after a cool-down stage one time. If the participant's resting blood 
pressure was ~ 130/90 mmHg or resting HR ~ 100 bpm, the participant was not allowed 
to continue with the SSTWT protocol. Polar HR (Vintage NV model, Polar CIC, Inc., 
Port Washington, NY) was recorded during the SSTWT protocol and the Borg Ratings of 
Perceived Exertion scale (RPE) was documented at the end of the warm-up stage and the 
workload stage. RPE provides a subjective indication of how hard the participant feels he 
or she is working with numbers, rating from 6 (very, very light) to 20 (very, very hard) 
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(Borg, 1970). Steady-state HR is defined as a HR within 5 bpm during the last 2 minute 
of the workload stage. The main outcome of the cardiorespiratory test estimated maximal 
oxygen uptake (V02max). The SSTWT prediction equation was used to estimate 
V02max based on age, sex, walking speed (mph), and steady-state HR. 
Estimated V02 max (ml/kg·min) = 15.1 +21.8 (speed in mph)- 0.327 (steady 
state HR in bpm}- 0.263 (speed x age in years)+ 0.00504 (SS HR in bpm age in 
years)+ 5.98 (sex; female= 0, male= 1) 
Assessment of adiposity. Adiposity was assessed using BMI and WC. BMI was 
calculated by dividing the participant's weight in kilograms by the height in meters 
squared (kg/m2). Height was measured without shoes to the nearest 0.1 em using a wall-
mounted stadiometer (Accustat, Genentech Inc.). Weight was measured to the nearest 
1/4th lb with a calibrated balance beam scale. Height and weight were measured with 
minimal clothing and without shoes and hats (National Health and Nutrition Examination 
Survey [NHANES], 201 0). WC was a measure of the degree of central of body fat. WC 
was measured to the nearest 0.1 em using a flexible, nonstrectchable tape. The tape 
measure was placed just above the uppermost lateral border of the right ilium crest and 
was extended around the waist in a horizontal plane (NHANES, 201 0). Height, weight, 
and waist circumference were repeated, and the mean of two measures was calculated. 
Measurement ofhs-CRP, IL-6, and TNF-a. Blood collection was taken after a 
12-hour overnight fast. A 10 ml blood sample was collected from an antecubital vein into 
two vacutainers containing ethylene diamine tetra acetic acid (EDT A) by the Pl. The 
blood samples were immediately centrifuged at 1,630 relative centrifugal force (ref) at-
4°C for 30 minutes (Centrifuge5810~ Eppendorf AG Hamburg, Germany). After 
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centrifugation, plasma samples were divided into eight aliquots and stored at -80°C until 
batch assayed. Plasma hs-CRP was determined by the CRP Ultra Wide Range Reagent 
kit (Sekisui Diagnostics, Inc., PE, Canada}, a latex-enhanced turbidimetric in vitro 
immunoassay (AU480 automated platform, Beckman Coulter, Marietta, GA) at the 
Atherosclerosis Clinical Research Laboratory at the Baylor College Medicine. The 
plasma hs-CRP samples exceeding the upper limit of linearity were diluted and repeated. 
The new values were multiplied by the dilution factor to generate a final reportable value. 
The detectable levels of hs-CRP ranged from 0.05 to 160 mg/L. Intra-assay coefficient of 
variations (CV) for hs-CRP was< 3.3%. Plasma IL-6 and TNF-a were determined using 
Quantikine high-sensitivity enzyme-linked immunosorbent assay (ELISA) kits (R&D 
System, MN, USA) at the Bioscience Laboratory in the UTHSC-H SON. The detectable 
levels ofiL-6 ranged from 0.156 to 10 pg/mL, and the detectable levels ofTNF-a ranged 
from 0.5 to 32 pg/mL. IL-6 and TNF-a were run on the WorkOut™ software (version 
2.5, Perkin Elmer Life and Analytical Sciences). The intra-assay CV and inter-assay CV 
for IL-6 were 9.4% and 2.3%, and inter-assay CV for TNF-a were 11.0% and 1.0% 
respectively. 
Age, sex, ethnicity, education, oral contraceptive use were considered as possible 
confounders related to inflammation based on the previous studies (Cauci et al., 2008; 
Dreon, Slavin, & Phinney, 2003; Friedman & Herd, 2010; Ferrucci et al., 2005; Kelley-
Hedgepeth et al., 2008; O'Connor et al., 2009; Paalani, Lee, Haddad, & Tonstad, 2011). 
Statistical Analysis 
Statistical analyses were performed by using statistical software SPSS version 
22.0 (SPSS Inc., Chicago, IL). Descriptive data were presented as mean± standard 
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deviation (SD), frequency and percentage. Data were checked for normality of 
distribution before analyses and were transformed as necessary. The distributions ofhs-
CRP, IL-6, and TNF-a were positively skewed and were log10-transformed. All statistical 
tests were two-tailed and p-value < .05 was considered statistically significant. Multiple 
regression analysis was used to examine aim 1 : the strength of the association of 
cardiorespiratory fitness and adiposity with inflammatory biomarkers. For aim 2, analysis 
of covariance (ANCOV A) was used to examine the association of cardiorespiratory 
fitness (continuous variable) x adiposity (categorical variables) interaction term with 
inflammatory biomarkers (continuous variable) as the outcome variable. Categories for 
adiposity were as follows; BMI was divided into < 25 kg/m2 (normal weight) and BMI ~ 
25 kg/m2 (overweight or obese), and we was divided at the 50th percentile (median value 
= 86.4 em); WC < 86.4 em and WC ~ 86.4 em. Separate analyses were conducted with 
each of the inflammatory markers (hs-CRP, IL-6, and TNF-a) as the dependent variable. 
Analyses for aim 1 and 2 were adjusted for possible confounders including age, sex, or 
oral contraceptives (females only), ethnicity and education. The dichotomous variables of 
sex and use of oral contraceptives were considered as an interaction term, which resulted 
in three categories (males, females without oral contraceptives, and female with oral 
contraceptives). Variables that were statistically significantly related to the dependent 
variable (p < .05) were included as confounding variables. 
Results 
Descriptive Characteristics of Participants 
One hundred and thirty young adults were assessed for eligibility; 88 participants 
completed the study as shown in Figure 1. The descriptive characteristics of the 
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participants are presented in Table 1. All participants (n = 88) had complete data for 
cardiorespiratory fitness, BMI, WC, hs-CRP, and TNF-a, and 87 participants had IL-6 
data. The mean of age of participants was 25.97 ± 3.84 (SD) years (range, 20-34 years), 
and 48.9% was males. The anthropometric and health characteristics of the sample are 
presented for the sample and for males and females separately in Table 2. Males had 
higher mean levels of cardiorespiratory fitness, and W C than females whereas female had 
higher mean levels of hs-CRP than males. Males and females had similar mean levels in 
BMI, IL-6, and TNF-a. 
Associations of Cardiorespiratory Fitness and Adiposity (BMI and WC) with 
Logtohs-CRP and LogtoiL-6 
Multiple linear regression analysis was used with log10hs-CRP as the outcome 
variable and cardiorespiratory fitness as predictor variables in Table 3. In multiple linear 
regression analysis, age, ethnicity, and education were not significant confounding 
variables related to logwhs-CRP (p < .20). This study identified sex and oral 
contraceptives as important confounders related to log10hs-CRP (p < .20). 
Cardiorespiratory fitness was significantly and negatively associated with logwhs-CRP 
after adjustment for sex x oral contraceptive interaction term (Modell: adjusted R2 = 
.300, F (2, 84) = 13.430,p < .0001; P-coefficient = -.639, t = -4.920,p < .0001). 
However, after BMI was added to this model, cardiorespiratory fitness was not 
significantly associated with log10hs-CRP (Model2: adjusted R2 = .429, F (4, 83) = 
17.324,p < .0001; ~-coefficient= -.178, t = -1.137,p = .259). Likewise, after WC was 
added as a predictor, cardiorespiratory fitness was not significantly associated with 
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log10hs-CRP either (Model3: adjusted R2 = .418, F (4, 83) = 16.64l,p <.0001; ~­
coefficient= -.202, t = -1.291,p = .200). 
In terms of log10 IL-6, multiple linear regression analysis was used with log10IL-6 
as the outcome variable and cardiorespiratory fitness as predictor variable in Table 4. In 
multiple linear regression analysis, age and ethnicity were not significant confounding 
variables related to log10IL-6 (p < .20). Therefore, this study identified sex and education 
as confounding variables in the statistical analysis of log10IL-6 (p < .20). 
Cardiorespiratory fitness was significantly and negatively associated with log10IL-6 after 
adjustment for sex and education (Modell: adjusted R2 = .216, F (3, 82) = 6.92l,p < 
.0001; ~-coefficient = -.638, t = -4.673, p < .0001 ). When BMI was added to this model, 
cardiorespiratory fitness was not significantly associated with log10IL-6 (Model 2: 
adjusted R2 = .283, F (5, 81) = 7.801,p < .0001; ~-coefficient= -.316, t = -1.854,p 
=.067). However, cardiorespiratory fitness was significantly and negatively associated 
with log10IL-6 after WC was added to this model (Model3: adjusted R2 = .273, F (5, 81) 
= 1.459,p < .0001; ~-coefficient= -.341, t = -1.995,p =.049). 
Interaction between Cardiorespiratory Fitness and Adiposity on Logt0hs-CRP 
The results of the analysis of covariance (ANCOV A) to examine the association 
of cardiorespiratory fitness (continuous variable) x BMI (categorical variables) 
interaction term with log10hs-CRP (continuous variable) as the outcome variable were 
presented in Table 5. There was a statistically significant cardiorespiratory fitness x BMI 
interaction term for log10hs-CRP (Modell: adjusted R2 = .229, F (3, 84) = 9.601,p < 
.0001; interaction term, partial eta2 =.051, F (1, 84) = 4.553,p = .036). The interaction 
effect is illustrated in Figure 2. For example, young adults with BMI ~ 25 kg/m2 and a 
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high cardiorespiratory fitness level (55rnL/kg·min) had a lower level ofhs-CRP (0.60 
mg/L) compared with the hs-CRP level (2.39 mg/L) of young adults with BMI ~ 25 
kg/m2 and a low cardiorespiratory fitness level (35mL/kg·min). This suggests that higher 
levels of cardiorespiratory fitness are associated with lower levels ofhs-CRP in young 
adults with BMI in the overweight/ obese range. In contrast, among those with BMI < 25 
kg/m2, the levels ofhs-CRP did not vary by the level of cardiorespiratory fitness. For 
instance, as illustrated in Figure 2 young adults with BMI < 25 kg/m2 and a high 
cardiorespiratory fitness level (55mL/kg·min) had a hs-CRP (0.45mg/L), which is very 
similar to those with BMI < 25 kg/m2 and a low cardiorespiratory fitness level 
(35mL/kg·min) hs-CRP (0.49mg/L). This suggests that higher levels of cardiorespiratory 
fitness are associated with lower levels of hs-CRP in young adults in the presence of high 
BMI ~ 25 kg/m2 group. However, the cardiorespiratory fitness x BMI interaction term 
was not statistically significant on hs-CRP after adjustment for sex x oral contraceptive 
interaction (p = .127) in model 2, Table 5. This means that the sex x oral contraceptive 
interaction has an important confounding effect in relation to cardiorespiratory fitness, 
BMI and hs-CRP. 
Table 6 shows the analysis of covariance (ANCOV A) to examine the association 
of cardiorespiratory fitneSS (continUOUS Variable) X WC (categorical Variables) interactiOn 
term with logt0hs-CRP (continuous variable) as an outcome variable. There was not a 
statistically significant cardiorespiratory fitness X we interaction term on logiOhs-CRP 
(Modell: adjusted R2 = .314, F(3, 84) = 14.283,p < .0001; interaction term partial eta2 
=.012, F (1, 84) = 1.059,p = .306 in Table 6). Similarly, there was not a statistically 
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significant cardiorespiratory fitness X we interaction term on logtohs-CRP after 
adjustment for sex x oral contraceptive interaction in model 2, Table 6. 
Interaction between Cardiorespiratory Fitness and Adiposity (BMI and WC) on 
LogtoiL-6 
The results of the analysis of covariance (ANCOV A) to examine the association 
of cardiorespiratory fitness (continuous variable) x BMI (categorical variables) 
interaction term with log10IL-6 (continuous variable) as an outcome variable were shown 
in Table 7. Modell shows that there was not a statistically significant cardiorespiratory 
fitness x BMI interaction term on log10IL-6 (Modell: adjusted R2 = .190, F (3, 83) = 
7.705 p < .0001; interaction term partial eta2 =.033, F (1, 83) = 2.79l,p = 0.099). 
Similarly, the cardiorespiratory fitness x BMI interaction term after adjustment for sex 
and education was not statistically significant on log10IL-6 (Model 2: adjusted R2 = .240, 
F (6, 80) = 5.528,p < .0001; interaction term partial eta2 =.022, F (1, 80) = l.820,p = 
.181 ). 
Table 8 shows the analysis of covariance (ANCOV A) to examine the association 
Of Cardiorespiratory fitneSS (continUOUS Variable) X WC (categorical Variables) interaction 
term with log10IL-6 (continuous variable) as the outcome variable. There was a 
statistically significant cardiorespiratory fitness X we interaction term on logtoiL-6 
(Modell: adjusted R2 = .228, F (3, 83) = 9.456,p < .0001; interaction term partial eta2 
=.080, F {1, 83) = 1.254,p = .009). The interaction effect is illustrated in Figure 3. For 
instance, young adults with we 2:: 86.4 em and a high cardiorespiratory fitness 
(55mL/kg·min) had lower levels ofiL-6 (0.83 pg/ml) compared with the IL-6level (1.83 
pg/ml) of young adults with we < 86.4 em and a low cardiorespiratory fitness 
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(35mL/kg·min). In contrast, young adults with WC < 86.4cm and a high 
cardiorespiratory fitness (55mL/kg·min) had a 0.84 IL-6level, which was similar to the 
level of IL-6 (0.88 pg/ml) of young adults WC < 86.4 em and a high cardiorespiratory 
fitness (35mL/kg·min). This significant interaction between cardiorespiratory fitness and 
WC on log10IL-6 was sustained after adjustment for sex and education (Model 2: adjusted 
R2 = .258, F (6, 80) = 5.991,p < .0001; interaction term partial eta2 =.056, F (1, 80) = 
4. 730, p = .033). Thus, the association between cardiorespiratory fitness and log10IL-6 
depends on which levels of we are being considered. 
TNF-a 
There were no associations of cardiorespiratory fitness and adiposity (BMI and 
WC) with log10 TNF-a in young adults. 
Discussion 
The finding of the present study was that cardiorespiratory fitness was not 
significantly associated with hs-CRP after adjustment for BMI (WC) and sex x oral 
contraceptive interaction. Cardiorespiratory fitness was not significantly associated with 
IL-6 after adjustment for BMI, sex and education. However, higher levels of 
cardiorespiratory fitness were significantly and negatively associated with lower IL-6 
levels after adjustment for we, sex and education in young adults aged 20 to 34 years. 
For aim two, neither BMI nor we significantly modified the strength of the associations 
of cardiorespiratory fitness with hs-eRP levels after adjustment for sex x oral 
contraceptives interaction. However, we significantly modified the strength of the 
association of cardiorespiratory fitness with IL-6 after adjustment for sex and education. 
Specifically, young adults with we ~ 86.4cm (median split) and high levels of 
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cardiorespiratory fitness had significantly lower levels of IL-6 compared with young 
adults with we ;::: 86.4cm with lower levels of cardiorespiratory fitness. This provides 
evidence that cardiorespiratory fitness may act as an anti-inflammatory role in lowering 
levels of circulating IL-6 particularly in young adults with central adiposity. 
In relation to the first aim, the findings of the associations of cardiorespiratory 
fitness and adiposity (BMI and WC) with hs-CRP of this present study were inconsistent 
with previous two studies (Kuo et al., 2007; Williams et al., 2005). Williams and 
colleagues reported that cardiorespiratory fitness levels are negatively associated with 
CRP levels after adjustment for BMI, systolic blood pressure, smoking, and combined 
oral contraceptive use in 26-year-old young adults (p :S 0.01). This inconsistent result 
could be explained by differences between the two samples in mean BMI. The means of 
BMI in the previous study were male (25.2kg/m2) and females (24.8 kg/m2), whereas the 
means of BMI in the present study were males (26.06 ± 5.03kg/m2) and females (26.23 ± 
6.81kg.m2). It has been reported that cardiorespiratory fitness is negatively associated 
with fatness (Martinez-Gomez et al., 201 0). Moreover, higher levels of BMI are 
associated with high levels ofhs-CRP (Choi, Joseph, & Pilote, 2013). The other previous 
study by Kuo and colleagues also reported that a significantly negative association 
between cardiorespiratory fitness and CRP after adjustment for age, race, BMI category, 
cardiovascular risk factors and anti-inflammatory medication or CVD medications in 
1438 adults aged 20-49 from the NHANES 1999-2002. This inconsistent result could be 
explained by statistically different adjustment for BMI variable. The previous study 
adjusted for BMI as categorical variables whereas this present study adjusted BMI as a 
continuous variable. This statistically different adjustment for adiposity (BMI or WC) 
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could explain the different results. The findings of present study, however, were 
consistent with previous study by Martinez-Gomez et al. (20 1 0), which showed that 
cardiorespiratory fitness was negatively associated with CRP, but this association did not 
remain statistically significant after adjustment for body fat in 192 adolescents aged 13-
17 years (Martinez-Gomez et al., 201 0). Previous review by Hamer (2007) has also 
reported that high levels of fitness are associated with lower levels of inflammation, 
although the associations were mixed after adjusting for measures of fatness. 
In terms of IL-6, no previous studies examined the association of 
cardiorespiratory fitness and adiposity (BMI and WC) with IL-6 in young adults aged 20-
34 years. To our best knowledge, the present study is the first study to examine the 
association of levels of cardiorespiratory fitness and adiposity (BMI and WC) with IL-6 
levels particularly in young adult aged 20-34 years. The present study found that higher 
levels of cardiorespiratory fitness are significantly associated with lower levels of IL-6 in 
young adults when controlling for we, sex and education. 
In relation to the second aim, this present study is the first to examine the 
interactions of cardiorespiratory fitness and adiposity (BMI and WC) in relation to hs-
CRP and IL-6levels in young adults. For circulating hs-CRP concentration, this present 
study did not find significant interactions between cardiorespiratory fitness and either 
BMI or we levels with hs-CRP levels after adjustment for sex X oral contraceptive 
interaction in young adults. This finding may suggest that both cardiorespiratory fitness 
and adiposity (BMI and WC) could be independently related to hs-CRP. In a previous 
literature review including diverse populations by Hamer (2007) reported that both 
fitness and fatness were associated with inflammatory factors although the relative 
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contributions of both may be dependent on sex, age, and disease status. Thus, both 
maintaining high levels of cardiorespiratory fitness and low levels of BMI and WC could 
be important factors for maintaining low hs-CRP levels in young adults. 
For circulating IL-6 concentration, however, cardiorespiratory fitness X we 
interaction was significantly associated with IL-6 after adjustment for sex and education 
in young adults. This means that young adults with central adiposity may have lower 
levels of IL-6 if they have higher levels of cardiorespiratory fitness, indicating that higher 
levels of cardiorespiratory fitness may exert an anti-inflammatory effect and thereby 
protect against low-grade inflammation (Wilund, 2007). The mechanisms for the 
potential anti-inflammatory roles of fitness are not completely understood. The possible 
mechanisms have suggested that regular physical exercise could improve endothelium-
dependent vasodilation by enhancing blood flow and shear stress, resulting in increased 
the bioavailability of nitric oxide production (Di Francescomarino, Sciartilli, Di Valerio, 
Di Baldassarre, & Gallina, 2009). In contrast, this present study did not find a significant 
interaction between cardiorespiratory fitness and BMI on IL-6 after adjustment for sex 
and education. That is, both cardiorespiratory fitness and BMI could be independently 
related to IL-6 after adjustment for sex and education. No previous findings can be 
compared with findings of the present study in interaction between cardiorespiratory 
fitness and adiposity (measured by BMI and WC) on IL-6 in young adults. 
Another important finding of this present study was that there was a significant 
interaction between cardiorespiratory fitness and WC with regards to IL-6, but there was 
no significant interaction between cardiorespiratory fitness and we with regards to hs-
CRP. This difference may be explicated by differences in hs-CRP and IL-6 secretion. IL-
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6 is produced in adipose tissue, and induces hepatic production of CRP (Shoelson, 
Herrero, & Naaz, 2007). CRP is an acute-phase reactant synthesized mainly in the liver 
and is regulated by IL-6 levels (Clearfield, 2005). At rest, approximately 30% of 
circulating IL-6 is released from adipose tissue (Mohamed-All et al., 1997), and visceral 
adipose tissue secretes 2-3times more IL-6 than subcutaneous adipose tissue (Fried, 
Bunkin, & Greenberg, 1998). This present study found that higher levels of 
cardiorespiratory fitness were significantly related to lower levels of IL-6 after 
adjustment for we, sex and education. This study also found that higher levels of 
cardiorespiratory fitness were significantly associated with lower levels of IL-6, 
particularly young adults with WC 2:: 86.4cm. Taken together, IL-6 levels influenced by 
visceral adipose tissue and higher levels of cardiorespiratory fitness are significantly 
related to reducing IL-6 levels in young adults with WC 2:: 86.4 em. 
This present study found that use of oral contraceptive was a significant 
confounding variable in relation to hs-CRP. Previous studies also have reported that hs-
CRP levels are significantly higher among oral contraceptive user versus non-users 
(Cauci et al., 2008; Dreon et al., 2003). The underlying mechanisms by which oral 
contraceptives induces higher levels of hs-CRP have not been fully clarified (Dreon et al., 
2003). Previous investigations have suggested that exogenous estrogenic hormones may 
have directly modulate hepatic synthesis and therefore may affect pro-inflammatory 
pathways (van Rooijen, Hansson, Frostegard, Silveira, Hamsten, & Bremme, 2006), but 
further investigations are required to clarify the pathways. 
In relation to TNF -a, this present study did not find any associations of 
cardiorespiratory fitness and BMI (WC) with TNF-a for aim land aim 2.This result is 
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possibly due to low concentrations of TNF -a in young adults. In previous studies of the 
association between adiposity and TNF-a, Wang and colleagues (2011) reported that 
TNF -a was not significantly related to BMI and percent body fat in university students, 
and this present study did not find any associations. In contrast, Moon et al and 
colleagues (2004) reported that TNF-a was significantly and positively associated with 
both BMI (r = .346;p < .005) and WC (r = .525;p < .001) in obese adolescents using a 
cross-sectional study. 
There are several limitations in this present study. Firstly, it is the inability to 
establish causal relationships from data collected cross-sectional time frame. Secondly, a 
non-probability quota sampling method in university and community settings limited 
generalization of the findings of this study to young adults. Thirdly, indirect estimate of 
V 02max through HR response to a submaximal single stage treadmill test estimated 
V02max instead of direct measurement of V02max through open circuit spirometry during 
maximal treadmill test (ACSM, 2010). Lastly, this present study found that 6 participants 
who had hs-CRP levels from 10.4 to 21.11mg/L, and these participants were not excluded 
from the data analysis. Albeit the American Heart Association (AHA)/Centers for 
Disease Control and Prevention (CDC) recommends that an hs-CRP level of > 1 Omg/L 
should be repeated in 2 weeks due to the possible presence of an acute infection (Pearson 
et al., 2003), the 6 participants of this present study were unlikely to have acute 
infectious conditions. This present study very carefully assessed an acute infection or any 
trauma through inclusion arid exclusion criteria and before blood testing. In addition, the 
6 participants were all females that were overweight or obese (BMI from 28 to 44.1 
kg/m2). Except for one participant, they all had taken oral contraceptive medications. 
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This suggests that more extreme levels of adiposity may be directly associated with acute 
chronic inflammation, and oral contraceptives also may contribute to higher levels of hs-
CRP. However, further study is needed to clarify this association. Moreover, exclusion of 
the 6 participants with an hs-CRP > 1 Omg/L did not significantly change the findings 
(aim 1 and 2) although the data were not shown in this paper. 
The main strengths of this present study includes careful selection of participants 
using rigorous inclusion and exclusion criteria, and control of important confounders in 
relation to each biomarker. In addition, this present study extends previous studies by 
including inflammatory biomarkers in addition to CRP, such as IL-6 and TNF-a in young 
adults. Furthermore, central adiposity assessed by waist circumference regarding this 
association is included, which has not been examined in young adults previously. 
Prospective studies are needed to ascertain the influences of cardiorespiratory 
fitness and adiposity on inflammatory biomarkers during young adulthood. Exercise 
intervention studies for improving cardiorespiratory fitness and weight reduction are also 
warranted to reduce hs-CRP and IL-6 and to improve cardiovascular health in young 
adults. Moreover, research is needed to investigate the associations of cardiorespiratory 
fitness and adiposity with TNF -a in overweight and obese young adults. 
In conclusion, cardiorespiratory fitness is significantly and negatively associated 
with IL-6 in young adults aged 20-34 years after adjustment for WC, sex, and education. 
Moreover, there is a significant interaction between cardiorespiratory fitness and WC in 
predicting IL-6levels after adjustment for sex and education in young adults aged 20-34 
years old. Therefore, cardiorespiratory fitness may decrease risk of atherosclerosis, CVD 
events, and CVD by reducing inflammatory biomarkers. Further studies are warranted to 
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determine if experimentally induced increases in cardiorespiratory fitness reduce 
inflammatory markers in young adults. Longitudinal studies are needed to understand the 
inflammatory mechanisms related to cardiorespiratory fitness and adiposity, and its 
influence on cardiovascular disease risk in young adults. 
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Figure]. Young adult recruitment flow diagram 
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Table I 
Participant characteristics 
All (N = 88) 
n %orMean±SD 
Age (years) 88 25.97 ± 3.84 
Sex 
Male 43 48.9% 
26.30 ± 3.90 
Female 45 51.1% 
25.66 ± 3.80 
Ethnicity 
Caucasian 24 27.3% 
African American 18 20.5% 
Hispanic 19 21.6% 
Asian 20 22.7% 
Mixed Race 7 8.0% 
Marital status 
Married or living 18 20.5% 
with partner 
Single 70 79.5% 
Occupation 
Employee 16 18.2% 
Doctoral student 9 10.1% 
Master student 28 31.8% 
College student 33 37.5% 
Other 2 2.3% 
Education 
Graduate degree 17 19.3% 
Undergraduate degree 49 55.7% 
High school degree 22 25.0% 
Oral contraceptives 45 
Yes 12 26.6% 
No 33 73.4% 
Table 2 
Descriptive statistics for anthropometric and inflammatory biomarkers in young adult aged 20-34 years (N = 88) 
All (N = 88) Males (n = 43) Females (n = 45) 
Mean± SD (Range) n (%) Mean± SD (Range) n(%) Mean± SD n(%) 
(Range) 
Height (em) 169.93 ± 9.42 176.22 ± 7.49 163.93 ± 6.83 
Weight (kg) 75.66 ± 18.76 81.00± 17.52 70.55 ± 18.68 
BMI (kg/m2) 26.15 ± 5.97 26.06± 5.03 26.23 ± 6.81 
Normal weight < 25 21.90 ± 1.74 44 (SO) 22.42 ± 1.51 21 (48.8) 21.43 ± 1.83 23 (51.1) 
Overweight/Obese ~ 25 30.39± 5.69 44 (50) 29.53 ± 4.76 22 (51.2) 31.25 ± 6.50 22 (48.9) 
we (em) 90.06 ± 14.30 91.03 ± 12.96 89.12 ± 15.57 
<86.4 80.01 ± 4.78 44 (50) 81.93 ± 4.33 18 (41.9) 78.67 ± 4.69 26 (57.8) 
;:::86.4 100.11 ± 13.59 44 (50) 97.59 ± 13.18 25 (58.1) 103.42 ± 13.74 19 (42.2) 
SBP (mm Hg) 114.31 ± 9.18 119.59 ± 5.89 109.26 ± 8.95 
DBP (mm Hg) 73.23 ± 8.66 74.97 ± 7.92 71.57 ± 9.08 
HR(permin) 68.72 ± 11.00 67.14 ± 9.73 70.22 ± 12.00 
CRF 45.72± 9.03 88 52.27 ± 5.06 43 39.47 ± 7.41 45 
(V02max(mL/kg· min)) (15 .42-59.84) (38.42-59.84) (15.42-56.53) 
hs-CRP (mg!L) 2.16 ± 3.81 88 1.35 ± 1.98 43 2.69 ± 4.87 45 
(0.067-21.11) (0.067-9.41) (0.085-21.11) 
IL-6 (pglml) 1.26 ± 1.17 87 1.07 ± 0.68 43 1.45 ± 1.48 44 
(0.33-8.69) (0.40-3. 70) (0.33-8.69) 
TNF-a (pg/ml) 1.09 ± 1.19 88 1.16 ± 0.99 43 1.03 ± 1.36 45 
loo-0 
~ 
\0 
(0.42-9.72) (0.48-5.71) (0.42-9.72) 
Abbreviations: eRF, cardiorespiratory fitness; BMI, body mass index; We, waist circumference; eRP, c-reactive protein; IL-6, interleukin-6; 
TNF-a, tumor necrosis factor-alpha; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate. 
Note: We was divided into two categories based on the 50th percentile (median value= 86.4cm). 
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Table 3 
Multiple linear regression of cardiorespiratory fitness and adiposity with /og10hs-CRP (N = 88) 
Predictor variables 
Model I 
Intercept 
CRF (mL/kg·min) 
Sex x OC 
Male (ref) 
Female (non-OC) 
Female (OC) 
Model2 
Intercept 
CRF (mL/kg·min) 
BMI (kglm2) 
Sex x OC 
Male (ref) 
Female (non-OC) 
Female (OC) 
Model3 
Intercept 
CRF (mL/kg-1·min-1) 
we (em) 
Sex x OC 
Male (ref) 
Female (non-OC) 
Female (OC) 
Models 
adjK F p 
.324 .300 13.430 .000 
.455 .429 17.324 .000 
.445 .418 16.641 .000 
Outcomes 
Log10hs-CRP (mg/L) 
B 
2.028 
-.042 
-.577 
.194 
-.838 
-.012 
.049 
-.144 
.443 
-1.253 
-.013 
.019 
-.125 
.484 
SEB 
.457 
.009 
.166 
.186 
.763 
.010 
.011 
.178 
.177 
.877 
.010 
.005 
.185 
.183 
Coefficients 
p t p 
-.639 
-.468 
.111 
-.178 
.484 
-.117 
.255 
-.202 
.462 
-.102 
.279 
4.435 .000 
-4.920 .000 
.000 
-3.475 .001 
1.040 .301 
-1.098 .275 
-1.137 .259 
4.464 .000 
.001 
-.806 .423 
2.498 .014 
-1.429 .157 
-1.291 .200 
4.252 .000 
.001 
-.679 .499 
2.647 .010 
Abbreviations: CRF, cardiorespiratory fitness; BMI, body mass index; WC, waist circumference; 
hs-CRP, high sensitive C-reactive protein; adj, adjusted; B, unstandardized coefficients; SE, 
standard error ; ~' standardized coefficients; OC, oral contraceptives; ref, reference. 
Model 1 : Multiple linear regression predicting CRF from log10hs-CRP after adjustment for sex x 
oral contraceptive interaction term 
Model 2: Multiple linear regression predicting CRF from log10hs-CRP after adjustment for BMI 
and sex x oral contraceptive interaction term 
Model 3: Multiple linear regression predicting CRF from log10hs-CRP after adjustment for WC 
and sex x oral contraceptive interaction term 
Note: hs-CRP was transformed into log10hs-CRP (mg/L). CRF, BMI, and WC, continuous 
variables 
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Table 4 
Multiple linear regression of cardiorespiratory fitness and adiposity with /oguJL-6 (N = 87) 
Outcomes 
Predictor variables LogwiL-6 (pglm1) 
Models Coefficients 
If adjK F p B SEB p t p 
Modell .252 .216 6.921 .000 
Intercept .933 .185 5.037 .000 
CRF (mL/kg·min) -.020 .004 -.638 -4.673 .000 
Sex 
Male (ref) 
Female -.196 .077 -.346 -2.548 .013 
Education .081 
Graduate degree (ref) 
Undergraduate degree -.162 .071 -.285 -2.275 .026 
High school degree -.113 .082 -.175 -1.386 .170 
Model2 .325 .283 7.801 .000 
Intercept .137 .405 .337 .737 
CRF (mL/kg·min) -.010 .005 -.316 -1.854 .067 
BMI (kg/m2) .017 .006 .361 2.952 .004 
Sex 
Male (ref) 
Female -.069 .085 -.122 -.810 .421 
Education .160 
Graduate degree (ref) 
Undergraduate degree -.129 .069 -.226 -1.868 .065 
High school degree -.123 .078 -.189 -1.571 .120 
Model3 .315 .273 7.459 .000 
Intercept .022 .465 .047 .963 
CRF (mL/kg·min) -.011 .005 -.341 -1.995 .049 
we (em) .007 .002 .334 2.727 .008 
Sex 
Male (ref) 
Female -.063 .088 -.112 -.715 .477 
Education .160 
Graduate degree (ref) 
Undergraduate degree -.131 .069 -.231 -1.889 .062 
High school degree -.120 .079 -.184 -1.517 .133 
Abbreviations: CRF, cardiorespiratory fitness; BMI, body mass index; WC, waist circumference; 
IL-6, inter1eukin-6; adj, adjusted; B, unstandardized coefficients; SE, standard error;~' 
standardized coefficients; ref, reference. 
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Model I: Multiple linear regression predicting eRF from log101L-6 after adjustment for sex and 
education 
Model 2: Multiple linear regression predicting eRF from log101L-6 after adjustment for BMI, sex 
and education 
Model 3: Multiple linear regression predicting eRF from log10IL-6 after adjustment for we, sex 
and education 
Note: IL-6 (pglmL) was transformed into logtoiL-6 (pglmL); eRF, BMI, and we, continuous 
variables 
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Table 5 
Analysis of covariance for log10hs-CRP as an interaction ofCRF and BMI (N = 88) 
Predictor variables adjK p B SE df F p Partial 
B eta2 
Model 1 .255 .229 .000 3 9.607 .000 .255 
Intercept -.235 .506 1 3.630 .060 .041 
CRF(mL/kg·min) -.002 .010 1 5.802 .018 .065 
BMI( <25kg/m2) (ret) 
BMI(~25kg/m2) 1.664 .626 7.061 .009 .078 
CRF(mL/kg· min )x BMI(~25kglm2) -.028 .013 4.553 .036 .051 
Model2 .385 .348 .000 5 10.280 .000 .385 
Intercept .753 .666 I 9.257 .003 .101 
CRF(mL/kg·min) 
BMI(<25kg/m2) (ret) 
-.020 .013 1 9.802 .002 .107 
BMI(~25kg/m2) 1.172 .594 I 3.894 .052 .045 
CRF(mL/kg· min)x BMI(~25kg/m2) -.019 .012 1 2.379 .127 .028 
Sex x OC 2 8.662 .000 .174 
Male (ret) 
Female (non-OC) -.400 .172 
Female (OC) .293 .184 
Abbreviations: CRF, cardiorespiratory fitness; BMI, body mass index; hs-CRP; high sensitive C-
reactive protein; oral contraceptives, OC; adj, adjusted; B, unstandardized coefficients; SE, 
standard error; OC, oral contraceptive; ref, reference. 
Modell: ANCOV A testing an interaction of CRF and BMI with log10hs-CRP without adjustment 
for sex x OC 
Model 2: ANCOV A testing an interaction of CRF and BMI with log10hs-CRP after adjustment 
for sex x OC. 
Note: hs-CRP was transformed into log10hs-CRP (mg/L); CRF, continuous variable; BMI was 
divided into two categories (normal weight <25; overweight and obese~ 25). 
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Figure 2. Modell: ANCOV A testing an interaction of CRF and BMI with log10hs-CRP 
without adjustment for confounders 
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Table 6 
Analysis of covariance for log whs-CRP as an interaction of CRF and WC (N = 88) 
Predictor variables adjk p B SEB df F p Partial 
eta2 
Modell .338 .3I4 .000 3 14.283 .000 .338 
Intercept .I 53 .440 I 6.212 .015 .069 
eRF(mL/kg·min) -.OI2 .009 1 8.745 .004 .094 
we (<86.4cm) (ret) 
we (~86.4cm) l.I 09 .568 I 3.82I .054 .044 
eRF(mL/kg·min)xWe(~86.4cm) -.OI2 .OI2 1 1.059 .306 .012 
Model2 .446 .412 .000 5 13.207 .000 .446 
Intercept .753 .631 1 7.490 .008 .084 
eRF(mL/kg·min) -.023 .OI2 I 7.456 .008 .083 
we (<86.4cm) (ret) 
we(~86.4cm) .626 .552 I 1.287 .260 .OI5 
eRF(mL/kg·min)xWe(~86.4cm) -.003 .OI2 I .079 .779 .001 
Sex x oe 2 8.0I5 .001 .164 
Male (ret) 
Female (non-Oe) -.244 .173 
Female (Oe) .406 .178 
Abbreviations: eRF, cardiorespiratory fitness; we, waist circumference; hs-eRP, high sensitive 
e-reactive protein; adj, adjusted; B, unstandardized coefficients; SE, standard error; oe, oral 
contraceptive; ref, reference. 
Modell: ANeOV A testing an interaction of eRF and we with log10hs-eRP without adjustment 
for sex x oe 
Model 2: ANeOV A testing an interaction of eRF and We with log10hs-eRP after adjustment for 
sex x oe. 
Note: hs-eRP (mg/L) was transformed into logwhs-eRP (mg!L); eRF, continuous variable; We 
was divided into two categories based on the 50th percentile (median value= 86.4 em). 
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Table 7 
Analysis of covariance for log10 IL-6 as an interaction ofCRF and BMI (N = 87) 
Predictor variables adjK p B SEB df F p Partial 
eta2 
Model 1 .218 .190 .000 3 7.705 .000 .218 
Intercept .080 .250 1 6.533 .012 .073 
CRF(mL/kg·min) -.004 .005 I 7.569 .007 .084 
BMI( <25kg/m2) (ret) 
BM1(~25kg/m2) .626 .307 4.154 .045 .048 
CRF(mL/kg·min)xBMI(~25kg/m2) -.011 .007 2.791 .099 .033 
Model2 .293 .240 .000 6 5.528 .000 .293 
Intercept .637 .338 I 10.644 .002 .117 
CRF(mL/kg·min) 
BMI( <25kg/m2) (ret) 
-.011 .006 I 10.731 .002 .118 
BMI(~25kg/m2) .501 .305 2.698 .104 .033 
CRF(mL/kg·min)xBMI(~25kg/m2) -.009 .006 1.820 .181 .022 
Sex 
Male .143 .080 3.195 .078 .038 
Female (ref) 
Education 2.696 .074 .063 
Graduate degree (ref) 
Undergraduate degree -.163 .081 
High school degree -.127 .070 
Abbreviations: CRF, cardiorespiratory fitness; BMI, body mass index; IL-6, interleukin-6; adj, 
adjusted; B, unstandardized coefficients; SE, standard error; ref, reference. 
Modell: ANCOV A testing an interaction of CRF and BMI with log10IL-6 without adjustment for 
sex and education 
Model 2: ANCOV A testing an interaction of CRF and BMI with log10IL-6 after adjustment for 
sex and education. 
Note: IL-6 (pg/mL) was transformed into log10IL-6 (~g/mL); CRF, continuous variable; BMI was 
divided into two categories (normal weight <25kg/m ; overweight and obese~ 25kg/m2). 
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Table 8 
Analysis of covariance for logw /L-6 as an interaction ofCRF and WC (N = 87) 
Predictor variables adjK p B SEB df F p Partial 
eta2 
Modell .255 .228 .000 3 9.456 .000 .255 
Intercept -.017 .224 I 8.596 .004 .094 
eRF(mL/kg·min) -.001 .005 1 9.823 .002 .106 
we ( <86.4cm) (ref) 
we (~86.4cm) .876 .287 9.306 .003 .101 
eRF(mL/kg·min)xWe(~86.4cm) -.016 .006 7.254 .009 .080 
Model2 .310 .258 .000 6 5.991 .000 .310 
Intercept .511 .332 I 10.763 .002 .119 
eRF( mL/kg·min) -.009 .006 1 10.918 .001 .120 
we (<86.4cm) (ref) 
We(2:86.4cm) .705 .292 5.818 .018 .068 
eRF(mL/kg·min)xWe(2:86.4cm) -.013 .006 4.730 .033 .056 
Sex 
Male .128 .083 2.386 .126 .029 
Female (ref) 
Education 2.039 .137 .048 
Graduate degree (ref) 
Undergraduate degree -.141 .070 
High school degree -.116 .080 
Abbreviations: eRF, cardiorespiratory fitness; we, waist circumference; IL-6, interleukin-6; adj, 
adjusted; B, unstandardized coefficients; SE, standard error; ref, reference. 
Modell: ANeOV A testing an interaction of eRF and we with log10IL-6 without adjustment for 
sex and education 
Model 2: ANeOV A testing an interaction of CRF and we with log10IL-6 after adjustment for sex 
and education. 
Note: IL-6 (pg/mL) was transformed into logtoiL-6 (pg/mL); CRF, continuous variable; WC was 
divided into two categories based on the 50th percentile (median value= 86.4cm). 
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Figure 3. Model 1: ANCOV A testing an interaction of cardiorespiratory fitness and WC 
with log1olL-6 
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ATTENTION!! 
Individuals between the ages of 20 and 34 are needed to 
participate in a new research study!! 
We are seeking individuals without heart disease, respiratory 
conditions and chronic disease for a study of young adults. 
During one visit to the research center participants in this study will: 
• Treadmill walk test to monitor heart rate 
• Have a blood test 
• Answer some basic questions about yourself. 
• Be compensated for your participation in this study. 
If you are inreresred or have fmtber questions please call 
716-909-4121 or email: Eunduck.Park@uth.tmc.edu 
Eunduck Park, MSN, ANP, RN 
University of Texas Health Science Center, School of Nursing 
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ATTENTION!! 
Individuals between the ages of 20 and 34 are needed to 
participate in a new research study!! 
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We are seeking young males and females 
who are in the green color (Body Mass 
Index (BMI) > 25) without smoking, heart 
disease, respiratory conditions and other 
chronic diseases. 
During one visit to the research center. 
participants in this study will : 
• Have treadmill walk test. 
• Have a blood test. 
• Answer some basic questions about yourself. 
, Pound• • Be compensated for your participation. 
If you are interested or ha,·e further questions please call e mail: 
Eunduck.Park@uth.tmc.edu or call 716-909-4121 =m= UTHealth I 
Eunduck Park, MSN, RN, ANP, The University of Texas School of 
Nursing 
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Participants' Initial Eligibility Checklist 
Identification 
1. futerviewers name 2. Date (lllllllddlyy) 
3. Participant Initials: 
-- --
First Last 
Inclusion Criteria 
(A check ··No" in any of following questions (Q4-Q8) indicates that the potential pa11icipant is 
not eligible for the study) 
If tile participa11t "Do11 't k11ow", clleck "F" 0111VO. 
Yes No 
4. ·y·otmg adults aged 20-34 
5. Is capable of canliorespiratory fitness test (Treadmill walk test)? 
6. Is able to speak. read. comprehend and respond in English? 
For JVotllell OIIIJ' 
7. !\1enstrual cycle length of 24-35 days dtumg the last 2 months 
8. Are you having yotu· period now? 
(If a participant is on a period now. she \Vill be scheduled a day when 
she is not on her tuenstruating period). 
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Exclusion Criteria 
(A check .. yes" in any of flowing questions (Q9-Q27) indicates that the potential participant is 
not eligible for the sntdy) 
If tile participant "Doll 't k11ow", clleck "F" 011 JVO. 
Yes No 
9. Acute sn1oking. current smokers or smoking cessation less than 1 year 
10. Alcohol dependence or regular alcohol consumption> 7 servings 
per week 
11. Acute infection. a cmTent or recent influenza illness or a 
recent flu shot recipient. acute respiratory infection within 2weeks 
12. Dental infection or problem within 2 weeks 
13. Chronic diseases: cardiovascular diseases: hypertension. lipidenua. 
and type 2 diabetes 
14. hnmtme disorders: rheumatoid arthritis 
15. History of osteoporotic injury and limitations due to the 
musculoskeletal demands of cardiorespiratory fitness test. or other bone 
diseases 
16. History of osteoporosis 
17. Recent surgery within 1 month 
18. C'tm·ently taking medications: hormone replacement therapy. anti-
hype11ensive medications. anti-platelet or coagulation medications. 
allergy shots or systenlic corticosteroids. or selective serotonin uptake 
inllibitors 
19 .. Anti-inflammatory medications: statin. aspirin or had taken these 
medications in the past 48 hours 
20. Other medical conditions or medications that would prohibit 
participation in exercise and blood sampling 
(If yes. please list below) 
166 
For wome11 Ollly, Yes No 
21. ~Ienopausal status 
22. Use ofh01mone replace therapy 
23. Is ClUTently pregnant 
2-t. Lactating female 
25. History of gynecologic problems. such as endometriosis or 
polycystic ovary syndrome 
26. Hormonal contraception use except oral contraception: patch. depo-
pro vera 
27. Intra Uterine Devices with hormones and Depo-Provera within past 
12 months 
Participant's Eligibility: Yes _____ _ ~o _______ __ 
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1 b.1\ed on :r 1J oc> ~dnull w:1 lk toe' 1) J\ a~\OCJal t>d wJt h 11111:mun:ltoJ y ma1 ker' Ill \'l)\11 boch·. 
':).-..:,•ndh . h ,•ll bc•d l Wl:'l\!ht h ,.,,u..:wk d w11h HrJ1anUJt<lllll ~ ll liU I.. I:'J ~ 111 ~ ~11 11 UL•dv. La~tly. how 
\~11 11 Ji tu l:' ~" .tmi ii'I:'IJ,tl ll all:' .. , Ol' l:ttl:'d With lllllduuuak•J~ utad,.,-, , 111 ~ 01 11 Vt•Ll~ . 
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Scientists h:we debated whether fi tness is more associated with intlallllllarory markers 0 1 it 
body wei!ilit is more associated with iuflaunnatory markers in your body. Hi!ili lew is or 
inflnnuuation bnve been shown to be rclnted to bean disease. ll1e findings of this smdy may 
hdp to improve health care nud to design programs to maintain nud improve the health of 
y01mg adults. However. the tests ped ormed m this study nrc not dtnguostic nud will not predict 
1f you Will get heart disease 
TI1ic. IS a loca l c,htcly tha t will em oil a total o f liS subject~ in l k •ILC.Inn. 
PROCEDllU:: 
Jfy,m ag1ee ami ;-u e ahle to take pml in t h i~ s tudy. yon wi ll uudel gn the foll,1wiug pwcedule, 
aite1 sigui11g thi~ iufunued l'UU~ell t · 
• Yon will be asked to fill out a pre-assessment health questionnaire to !demit)· 1f it is 
sate for yon to take the fitness test. If tt is not safe to test your fi tness. you will be 
excluded from this sntdy. The demoll:r.lphic questiom1nire mcludes age. gender. 
etlmicity. m.mia l stai11S. and educntion. You will also be inten·iewed abom your health 
conditions. 
• lf you are eligible to prut icipate m tlus st11dy. you Wi ll be scheduled for blood testing. 
body measuremen ts. such as height 11nd weight. m1d physic il l fitness test. Tills test mll 
he perfonnecl one d11y at the rm JSC -IT. School of~nr-;;ing anclraken ahont 3 hPnr~ 
• fl1l yuu1 ~dt~uled test day, you are asked uot 10 eat aftet S pw tl!e uightbefme the te~ t. 
_-\dditiuually. you are asked not to do streuuons exeu:ise m J.lh~ ~ical acti' 11~. iliiill. 
alcohol. or use anti-iu1lallllll:-ti01Y dmgs 2-l hom s prior to the blood draw. You are 
asl.:.ed to aniw at the laboratory at the School of1\m~iu~ l>etwee11 Saw aud !Oaut io1 
l>lood test We \\ill draw 10 ll1l (al>out 2 teas)Xlou~) ofuhx.1d for iuflaunnatio11 1e tiug . 
For the iimess test, you are asked to wear comfortable ~xercise-type clothing. 11nd a\·oid 
tobacco and caffeine 3 hours prior to test. Yon are also asked to haw an adequate 
amomu s leep the night before the tesl. 
• "\ ft~r blood test. study professiOnal staff will measure your height. weight and wmst 
eircumfercuce. Th.?Sc rncnsm cs nrc to nssess your body s ize. You Wi ll be asked to 
tcmo\·e at~y outer clothlllg. such as a sweater. :15 well 35 hat and shoes. 
• After the'ie mea~urement~. ynn will be gi-·en 11 lighr !Tee lunch with juice 01 wnter 
• After bilviug 11 light lunch and brief r~stmg period. the im·estigator will test your fimess. 
T his test assesses how your body handles physical activity. Tllis rest will rake 20-30 
minmes of walking on rhe n·eadmjl! with w:mn-up and cool down stages. You will be 
asked to w~ar a bean ra te mo1litor around your chest. Smdy staff will guide you dming 
the test. 
IRB NUMBER: HSC- SN - 12 - 0323 
t:Tf ft·.tilh IRB APPROVAL DI.TE: 10/ 31/2012 
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AppendixD 
Pre-Assessment Health Questionnaire 
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Pre-assessment Health Questionnaire 
Pre-assessment Health Questionnaire consists of two sec tions: section l. demographic 
infomwtion and section 2. pre-assessment questi01maires. Section 1 demographic iufonuation 
includes infonnation on age. gender. etlmicity. marital status. and education. Section 2 pre-
assessment health questiOJmaire will be used to determine the i.ndiYidnar s risk related to 
cardiorespiratory fitness participation. The questi01maire is designed to identify whether the 
pa11icipants are appropriate and safe to test for cardiorespiratory fitness. 
The objectiws of the pre-assessment health questionuaire are: 
• To identify those with a medica l contraindication. 
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• To identify those with other health risk!meclical concems that may influence the decision 
about petfomung a cardiorespiratory fitness test (sub-maximal treadnull test). 
Pre-Health Assessment Questionnaire 
futerviewer's name: 
Study tmit identifier: 
Date of futerview: l_l __ l / ~__l __ l / 
Question 
# 
(rvionth) (Date) 
Section 1: Demographic Information (Q1-Q6) 
1 Respondent· s gender: 
Item 
__ ~L.U.E [ 1 ] __ FEl\,IALE [ 2 ] 
2 ··How old did you ttlfll on your last birthday?" 
._I __ .I___ I years old 
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(Year) 
3 ""\Vhat is your etlmicity?'' 
___ Caucasian [ 01 ] 
___ Afiican American [ 02 ] 
__ Hispanic [ 03 ] 
___ Native American [ 04 ] 
__ Asian [ 05 ] 
___ Pacific Islander [ 06 ] 
__ ~Iixed Race [ 07 ] 
__ DON'T KNO\V [ 97 ] 
-t .. \Vhat is your martial stants?" 
___ ~Jarried or living with partner [ 01 ] 
__ Single [ 02 ] 
___ Divorced or \Vidowed [ 03 ] 
__ Refitsed [ 97 ] 
5 ""\Vhat is yotu· education level?" 
___ Post doctoral--~Skip question #6 [ 01] 
__ ..... PhD -~Continue with question #6 [ 02] 
__ ..... ~~laster's degree -•Continue with question #6 [ 03] 
___ Bachelor's degree-. Continue with question #6 [ 04] 
___ High school's degree - ~skip question #6 [ 05 ] 
__ ..... :tvfiddle school's degree -~Skip question #6 [ 06 ] 
___ .Don't know ~skip question #6 [ 07 ] 
6 .. If you are sntdent. what year are you in?" 
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Section 2: Pre-Assessment Questionnaires 
Reference: American College of Spot1s Medicine (b). ACS!vl's health-related physical fitness 
assessment manual. 3rd ed. Philadelphia (PA): Lippincott. Williams & \Vilkins: 2010 (p.20-21 
Please provide responses (YES or NO) co the followin~ concern in~ family history, your own history, and any 
symptoms you have had: 
FAMILY HISTORY PERSONAL HISTORY SYMPTOMS 
H<~vP ;~ny•mmPc1:1tP ~mllymPmhPrc; Have you ever had: Have you e\'er had: 
had a: YES NO YES NO 
YES NO High blood pressure 0 0 Chest pain 0 0 
~eart attack 0 c High chole~terol 0 0 Shortness ofbrea:h 0 0 
~cart surgery 0 u 
coronary ste:-lt 0 c 
cardiac catheterization 0 0 
DiabrtP<;. 0 0 Heart palpitaticns 0 0 
Any heart problems ;::) 0 Skipped heartbears 0 0 
Oisea:oe of a.ncries 0 0 Heart murmur 0 0 
congPnir;~l hP:t'"t dPft>Cr 0 0 
srroke 0 0 
I hyroid disease 0 0 lmermittent leg pam 0 0 
lung disease 0 0 Dizziness or fainting 0 0 
Odler chronic Ciseasc: Asthma 0 0 Fatigt;e - usual activities 0 0 
Ce1ncc:r 0 0 ~n01·ins 0 
Kidrey disease 0 0 Bac~ pain 0 0 
Hepatitis 0 0 Orthofcdic problems 0 0 
Other:---~---- --~~ Orher: 
STAFF COMMENTS: ____________________________________________________ _ 
Have you ever had your cholesterol measured? Yes 0 No U If yes, value __ Where: ____ _ 
1\re you raking any prescription (include birth control pills) or nonprescription medications? Yes 0 No 0 
For each of your current medications, provide the following information: 
MEDICATION Dosage-times/day Time taken Years on medication Reason for taking 
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HOSPITALIZATIONS: Plt"ase li~r recent hospitalizations (Women: do not list normal pregnancies) 
Location Reason 
Any orh~r medrcal prohlems/concerns not already identifrcd? Yes D No 0 If so, please list: ____ _ 
LIFESTYLE HABITS 
Do you e\'er have an uncomfortable: shortness of breath during exercise or when doing activities? 
YesD NoD 
Do you ~·cr have chest drscomfort during e><ercise? Yes IJ No U 
If so, does it go away with rest? Yes D No 0 
-------------- ~~------~ 
Do you currently smoke? Yes 0 No 0 If so, what? Cigarettes 0 Crgars 0 Pipe 0 
How long have you smoked? years 
How much per day: < 'h pack C fi to 1 pack 0 1 to 1 Y.! packs 0 1 h to 2 packs 0 > 2 packs 0 
Have you ever quit smoking? Yes 0 No 0 \\/hen? -----
How many years and how much did you smoke? --------
Do you drink an)' alcoholic beverages? Yes :J No 0 If yes, how much in 1 week? (indicate below) 
Beer __ (cans) \Vine __ (glasses) Hard liquor __ (drinks) 
Do you dnnk an)' caffeinated beverages? Yes 0 No 0 If yes, how much in 1 wt:ek? (indicale below) 
Coffee __ (cups) Tea __ (glasses) Soft drinks __ (cans} 
Are you currently following a weight reduction diet plan? Yes 0 No 0 
If so, how long have you been dieting? __ months 
Is the plan prescribed by your doctor? Yes 0 No 0 
Have you used weight reduction diets in the past? Yes 0 No 0 If yes, how often and what type? __ 
~E.VALUllli<JJ'I{ 
What is your occupational activity level? Sedentary r: Lighr r J Moderate 0 Heavy 0 
Do you., currently engage in vigorous physical activity on a regular basis? Yes 0 No 0 
If so, what type(s)? How many days per week?-------
How much time per day? <15 min 0 15-30 min 0 31-60 min 0 >60 min 0 
How long have you engaged in this type of activit~·? <3 rnonths 0 3-12 months 0 > 1 year 0 
Do )'OU engage in any recreational or leisure-time physical activities on a regular basis? YcsO NoD 
If so, what activities? -------------
On average: How often? ___ timesjwcck; for how long?------ rime/session 
How long have you engaged in this type of activity? < 3 months 3- i 2 months > 1 year 
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AppendixE 
Flow Chart for Sampling and Data Collection 
Screening cubjccts:' 
eligibilit y using o telephone: 
Interview a nd email 
YU 
r_ 
Expl,.ln tho d etailed study 
purposes, proced u ru, benefitc, 
risks, and d iscomforts, "nd 
confidentiality ot the School of 
Nursing, UTHSC-H 
Yes 
Obtain Informed 
a m sen ts 
Pro-asso.ssmant c.c:rccning for 
CR fitnaos and blood s ample 
test (health history and 
dc:mogrophlc information) 
Yes 
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No 
No 
No 
Give instructions of blood 
test, CR fitness test, 
adiposity and schedule a 
date 
Blood test at UT SON 
Bioscience Lab 
Lunch and Break 
Adipostiy /CR fitness at 
UT SON center for 
Nursing Research 
Collected data 
Data entry, 
validation, editing 
Analyze Data 
Data save 
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AppendixF 
Time Frame for Project 2012-2013 
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Tim~ Fram~ for Proj~<'t 2012-2013 
Jun Aug Sep Oct No\· Dec Jan Feb Mar Apr May Jun July Aug 
2012 2013 
Human subJects X 
approval 
Setting study room X X X X 
and equipment 
Recruit X X X X X X X X X X 
participants 
Data X X X X X X X X X X 
Collection 
Data Entry X X X X X X 
Analyze data X X 
AppendixG 
Notification Approval 
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UTH~ili Committee tor th• Prot•cuon of Human SubJects 
The University of Texas 
Health Science Center at Houston 
NOTICE OF APPROVAL TO IMPLEMENT REQUESTED CHANGES 
May 28, 2013 
HSC-SN-12-0323- Association of Cardiorespiratory Fitness and Adiposity with Inflammatory 
Biomarkers in Healthy Young Adults 
PI: Eun Duck Park 
Reference Number: 096182 
'It 
--, , 
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PROVISIONS; Unless otherwise noted, this approval relates to the research to be conducted under 
the above referenced title and/or to any associated materials considered at this meeting, e.g. study 
documents, informed consent, etc. 
APPROVED: By Expedited Review and Approval 
CHANGE APPROVED: Posting CPHS approved flyers at Harris County Community College and 
University of Houston 
REVIEW DATE: 
APPROVAL DATE: 
CHAIRPERSON: 
May 27, 2013 
May 28,2013 
John C. Ribble, MD 
Upon receipt of this letter, and subject to any provisions noted above, you may now implement the 
changes approved. 
CHANGES: The principal investigator (PI) must receive approval from the CPHS before initiating 
any changes, including those required by the sponsor, which would affect human subjects, e.g. 
changes in methods or procedures, numbers or kinds of human subjects, or revisions to the 
informed consent document or procedures. The addition of co-investigators must also receive 
approval from the CPHS. ALL PROTOCOL REVISIONS MUST BE SUBMITTED TO THE 
SPONSOR OF THE RESEARCH. 
INFORMED CONSENT: Informed consent must be obtained by the PI or designee(s), using the 
format and procedures approved by the CPHS. The PI is responsible to instruct the designee in the 
methods approved by the CPHS for the consent process. The individual obtaining informed consent 
must also sign the consent document. Please note that if revisions to the informed consent 
form were made and approved. then o ld blank copies of the ICF MUST be destroyed. Only 
copies of the appropriately dated. stamped approved informed consent form can be used 
when obtaining consent. 
UNANTICIPATED RISK OR HARM, OR ADVERSE DRUG REACTIONS: The PI will immediately 
inform the CPHS of any unanticipated problems involving risks to subjects or others, of any serious 
harm to subjects, and of any adverse drug reactions. 
RECORDS: The PI will maintain adequate records, including signed consent documents if required, 
in a manner that ensures subject confidentiality. 
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..!IL 
UTH~th Comm1tteo tor tho Ptoteetton of Human Suhjoct.s 
The Universi ty o f Texes "II ' r' II' 
Health Scien ce Center at Houat on 
"' 
NOTICE OF APPROVAL TO IMPLEMENT REQUESTED CHANGES 
October 31 , 2012 
HSC-SN-12-0323 - Association of Cardiorespiratory Fitness and Adiposity with 
Inflammatory Biomarkers in Healthy Young Adults 
PI : Dr. Eunduck Park 
Reference Number: 088871 
PROVISIONS: Unless otherwise noted, this approval relates to the research to be 
conducted under the above referenced title and/or to any associated materials 
considered at this meeting, e.g. study documents, informed consent, etc. 
APPROVED: By Expedited Review and Approval 
CHANGE APPROVED: Revised Protocol Version 1.4. (dated 9/29/2012) 
And Consent Document Version 1.1 (dated 10/31 /2012) 
REVIEW DATE: October 30, 2012 
APPROVAL DATE: October 31 , 2012 
CHAIRPERSON: Richard Kirkeeide, PhD 
Upon receipt of this letter, and subject to any provisions noted above, you may now 
implement the changes approved. 
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CHANGES: The principal investigator (PI) must receive approval from the CPHS before 
initiating any changes, including those requ ired by the sponsor, which would affect 
human subjects, e.g. changes in methods or procedures, numbers or kinds of human 
subjects, or revisions to the informed consent document or procedures. The addition of 
co-investigators must also receive approval from the CPHS. ALL PROTOCOL 
REVISIONS MUST BE SUBMITIED TO THE SPONSOR OF THE RESEARCH. 
INFORMED CONSENT: Informed consent must be obtained by the PI or designee(s), 
using the format and procedures approved by the CPHS. The PI is responsible to 
instruct the designee in the methods approved by the CPHS for the consent process. 
The individual obtaining informed consent must also sign the consent document. Please 
note that if revisions to the informed consent form were made and approved, then 
old blank copies of the ICF MUST be destroyed. Only copies of the appropriately 
dated. stamped approved informed consent form can be used when obtaining 
consent. 
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UNANTICIPATED RISK OR HARM, OR ADVERSE DRUG REACTIONS: The PI will 
immediately inform the CPHS of any unanticipated problems involving risks to subjects 
or others, of any serious harm to subjects, and of any adverse drug reactions. 
RECORDS: The PI will maintain adequate records, including signed consent 
documents if required, in a manner that ensures subject confidentiality. 
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The State University ofNew York 
at Buffalo 
The State University ofNew York 
at Buffalo 
Suwon Women's College 
Suwon, South Korea 
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